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Abstract 
In the 21st Century molecular hydrogen (H2) has become an essential industrial commodity. It 
is widely heralded as an exciting alternative to petroleum-based transportation fuels and also 
plays indispensable roles in many other important industrial processes, including 
hydrogenation of fats and oils, methanol production, and ammonia production – an essential 
component of agricultural fertilizers. 
Biohydrogen (Bio-H2) is molecular hydrogen produced by microorganisms and is an exciting 
prospect as a fully renewable, commercially-viable second-generation biofuel. Bio-H2 can be 
produced at ambient temperatures by metal-dependent hydrogenase enzymes, with 
potentially no CO or H2S contamination, and is a carbon neutral/positive process. 
Escherichia coli naturally produces Bio-H2 during mixed-acid fermentation via its own 
endogenous nickel-dependent hydrogenase enzymes. The main aim of this project is to 
enhance Bio-H2 production by E. coli, and to achieve this goal a number of alternative synthetic 
biology approaches were investigated. A synthetic [FeFe]-hydrogenase based on a 
thermostable NADH-dependent hydrogenase was designed, constructed and expressed in E. 
coli. The structure and activity of the synthetic hydrogenase has been characterised in vitro 
using a number of techniques including autoradiography, spectroscopy, SEC-MALLS, protein-
film voltammetry and H2 production assays. Metabolic engineering of various E. coli strains and 
directed protein evolution has been carried out to integrate this synthetic hydrogenase activity 
into cellular metabolism and the resulting strains were characterised using metabolomics and 
standard microbiological approaches. 
Another approach used in this project involved the construction and expression of active H2-
producing synthetic chimeric metalloenzymes, which combined the catalytic activity of two 
different enzymes: thiosulfate reductase from Salmonella; and E. coli Hyd-2. The activity of this 
synthetic fusion enzyme could be improved by increasing/maintaining the proton motive force 
across the cytoplasmic membrane, through the heterologous expression of a proton-pumping 
proteorhodopsin. Finally the bidirectionality of E. coli Hyd-2, i.e. H2 oxidation and H2 
production, was demonstrated, suggesting that it may operate as a quinol release valve in vivo.  
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 Energy supply and demand in the 21st Century 1.1
Climate Change is an unequivocal, urgent global issue. Global mean atmospheric temperature 
is rising and this has many effects around the world. Sea levels have already risen by 15-20 cm 
on average over the last century (Meyssignac and Cazenave, 2012), glaciers are retreating and 
extreme fluctuations in temperature and rainfall are increasing (Solomon and (eds.), 2007). 
Human health has already been hugely affected as a direct result of these physical symptoms 
of an ailing planet (Campbell-Lendrum and Woodruff, 2007). This has now been conclusively 
attributed to anthropogenic greenhouse gas (GHG) emissions (Solomon and (eds.), 2007). 
The world population is conservatively projected to reach 9.6 billion people by 2050 (UN 
Department of Economic and Social Affairs, 2013), creating a massive corresponding increase 
in world energy consumption demand. We have already seen a doubling of the average annual 
world energy consumption from 1980 to 2005 and this increase in demand shows no sign of 
stopping. World energy consumption demands are projected to increase by over a third by 
2035, mostly driven by emerging economies such as India and China (60% rise in demand by 
2035) (IEA, 2012). 
The energy sector is responsible for over two thirds of global GHG emissions, due to its 
continuing dependence on fossil fuels (IEA, 2013). It is therefore clear that our heavy reliance 
on fossil fuels as energy sources must be reduced and alternative carbon-neutral energy 
sources must be developed. 
There are worrying signs, however, amid current global economic uncertainties that climate 
change is not as high a political priority. It will be interesting to monitor developments in 
Ireland over the next 20 years, which has implemented many progressive green policies in the 
past two decades. Now, however, the discovery of Ireland's first commercially viable oil field, 
Barryroe off the west coast of Ireland (1.7 billion barrels, of which at least 270 million can be 
recovered), is viewed as the possible saviour of Ireland’s bankrupt economy, and measures are 
underway to rapidly exploit this not-so-white knight. 
Evidence of this abandonment of many admirable global policies to tackle climate change 
came from the recent International Energy Authority’s special report on climate and energy 
where they concluded that the agreed global target to limit the anthropogenic rise in 
temperature to 2 °C, will not be met based on current proposals (3.6 °C – 5.3 °C more likely) 
and intensive action is required before 2020 (IEA, 2013). 
With the rejection of nuclear power in many countries around the world, the options  available 
to supply sustainable, carbon-neutral (or even carbon negative) energy sources include various 
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renewable energy sources such as wind, tidal, solar and hydroelectric, as well as biofuel energy 
sources such as biodiesel, biobutanol, biohydrogen, biomethane and bioethanol. In order to 
achieve this necessary development of greener energy sources, subsidies for fossil fuels 
however must be reduced ($523 billion in 2011, six times the amount of renewables subsidies: 
$88 billion) and carbon prices increased (fallen from €20/tonne in 2008 to €3.5/tonne in 2013), 
otherwise the incentive to develop sustainable energy sources will not exist (IEA, 2013).  
First-generation biofuels used food crops as substrates for biofuel production (e.g. biodiesel or 
bioethanol). This is extremely controversial as it firstly drives up the price of foods such as 
wheat and sugar, but it also means that more land is needed to grow crops and therefore 
many first-generation biofuels actually lead to a net increase in GHG emissions and cannot be 
regarded as sustainable (Searchinger, et al., 2008; Danielsen, et al., 2009). Second-generation 
biofuels were developed to avoid this “food versus fuel” conundrum, as they do not use food 
crops as their main substrate. The ideal second-generation biofuels are those that use a variety 
of waste products as the substrate for biofuel production. Fourth-generation biofuels are now 
in development, which essentially integrate carbon capture and sequestration steps into the 
biofuel production process. 
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 H2 as an industrial commodity 1.2
Molecular hydrogen (H2) in the 21st Century has become an essential industrial commodity. It 
plays indispensable roles in many important industrial processes (Figure 1.1), including the 
hydrogenation of fats and oils, methanol production, and ammonia production – an essential 
component of agricultural fertilizers. As legal requirements for cleaner automotive fuels rightly 
continue to get stricter around the world, H2 is also used in refineries to remove dangerous 
pollutants, such as organic sulfur from crude oil, through a process called hydrodesulfurisation, 
as well as in the conversion of heavy crude oil to lighter fuels. 
Moreover, due to its high energy density by weight, H2 is widely heralded as an exciting 
alternative to petroleum-based transportation fuels, as it can be used directly in Proton 
Exchange Membrane (P.E.M.) fuel cells to generate electricity, with water vapour as its only 
emission, thus reducing greenhouse gas emissions from transportation. 
The majority of H2 is currently produced through steam-methane reformation (SMR), which 
requires a large energy input and produces large amounts of greenhouse gas emissions 
(Environmental Protection Agency, 2008) (Figure 1.1). Worldwide ammonia production in 2009 
for example, required the production of 23 million metric tons of H2, resulting in 198 million 
metric tons of CO2 emissions, or 0.7% of global CO2 emissions (Environmental Protection 
Agency, 2008; Geological Survey, 2011). The current unsustainable methods of H2 production, 
in combination with issues such as hydrogen purification and storage as well as the high cost of 
fuel-cell technology mean that a number of significant economic and environmental hurdles 
must be surmounted before a fully-fledged “hydrogen economy” becomes a reality (Turner, 
2004). 
 
  
Figure 1.1 Worldwide H2 demand and production methods, 2008. The majority of H2 is used by the fertiliser 
industry to produce ammonia. The main method of H2 production is steam-methane reformation (SMR) and 
other fossil-fuel production methods. (Environmental Protection Agency, 2008) 
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 Biohydrogen 1.3
Biohydrogen (Bio-H2), hydrogen produced biologically from sustainable sources, is an exciting 
candidate for use as a commercially-viable second-generation biofuel. Bio-H2 can be produced 
at ambient temperatures, often with no CO or H2S contamination, and is a carbon neutral 
process. Bio-H2 truly is sustainable and reduces GHG emissions by 57-73% and non-renewable 
energy use by 65-79% when compared to SMR (Manish and Banerjee, 2008). Bio-H2 can be 
considered carbon neutral as although CO2 is often released during biohydrogen production 
from biomass, this biomass has always been recently cultivated using CO2 fixed from the 
atmosphere. This is in stark contrast to the combustion of fossil fuels, where the carbon has 
been sequestered and locked down over millions of years only to be rapidly released as CO2 
over tens of years. The fact that the CO2 release occurs during Bio-H2 production, and not at 
the combustion stage of the carbon cycle, means that immediate carbon capture and 
sequestration could be integrated into production to make Bio-H2 a carbon-negative process 
(Hallenbeck and Ghosh, 2012). 
Many microorganisms naturally produce H2. In the absence of O2, they reduce protons to 
dispose of excess reducing equivalents and reoxidise their coenzymes. Photosynthetic 
microorganisms such as microalgae, cyanobacteria and purple non-sulphur bacteria (PNSB), 
use sunlight to produce H2 through either “direct” or “indirect” photolysis and also in an 
oxygenic/non-oxygenic manner. Microalgae such as Chlamydomonas reinhardtii (Melis, et al., 
2000), and cyanobacteria such as Synechococcus sp. (Howarth and Codd, 1985), Synechocystis 
sp. strain PCC 6803 (Howarth and Codd, 1985) and Anabaena variabilis (Happe, et al., 2000) 
can produce H2 during oxygenic photosynthesis. Direct photolysis occurs when the light energy 
absorbed by Photosystem II (PSII) is used to reduce the intermediate electron carrier, 
plastoquinone, which then transfers these electrons through the cytochrome b6/f complex, 
plastocyanin, Photosystem I (PSI) and finally to ferredoxin (Fd), which is ultimately reoxidised 
to produce H2 (Ghirardi, et al., 2009). Indirect photolysis occurs in some filamentous 
cyanobacterial strains that are capable of forming heterocysts, where H2 is a by-product of N2 
fixation. Purple non-sulphur bacteria such as various Rhodobacter sp. (Ghirardi, et al., 2009) 
are also capable of H2 production, with extremely high yields, during N2 fixation, however 
these bacteria are non-oxygenic and they perform cyclic photosynthesis. 
Various obligate and facultative anaerobic bacteria are capable of H2 production during so-
called “dark fermentation” (no light required). Indeed it has been suggested that fermentative-
Bio-H2 production is the most promising approach to commercial Bio-H2 production (Levin, et 
al., 2004). Many species of Clostridiaceae have been reported to produce H2 with modest 
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yields, including C. butyricum CGS5 (2.78 mol H2 mol-1 sucrose) (Chen, et al., 2005), C. 
saccharoperbutylacetonicum ATCC 27021 (2.7 mol H2 mol-1 lactose (Ferchichi, et al., 2005) and 
C. thermolacticum DSM 2910 (2.1-3 mol H2 mol-1 lactose) (Collet, et al., 2004). The other well 
studied family of fermentative, H2-producing bacteria are Enterobacteriaceae. Well studied 
members of this family include various Escherichia coli strains (2 mol H2 mol-1 glucose) 
(Bisaillon, et al., 2006) and (1 mol H2 mol-1 formate) (Yoshida, et al., 2005), Citrobacter sp. Y19 
(2.49 mol H2 mol-1 glucose) (Oh, et al., 2003) and Klebsiella pneumonia. Other bacterial species 
that produce H2 during fermentation included some thermophilic organisms such as 
Caldicellulosiruptor saccharolyticus DSM8903 (5.9 mol H2 mol-1 sucrose) (van Niel, et al., 2003) 
and Thermotoga maritima (Verhagen, et al., 1999).  
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 Hydrogenases 1.4
 Hydrogenase fundamentals and their discovery 1.4.1
The observation that a wide variety of organisms from all three Domains of life, and many 
different environmental niches, were capable of producing H2 led to intense research from 
1930 onwards into the mechanisms involved. The term “hydrogenase” was coined by 
Stephenson and Stickland in 1931, as they described an enzyme that “activates” molecular 
hydrogen in different bacteria, including Escherichia coli (Stephenson and Stickland, 1931). 
Hydrogenases catalyse the reversible reaction H2 ↔ 2H+ + 2e- (Stephenson and Stickland, 
1932; Green and Stickland, 1934). In the 1930s, 40s and 50s, they were viewed by many in the 
scientific community as an ideal “simple” model enzyme to study. The partial purification of 
hydrogenases from the cell was essential to allow their true characterisation (Joklik, 1950b; 
Gest, 1952; Krasna, et al., 1960), but the fact that they were only partially purifiable indicated 
that they were not all localised in the cytoplasm (Ackrell, et al., 1966). Hydrogenases were 
found to be reversibly (Joklik, 1950b; Joklik, 1950a; Gest, 1952) or irreversibly (Abeles, 1964) 
inactivated by O2, and other oxidising agents, and many organisms were found to have more 
than one hydrogenase activity (Ackrell, et al., 1966). However, the nature of the assumed 
cofactors responsible for the catalytic activity remained elusive for many years, and early 
attempts to dissociate them from the protein structure were unsuccessful (Gest, 1952; Krasna, 
et al., 1960). 
Many hydrogenases have now been purified to homogeneity and the identity of their essential 
cofactors confirmed. Hydrogenases are thus divided into three phylogenetically distinct classes 
of enzyme, based on the metal content of their active sites. They are the [NiFe]-hydrogenases, 
the [FeFe]-hydrogenases and the Fe-only (FeS-cluster free) hydrogenases. Nitrogenases also 
produce H2 during N2 fixation (reviewed in Vignais and Billoud, 2007), but this reaction is not 
reversible and usually has a lower rate of catalytic activity than true hydrogenases. 
 [NiFe]-hydrogenases 1.4.2
It was known since the 1940s that iron was important for hydrogen metabolism in bacteria 
(Waring and Werkman, 1944; Gray and Gest, 1965). Iron was subsequently shown to be an 
essential component of purified hydrogenases  as well as iron-sulfur complexes (Nicholas, et 
al., 1960; Sadana and Rittenberg, 1963; Sadana and Rittenberg, 1964; Legall, et al., 1971; 
Nakos and Mortenson, 1971). Nickel, however, was not conclusively proven to be a true 
hydrogenase cofactor until the 1980s. 
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It was known that nickel was essential for chemolithotrophic growth on H2 (Bartha and Ordal, 
1965), but it required the use of improved characterisation techniques, such as electron 
paramagnetic resonance (EPR) spectroscopy, in vivo radiolabelling, immunochemical, and 
advances in molecular genetics, to demonstrate conclusively that some hydrogenases contain 
nickel (Lancaster, 1980; Diekert, et al., 1981; LeGall, et al., 1982; Sawers and Boxer, 1986; 
Waugh and Boxer, 1986). The crystal structure of two [NiFe]-hydrogenases: Desulfovibrio gigas 
(Volbeda, et al., 1995) (Volbeda, et al., 1996); and Desulfovibrio vulgaris Miyazaki (Higuchi, et 
al., 1997) further elucidated the structure of the polypeptide-backbone, active site and FeS 
clusters. The catalytic complex of all [NiFe]-hydrogenases consists of an αβ heterodimer and 
this catalytic core is sometimes found in complex with other subunits. 
The Desulfovibrio gigas [NiFe]-hydrogenase structure (Volbeda, et al., 1995) was resolved to 
2.85 Å resolution. The large (α) and small (β) subunits interacted extensively over a surface of 
3,500 Å (Volbeda, et al., 1995). The large 60 kDa subunit contains the deeply buried active site. 
The active site was shown to be ligated by four cysteines, Cys68 and Cys533 are bridging 
ligands of both metal ions, while Cys65 and Cys530 are bound to the Ni atom alone (Volbeda, 
et al., 1995). The identity of the other metal was suggested to be Fe however could not be 
confirmed in this study (Volbeda, et al., 1995). This was confirmed in a later study (Volbeda, et 
al., 1996), which also showed the presence of a bridging oxygen species between Ni and Fe 
(suggesting this was a crystal of an inactive [NiFe]-hydrogenase) and that the Fe atom binds 
three diatomic ligands, which were shown by infrared analysis to be two CN- and one CO 
ligands, a finding that was later confirmed using Fourier transform infrared (FTIR) spectroscopy 
(Fichtner, et al., 2006). The identity of the bridging ligand between the Ni and Fe atoms was 
controversial for many years, until it was shown to be a hydroxo species in the ‘ready’ or ‘Ni-B’ 
(EPR) state and a hydro-peroxide in the ‘unready’ or  ‘Ni-A’/’Ni-SU’ state (Volbeda, et al., 2005). 
A hydrophobic channel for H2 diffusion connects the [NiFe] active site to the protein surface 
(Fontecilla-Camps, et al., 2007). A Mg2+ ion was also found in large subunit of some [NiFe]-
hydrogenases (Higuchi, et al., 1997). 
The small 28 kDa subunit was found to be structurally similar to a Clostridial flavodoxin and 
consisted of three FeS clusters: the proximal [4Fe-4S] cluster (6.1 Å from [NiFe] active site); the 
medial [3Fe-4S] cluster (5.7 Å from the proximal cluster) and the distal [4Fe-4S] cluster (5.2 Å 
from the medial cluster) (Volbeda, et al., 1995). These FeS clusters align nicely to pass 
electrons from the active site to the electron acceptor, with the previously unseen histidine 
ligand of the distal cluster suggested to play a role in interaction with its cytochrome c3 partner 
(Volbeda, et al., 1995). 
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[NiFe]-hydrogenases are very diverse in their physiological roles in their native organisms 
(reviewed in Vignais and Billoud, 2007). Most are involved exclusively in H2 uptake from the 
environment and eventually pass the electrons from H2 oxidation to various terminal electron 
acceptors such as fumarate or O2. Bidirectional NAD(P)+-linked hydrogenases are capable of 
reducing or oxidising NAD(P)+ and NAD(P)H, respectively, depending on the cellular redox 
environment. Some membrane-bound [NiFe]-hydrogenases produce H2 during fermentation to 
remove excess reducing equivalents and some of these are thought to have an associated 
energy-conserving proton pumping activity. A subgroup of the [NiFe]-hydrogenases has been 
identified that contain selenocysteine in their active sites (Garcin, et al., 1999) and these are 
called [NiFeSe]-hydrogenases. 
 
 
Figure 1.2 X-Ray Structure of [NiFe]-hydrogenase from Desulfovibrio gigas. The active site consists of a Ni and Fe 
core ligated by four cysteines and the Fe atom has three diatomic ligands (2 x CN- and 1 x CO). (Volbeda, et al., 
1995) 
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1.4.2.1 NiFe active site maturation 
The accessory proteins essential for [NiFe]-hydrogenase large subunit maturation were first 
identified through classic genetic studies in E. coli. Researchers found that certain mutations, 
located in regions of the chromosome distinct from the genes encoding the structural subunits 
of the [NiFe]-hydrogenases, led to a pleiotropic loss in hydrogenase activity. These regions 
were eventually found to contain the hyp genes, hypA-E and hypF (Lutz, et al., 1991). HypD 
contains a [4Fe-4S] cluster, acts as a scaffold protein and forms a (hetero)tetramer with HypC, 
HypE & HypF (Soboh, et al., 2012; Stripp, et al., 2013). These co-ordinate the two CN- ligands, 
which are derived from carbamoyl phosphate (Paschos, et al., 2001; Petkun, et al., 2011), and 
the CO ligand, the origin of which is still unknown (Forzi, et al., 2007; Forzi and Sawers, 2007b; 
Lenz, et al., 2007) to the Fe atom (Soboh, et al., 2012). HypC then transfers this immature 
structure into an apo-form of the large subunit. The Ni atom is then inserted into the large 
subunits by the complex containing the nickel binding proteins HypA and HypB (also a GTPase) 
(Forzi and Sawers, 2007b; Chan, et al., 2012a; Chan, et al., 2012b), and some researchers 
believe SlyD has a role here too. Finally, a dedicated protease catalyses cleavage of a short C-
terminal peptide from the large subunit, which renders the process reversible and assembly of 
the holoenzyme is completed (Forzi and Sawers, 2007a). 
  
Figure 1.3 The [NiFe] active-site maturation machinery. A. HypC, D, E & F form a tetramer and the CO and CN 
ligands are assembled on a [4Fe-4S] cluster on HypD. B. HypC accepts the Fe, CO, CN scaffold. C. HypC inserts this 
into the large [NiFe]-hydrogenase subunit. D. HypB in combination with HypA and SlyD inserts the Ni cofactor onto 
the scaffold in the  large subunit completing the active site. E. A system-specific protease cleaves off the C terminal 
peptide of the large subunit. F. The holoenzyme is complete. 
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 [FeFe]-hydrogenases 1.4.3
In 1984, the hydrogenases of Clostridium pasteurianium were both shown to only contain iron 
and sulphur and no nickel (Adams and Mortenson, 1984). A similar finding was made with a 
periplasmic hydrogenase from Desulfovibrio vulgaris (Huynh, et al., 1984). Further 
characterisation of previously suspected [FeFe]-hydrogenases indicated the presence of 20 
gram atoms of Fe and 18 atoms of S2- per mole of protein (Adams, et al., 1989). It was further 
shown that each active site contained 6 Fe atoms per active-site (Fauque, et al., 1988; Adams, 
et al., 1989; Filipiak, et al., 1989), suggesting that the active site or H-cluster was in fact a 
modified [4Fe-4S] cluster with additional iron atoms. A complicating factor in the 
classification/characterisation of these hydrogenases was the heterogeneity of the enzyme 
complexes between different organisms. Over 140 [FeFe]-hydrogenases have now been 
characterised and examples of monomers, heterodimers, heterotrimers and heterotetramers 
have all been reported (reviewed in Vignais and Billoud, 2007). These nickel-free [FeFe]-
hydrogenases typically display much higher catalytic rates than [NiFe]-hydrogenases (reviewed 
in Adams, 1990). Most are thought to be involved in H2 production (reviewed in Adams, 1990), 
as is reflected by their catalytic bias in hydrogenase assays, although the physiological role of 
the periplasmic [FeFe]-hydrogenase from Desulfovibrio vulgaris Hildenborough has now been 
shown to be H2 uptake (Pohorelic, et al., 2002). [FeFe]-hydrogenases are the only 
hydrogenases found so far amongst eukaryotes. 
The first crystal structures of [FeFe]-hydrogenases were published at the end of the 1990s 
(Peters, et al., 1998; Nicolet, et al., 1999). It was known through various spectroscopic studies, 
that the Fe and S of hydrogenase I of Clostridium pasteurianum (CpI) were organised into 5 
distinct metal clusters (Peters, et al., 1998). The authors proposed that there were four 
different domains to the enzyme. The first large (60 kDa) active site-containing domain makes 
up 2/3 of the total protein. It is arranged in 2 lobes, each consisting of a four strand β sheet 
with five α helices per lobe. The active site or H cluster lies at the interface between each lobe. 
It consists of a [4Fe-4S] cluster bridged via a single cysteinyl S (Cys300) to the [FeFe] core. This 
cysteinyl S is the only covalent ligand of the active site to the protein backbone, a 
characteristic noticed previously with the active site of sulphite reductase. The [4Fe-4S] cluster 
is ligated by four cysteines (Cys300, Cys355, Cys499 and Cys503). The two Fe atoms are held 
2.62 Å apart and each Fe atom has 5 ligands. These were tentatively identified as two CO/CN- 
ligands; one bridging CO/CN-; and two bridging S atoms (bound to another unknown atom). 
The next domain, closest to active site and interacting with it, contains two [4Fe-4S] clusters 
(each ligated by four cysteines). The first [4Fe-4S] cluster (FS4A) lies 9 Å (edge to edge) from 
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the FeS cluster of the H-cluster with the second (FS4B) 10 Å away from it. The other two 
domains contain the third and fourth FeS clusters. The third [4Fe-4S] cluster (FS4C), which is 
ligated by a histidine (His94) and three cysteines and it is situated 8 Å from the FS4B cluster. 
The final FeS cluster is a 2Fe-2S cluster (FS2) and it is ligated by four cysteines. It lies 11 Å from 
FS4B and 17 Å from FS4C. These last two FeS clusters (FS4C and FS2) are both located near the 
protein surface and therefore likely to be involved in accepting electrons from the 
physiological electron donor. 
The crystal structure (resolution: 1.6 Å) of the periplasmic [FeFe]-hydrogenase from 
Desulfovibrio desulfuricans showed some subtle differences to that of CpI and answered some 
remaining questions (Nicolet, et al., 1999). Its structure, apart from a ferredoxin-like domain 
had a very novel fold. It contained three FeS clusters, all of which were of the [4Fe-4S] variety. 
This structure was able to confirm that the non-protein ligands of the Fe atom were two CO 
and two CN- (1 each per Fe) ligands. Erroneously, the authors suggested that the two bridging 
S of the two Fe atoms was a propanedithiol bridge. This has now been shown to be an 
aminedithiolate bridge (Nicolet, et al., 2001). It was also suggested, as a result of its empty 
coordination sphere and its proximity to both Lys237 and hydrophobic channel to the protein 
surface, that the second Fe atom is involved in H2 binding (Nicolet, et al., 1999). 
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Figure 1.4 The crystal structure of the [FeFe]-hydrogenase from Clostridium pasteurianum. The [FeFe] active site 
is highlighted and the FeS clusters can also be seen. (Peters, et al., 1998) 
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1.4.3.1 FeFe active site assembly 
Assembly of the metals and non-protein ligands into the active sites of hydrogenases are not 
spontaneous events. Elaborate networks of accessory proteins are required to assemble and 
insert the cofactors. The accessory proteins essential for holoenzyme maturation of [FeFe]-
hydrogenases have been identified as HydE, HydF, and HydG (Posewitz, et al., 2005). HydF is 
thought to act as the scaffold for H-cluster assembly (McGlynn, et al., 2008) and has been 
shown to bind one [4Fe-4S] and hydrolyse GTP to GDP (Brazzolotto, et al., 2006). HydE, a 
radical S-adenosylmethionine (SAM) enzyme, binds two [4Fe-4S] clusters and synthesizes the 
bridging dithiolate group on a 2Fe core of apo-HydF (Rubach, et al., 2005). HydG, another 
radical SAM enzyme, binds one [4Fe-4S] cluster and uses tyrosine to synthesise the CO and CN- 
ligands for each Fe atom (Shepard, et al., 2010a). HydF then transfers the mature active site 
into the large hydrogenase subunit, leading to catalytically-competent hydrogenase (Mulder, 
et al., 2010; Mulder, et al., 2011). The GTPase activity of HydF is thought to be essential for the 
interactions between HydE, HydG and HydF, possibly through the induction of conformational 
changes in HydF (Shepard, et al., 2010b). 
 
 
  
Figure 1.5 The maturation enzymes required for construction of the [FeFe] active site. HydF acts as a scaffold for 
H-cluster assembly. HydE and HydG, two radical SAM enzymes synthesise the bridging dithiolate group onto the 
2Fe core of HydF and then the CO and CN ligands. Finally once fully assembled, the [FeFe] active site is transferred 
into the large subunit. 
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 FeS-cluster free hydrogenases 1.4.4
The third phylogenetic class of hydrogenases are the [Fe]-only/FeS-cluster free hydrogenases. 
They were discovered in methanogenic archaea (Zirngibl, et al., 1992; Hartmann, et al., 1996) 
and initially thought be metal-free hydrogenases. A crystal structure revealed a unique 
structure and catalytic mechanism compared to the [NiFe] and [FeFe] classes of enzymes 
(Shima, et al., 2008). The enzyme is a homodimer and its active site is found on the surface of 
the enzyme. It simultaneously binds both methylenetetrahydromethanopterin and protons, 
allowing them to react directly. This this direct binding of both substrates to the same active 
site on the surface of the protein removes the necessity for FeS clusters to relay electrons. 
 Hydrogenases couple H2–oxidation to a variety of physiological electron donors and 1.4.5
acceptors 
[NiFe] and [FeFe]-hydrogenases are involved in a wide variety of biochemical processes, 
depending on the environmental niche of the host organism and the local redox requirements. 
Because of this, ten classes of hydrogenases are now proposed (reviewed in Vignais and 
Billoud, 2007). For example, the [NiFe]-hydrogenase of Desulfovibrio vulgaris is a respiratory 
“uptake” enzyme and as such oxidises H2 and transfers the electrons to cytochrome c3 , which 
subsequently is used to reduce Fe(III) or U(VI) (Elias, et al., 2004). Likewise, membrane-bound 
[NiFe] hydrogenases have been described that link hydrogen oxidation directly to quinone 
reduction. In addition, ferredoxin has been known to play an essential role in H2 metabolism in 
certain microorganisms for many years. In Clostridium pasteurianium and Micrococcus 
lactilyticus, ferredoxin accepts electrons from pyruvate:ferredoxin oxidoreductase (PFOR) and 
passes those to an [FeFe]-hydrogenase to produce H2. Ferredoxin also plays a role in H2 
oxidation as the intermediate electron carrier for H2-dependent reduction of nitrite and 
hydroxylamine (Valentine and Wolfe, 1963; Gray and Gest, 1965). Chlamydomonas reinhardtii 
has a reversible [FeFe]-hydrogenase that is capable of coupling NADP+/NAD+ reduction directly 
to H2 oxidation in the dark, but can switch to H2 production with NADPH/NADH as electron 
donors when in the light (Abeles, 1964). Some hydrogenases produce H2 during fermentation 
with formate as the sole electron donor (Sawers, 2005). 
 Inhibitors of hydrogenases 1.4.6
The catalytic activity of all hydrogenases can be inhibited either reversibly or irreversibly by a 
number of molecules/compounds. Molecular oxygen is the best studied and probably the most 
relevant to any discussion of hydrogenases (Joklik, 1950a; Joklik, 1950b; Gest, 1952). O2 binds 
to the active site of both [NiFe]- and [FeFe]-hydrogenases. The majority of [NiFe] enzymes can 
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be reactivated upon reduction with a strong reducing agent such as dithionite or upon 
prolonged exposure to H2. Some [NiFe]-hydrogenases are able to perform this reduction 
extremely quickly (and are therefore named oxygen-tolerant hydrogenases) due to the 
presence of a unique [4Fe3S] proximal cluster (Goris, et al., 2011; Parkin, et al., 2012; Parkin 
and Sargent, 2012; Evans, et al., 2013). However, all [FeFe]-hydrogenases characterised until 
now are sensitive to O2 and irreversibly inactivated by it. This inactivation is thought to be the 
result of the formation of a reactive oxygen species-like superoxide, which leads to instability 
and degradation of the H-cluster (Lambertz, et al., 2011). Other strong oxidising agents such as 
ferricyanide, iodine and hydrogen peroxide are also capable of inactivating hydrogenases, 
however most are reversible. Indeed the deliberate/accidental oxidation of certain [FeFe]-
hydrogenases with something other than O2 (e.g. ferricyanide) can allow them to form the Hox 
inactive state, which protects from O2 attack and can be reactivated upon H2 exposure 
(Miyake, et al., 2013). Carbon monoxide has long been shown to inhibit hydrogenase activity  
(Joklik, 1950a) and recently it was shown that aldehydes such as formaldehyde could also 
reversibly inhibit them (Wait, et al., 2011). Other known inhibitors of hydrogenases include 
heavy metals such as copper sulphate (Sawers and Boxer, 1986), mercury, azide (Sawers and 
Boxer, 1986), N-bromosuccinimide (NBS) (Sawers and Boxer, 1986), acetylene (Sun, et al., 
1992) and nitric oxide (NO) (Berlier, et al., 1987).  
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 E. coli expresses three hydrogenases under anaerobic conditions 1.5
The E. coli chromosome contains genes for four [NiFe]-hydrogenases, three of which have 
been biochemically characterised (Figure 1.6). Hyd-1, Hyd-2 and Hyd-3 are encoded by the hya, 
hyb and hyc operons respectively (Figure 1.7). The hyf operon, encoding Hyd-4, appears to be 
cryptic in E. coli K-12 and has not been found to be expressed under laboratory conditions 
tested so far. Hyd-1 and Hyd-2 are membrane-bound, periplasmic-facing hydrogen uptake 
enzymes, while Hyd-3 is a loosely membrane-attached, cytoplasmic-facing hydrogen-producing 
enzyme (Section 1.5.3). Due to their periplasmic localisation and extensive cofactor content, 
Hyd-1 and Hyd-2 are both substrates of the twin-arginine translocation system (Tat), which 
transports folded proteins across the cytoplasmic membrane (Sargent, et al., 1998b; Weiner, 
et al., 1998; Rodrigue, et al., 1999; Sargent, et al., 1999; Berks, et al., 2000; Jack, et al., 2004).  
  
Figure 1.6 The three [NiFe]-hydrogenases of E. coli. Hyd-1 and Hyd-2 are predominantly H2 uptake enzymes 
whereas FHL produces H2 from formate. 
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 The operons encoding Hyd-1 and Hyd-2  1.5.1
The hya operon is comprised of six genes: hyaABCDEF (Menon, et al., 1991) (Figure 1.7A). Two 
of the genes, hyaA and hyaB, encode the small and large structural subunits of Hyd-1, 
respectively, however native levels of hydrogenase activity require the expression of all six hya 
genes (Menon, et al., 1991). The gene product of hyaC is a b-type cytochrome with a 
calculated molecular mass of 27.6 kDa and contains four hydrophobic transmembrane 
domains (Menon, et al., 1990; Volbeda, et al., 2013). HyaC is most likely a ubiquinone 
reductase, transferring electrons from the core hydrogenase in the periplasm to quinone at 
the cytoplasmic side of the membrane. The hyaD gene encodes a protease required for C-
terminal processing of the Hyd-1 large subunit. The gene product of hyaE has been shown to 
interact specifically with HyaA and prevents its premature transport by the Tat machinery 
(Dubini and Sargent, 2003). The gene hyaF is thought to encode a maturase involved in nickel 
incorporation into Hyd-1 active site, but is not essential, as a ∆hyaF mutant retains two thirds 
of the Hyd-1 activity of the wild-type strain (Dubini, et al., 2002) and this reduction in Hyd-1 
activity can be rescued by the addition nickel to the growth media (Menon, et al., 1991). 
Hyd-1 forms a large membrane-attached complex with a molecular mass of 200 kDa, consisting 
of two large (64 kDa) subunits and two small (35 kDa) subunits (Sawers and Boxer, 1986), 
which is consistent with the recently solved crystal structure of Hyd-1, which shows the 
Figure 1.7 The hya, hyb and fhl operons of E. coli. The hya operon encodes Hyd-1, the hyb operon encodes Hyd-2 
and the hyc operon and fdhF gene encode the FHL complex. FhlA is the transcriptional activator of the formate 
regulon and it regulates expression of the FHL-encoding genes in addition to the hyp operon. 
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enzyme is a physiologically-active dimer of heterodimers (Volbeda, et al., 2012). An important 
feature of O2-tolerant [NiFe]-hydrogenases is the unique [4Fe-3S] proximal cluster, ligated by 
six conserved cysteine residues, that are capable of donating two electrons to the oxidised 
[NiFe] active site to help reduce and remove attacking O2 (Fritsch, et al., 2011; Goris, et al., 
2011; Parkin and Sargent, 2012). The crystal structure of Hyd-1 with its b-type cytochrome 
(HyaC) was also recently solved (Volbeda, et al., 2013) (Figure 1.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The hyb operon is comprised of eight genes, hybOABCDEFG (Figure 1.7B) (Sargent, et al., 
1998a). The large subunit is encoded by hybC (Menon, et al., 1994). Originally the identity of 
the gene encoding the small subunit of Hyd-2 was suggested to be hybA, as it contains 
cysteines capable of ligating FeS and it possesses an N-terminal twin-arginine signal peptide 
(Menon, et al., 1994). It was later shown that an open reading frame existed immediately 
upstream of hybA and that this gene, named hybO, encoded the small subunit (Sargent, et al., 
1998a). The original paper which suggested HybA was the small subunit claimed that 
expression of hybA-G (i.e. no hybO expression necessary) was sufficient to restore wild type 
levels of Hyd-2 activity in ∆hybA-G mutants (Menon, et al., 1991), which is controversial. The 
gene products of hybB and hybA are essential for H2-dependent quinone reduction by Hyd-2 
(Menon, et al., 1994; Dubini, et al., 2002). The hybB gene is thought to encode a large integral 
membrane protein with ten transmembrane domains (Menon, et al., 1994) and shares 40% 
Figure 1.8 Crystal Structure of E. coli hydrogenase-1 with its b-type cytochrome 
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overall sequence identity to the Hmc cytochrome of Desulfovibrio vulgaris. The hybA gene is 
thought to encode a periplasmic-facing 16Fe ferredoxin. The gene product of hybD shares 40% 
sequence identity to HyaD, and therefore assumed to play an essential role in Hyd-2 
processing. The products of hybE, hybF, and hybG are still poorly understood but are thought 
to act as chaperones for cofactor assembly or protein translocation (Dubini, et al., 2002). HybE 
shares homology with known Tat chaperones (e.g. 26% sequence identity and 38% sequence 
similarity with HoxT from Ralstonia eutropha), and is involved in proofreading the HybOC 
complex before Tat-mediated translocation (Dubini and Sargent, 2003; Jack, et al., 2004). HybF 
and HybG are homologs of HypA and HypC and are specifically involved in large subunit 
maturation of both Hyd-1 and Hyd-2 (Blokesch, et al., 2002; Blokesch, et al., 2004; Butland, et 
al., 2006). 
Hyd-2 is a periplasm-facing and membrane-attached enzyme with a molecular mass of 180 
kDa. The core active hydrogenase fragment was released from the membranes using tryptic 
digestion and an active dimer-of-heterodimers was isolated (Ballantine and Boxer, 1986). The 
small subunit of the non-trypsin treated enzyme has a molecular mass of 35 kDa, and the 
trypsin treatment removed a 5 kDa stretch of polypeptide thought to be the short hydrophobic 
transmembrane helix that anchors Hyd-2 to the membrane on the periplasmic side, to give a 
30 kDa tryptic fragment (Ballantine and Boxer, 1986; Dubini, et al., 2002). In its native form, 
HybOC forms a large respiratory complex with HybA and HybB (Figure 1.6) and this association 
with HybA and HybB is essential for H2-dependent fumarate reduction and growth on 
hydrogen and fumarate alone (Dubini, et al., 2002). 
 The physiological roles of Hyd-1 and Hyd-2 1.5.2
The physiological role of Hyd-2 has been firmly established as a H2-uptake hydrogenase under 
anaerobic respiratory conditions. Expression of the hyb operon is strongly induced in anaerobic 
conditions, which is predominantly regulated by FNR, ArcBA and to a lesser extent IscR 
(Richard, et al., 1999; Giel, et al., 2006). The expression of the hyb operon is also affected by 
catabolite repression (Richard, et al., 1999). It is responsible for the majority (92%) of 
hydrogenase activity in membranes purified from grown cells under anaerobic respiratory 
conditions (Sawers and Boxer, 1986). It can catalyse the H2-dependent reduction of a wide 
variety of artificial electron acceptors including MV and BV, and, via quinols, can form one half 
of short electron transport chains driving H2-dependent reduction of many respiratory electron 
acceptors, including fumarate, DMSO and nitrate  (Laurinavichene and Tsygankov, 2001). Hyd-
2 most active under reducing/anaerobic conditions, and is inactive under aerobic conditions 
(Laurinavichene, et al., 2001; Lukey, et al., 2010). This maximal activity during anaerobic 
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respiratory conditions correlates neatly with the amount of protein found in cells grown 
anerobically on H2 or glycerol with fumarate as the terminal electron acceptor (Sawers, et al., 
1985).  
The physiological role of Hyd-1 has remained somewhat elusive. Biochemical studies on Hyd-1 
have been performed and showed that it was capable of H2-dependent reduction of BV 
(Sawers and Boxer, 1986) in vitro, as well as, via quinols as one half of a membrane-bound 
electron transfer chain, being able to couple H2 oxidation to the reduction of O2, DMSO and 
nitrate (Laurinavichene and Tsygankov, 2001; Laurinavichene and Tsygankov, 2003). Hyd-1 is 
also capable of sustaining H2 uptake activity in more oxidising conditions than Hyd-2, as well as 
showing tolerance to O2 attack (Lukey, et al., 2010). The ability of Hyd-1 to  tolerate O2 has led 
to suggestions that it may play a role as an O2 scavenger during microaerobic conditions 
(Laurinavichene, et al., 2001). This hypothesis is intriguing when it is considered that the two 
genes at the 3’ end of the hya operon, appC and appB, encode cytochrome bd II oxidase 
(Dassa, et al., 1991). Perhaps Hyd-1 is involved in supplying reduced quinols (from the 
oxidation of H2) for this oxidase upon the onset of aerobiosis or under fluctuating 
environmental conditions. 
Many theories on the physiological role of Hyd-1 are based on gene expression studies. These 
studies take advantage of transcriptional fusions between the hyaA promoter (PhyaA) and lacZ, 
for example (Richard, et al., 1999). The expression of hya is repressed by IscR under aerobic 
conditions (Giel, et al., 2006) and strongly induced in anaerobic conditions (Brondsted and 
Atlung, 1994; Nesbit, et al., 2012; Pinske, et al., 2012). ArcA and AppY antagonise the binding 
of IscR to Phya (ArcA and IscR DNA-binding sites overlap and the binding of one to DNA prevents 
the binding of the other) (Nesbit, et al., 2012). The hya operon is transcribed at a much higher 
level than the hyb operon (Richard, et al., 1999) and yet only contributes 8% of total 
membrane hydrogenase activity, as assayed using BV (Sawers and Boxer, 1986; Menon, et al., 
1991). It was shown that a hyaA’-‘lacZ translational fusion had only 5% of the activity of a 
transcriptional fusion, indicating that post transcriptional regulation played an important role 
in determining the amount of Hyd-1 in the cell (Pinske, et al., 2012). Another possible role for 
Hyd-1, and one that has been shown in Salmonella, is that it plays a role in H2 re-uptake during 
fermentative conditions, thus acting to conserve energy (the so-called “hydrogen cycling” 
hypothesis). In Salmonella the expression of hyaA is highest under anaerobic conditions when 
cells are grown on glucose (i.e. fermentatively) and a 25% reduction in growth rate is observed 
in ∆hya mutants (Zbell, et al., 2007). No similar growth rate defect was observed with E. coli 
∆hya mutants when grown in rich media supplemented with glucose (Menon, et al., 1991). The 
addition of formate to growth media was found to induce hya expression (Brondsted and 
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Atlung, 1994) and cellular levels of Hyd-1 enzyme (Sawers, et al., 1985), however hya 
expression is actually higher in anaerobic respiratory conditions (Brondsted and Atlung, 1994; 
Richard, et al., 1999), which led to the suggestion that perhaps Hyd-1 acts as an intermediate 
electron transport protein operating between formate hydrogenlyase and fumarate reductase 
(or another terminal reductase) (Francis, et al., 1990; Brondsted and Atlung, 1994). 
 Hyd-3, a component of the formate hydrogenlyase complex 1.5.3
Hyd-3 is the [NiFe]-hydrogenase component of the formate hydrogenlyase complex (FHL). FHL 
is a large membrane-attached complex of at least seven-proteins that is responsible for H2 
production during mixed-acid fermentation by E. coli (Section 1.6.1). The enzyme couples 
formate oxidation at the cytoplasmic side of the membrane directly to proton reduction, also 
at the cytoplasmic side of the membrane. 
1.5.3.1 Expression 
The hyc operon consists of 9 genes: hycABCDEFGHI (Figure 1.7C). The structural subunits of 
FHL are encoded by six of these genes (hycBCDEFG) and another gene, fdhF, which is 
transcribed elsewhere on the E. coli chromosome (reviewed in Sawers, 2005). The gene 
product of fdhF is the formate dehydrogenase responsible for formate oxidation during H2 
production (Fdh-H) (Boyington, et al., 1997). The hycB gene encodes the predicted small 
subunit (molecular mass of 21.8 kDa) ferredoxin-like subunit of FdhF (Sauter, et al., 1992). The 
hycE gene encodes the [NiFe] hydrogenase large subunit (the catalytic subunit of Hyd-3) 
(Rossmann, et al., 1994). The hycG gene encodes an FeS cluster-containing protein, which is 
the best candidate for a small subunit partner for HycE (Sauter, et al., 1992). The hycC and 
hycD genes encode predicted integral membrane proteins, while hycF is thought to encode 
another ferredoxin-like electron transfer subunit (Sauter, et al., 1992).  
The hycA gene product is not part of the enzyme complex but instead is a repressor of hyc 
operon expression (Sauter, et al., 1992). Likewise, the hycI gene product is not part of the 
enzyme but encodes the HycE specific endopeptidase involved in C-terminal processing of the 
large subunit after Ni cofactor insertion. The function of the hycH gene product remains 
unknown (Sauter, et al., 1992). The fdhF gene and the hyc operon are regulated by both FNR 
and the presence of formate. These genes have upstream regulatory sequences to which FhlA, 
the formate-associated transcriptional activator, can bind when formate is present. The fhlA 
gene itself is expressed at low levels in all conditions due to its own constitutive weak 
promoter. This is boosted further during anaerobic conditions as fhlA sits downstream of the 
hypABCDE operon and when the hyp operon is induced by FNR under anaerobic conditions, 
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fhlA is also co-transcribed with hyp (Sawers, 2005). The FhlA transcriptional activator is 
activated by formate, which binds to one domain of FhlA (Km of FhlA for formate = 0.5 mM 
(Hopper and Bock, 1995)). This binding increases the affinity of FhlA’s DNA-binding domain to 
the regulatory sequences of the formate regulon. FhlA subsequently aids the recruitment of 
σ54 (NtrA), which induces the transcription of genes with σ54-dependent promoters 
(Leonhartsberger, et al., 2000). Transcription of fhlA itself increases in a positive feedback 
circuit (Sawers, 2005). HycA (the hyc operon repressor) and OxyS, a small mRNA expressed in 
oxidative stress conditions, inhibit FhlA activity and fhlA mRNA translation to further regulate 
this formate regulon (Sawers, 2005). 
1.5.3.2 Biochemical data and physiological role of FHL 
There is very little structural information on the entire FHL complex and most of the individual 
subunits, as the complex is unstable after purification and has proved recalcitrant to 
purification. It is thought to be membrane anchored by the integral membrane subunits HycC 
and HycD but is oriented towards the cytoplasm (Figure 1.6) (Rossmann, et al., 1994). HycC, 
HycD, HycE, HycF, and HycG share sequence identity with Nqo12, Nqo8, Nqo4, Nqo9, and 
Nqo2, respectively, of prokaryotic respiratory Complex I (NADH dehydrogenase), the crystal 
structure of which was recently solved (Error! Reference source not found.) (Efremov and 
Sazanov, 2012; Baradaran, et al., 2013). This allows the structures of these FHL subunits to be 
predicted and physiological roles to be inferred. The crystal structure of Fdh-H has also been 
solved (Boyington, et al., 1997). FdhF contains selenocysteine, bis-molybdopterin guanine 
dinucleotide (MGD) and a [4Fe-4S] cluster (Figure 1.10) (Boyington, et al., 1997).  
The physiological role of the FHL complex is to catalyse the oxidation of formate and 
concurrent reduction of protons to produce H2 during mixed-acid fermentation. At 
physiological pH, formate is charged and so not freely membrane permeable (pKa = 3.75). 
Formate produced in the cell cytoplasm during anaerobic metabolism is exported to prevent 
acidification using the formate channels, FocA (Suppmann and Sawers, 1994), FocB, and 
possibly another unknown formate transporter. Under anaerobic respiratory conditions when 
electron acceptors such as nitrate, TMAO or exogenous fumarate are present, this extracellular 
formate is oxidised by respiratory formate dehydrogenases Fdh-N or Fdh-O (Axley, et al., 
1990)), which are membrane-bound but periplasmically-localised formate dehydrogenases. 
However, if no electron acceptors are present, the build-up of secreted formate, acetate and 
lactate can cause the extracellular pH to drop below 6.8, at which point the formate is re-
imported into the cell, activates FhlA, and ultimately is oxidised to produce H2 by FHL (Sawers, 
2005). 
24 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.10 The crystal structure of Fdh-H. The MGD 
cofactor and [4Fe-4S] cluster are highlighted. This is the 
enzyme responsible for formate oxidation during mixed-acid 
fermentation and forms part of the FHL complex. 
(Boyington, et al., 1997) 
Figure 1.9 The crystal structure of respiratory complex I from Thermus thermophiles. The FHL homologues of 
Hqo2, 9, 4, 8 and 12 are indicated. (Baradaran, et al., 2013) 
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 Other genes involved in hydrogenase expression, biosynthesis and maturation  1.5.4
In addition to the specific machinery dedicated to active site assembly and insertion, many 
other systems are essential to successfully load the other cofactors found in hydrogenase 
enzymes. The iron-sulphur machinery of E. coli is essential for the assembly and insertion of 
FeS clusters into the small and large subunits of hydrogenases. The main pathways for these 
are the Isc (encoded by iscRSUA) and Suf (encoded by sufABCDSE) pathways, which operate 
under normal and oxidative stress conditions respectively and have been studied and reviewed 
extensively (Johnson, et al., 2005; Ayala-Castro, et al., 2008; Fontecave and Ollagnier-de-
Choudens, 2008; Lill, 2009; Vinella, et al., 2009). The sulphur of FeS clusters is supplied in the 
form of sulphide, which is delivered by a cysteine desulfurase, IscS/SufS. The FeS clusters are 
assembled on the scaffold proteins IscU/SufU (U-type carrier protein) or IscA/SufA (a type II A-
type carrier protein), which accepts the sulphide and the iron. One protein shown to be 
involved in iron delivery is CyaY, which has been shown to bind iron and also interact with IscU 
and IscS (Layer, et al., 2006). The electrons required for the reduction of the sulphide to 
sulphur is supplied by ferredoxin and finally the insertion of the assembled FeS cluster into the 
target protein requires the action of an ATPase. In the Isc machinery this is carried out by HscA, 
with its chaperone, HscB (Reyda, et al., 2009), and in the Suf machinery, this is carried out by 
SufC (Saini, et al., 2010). It has recently been shown that IscU, IscA and a type I A-type carrier 
protein, ErpA, are essential for FeS cluster assembly and insertion into the small subunits of 
both E. coli Hyd-1 and Hyd-2, but SufA is not required (Pinske and Sawers, 2012a; Pinske and 
Sawers, 2012b). 
The uptake of nickel is of course essential for the activity of all [NiFe]-hydrogenases and is 
catalysed by the Nik machinery (encoded by the nikABCDER operon) (Navarro, et al., 1993; 
Eitinger and Mandrand-Berthelot, 2000). NikA is the periplasmic Ni-binding component of the 
Nickel ABC transporter, NikR is the repressor of the operon, NikB & C are the membrane 
components of the ABC transporter and NikD & E bind ATP, which energises the transporter. 
Iron uptake is poorly understood in E. coli. Candidates for proteins involved in Fe uptake for 
use in hydrogenases etc. include MntH, a Mn2+/Fe2+:H+ symporter (Makui, et al., 2000) and the 
FeoAB system, which takes up ferrous iron (Kammler, et al., 1993; Cartron, et al., 2006). 
Finally, the radical SAM enzymes involved in H-cluster maturation, HydE and HydG, require the 
production of S-adenosyl-L-methionine. This is carried out by the products of the met genes 
and involves one additional reaction to the de novo methionine biosynthesis pathway. MetJ is 
a transcriptional repressor and when bound to S-adenosyl-L-methionine represses the 
expression of this operon. MetA catalyses the first step and converts L-homoserine to O-
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succinyl-L-homoserine (Born and Blanchard, 1999), which in combination with L-cysteine is 
converted to succinate and L-cystathionine in a reaction catalysed by MetB (Holbrook, et al., 
1990). L-cystathionine is further converted to L-homocysteine (catalysed by MetC) (Rowbury 
and Woods, 1964; Laber, et al., 1996). The final step in the methionine biosynthesis pathway 
occurs by two possible routes, catalysed by either MetE or MetH (Whitfield, et al., 1970; 
Gonzalez, et al., 1992). S-adenosylmethionine (AdoMet) is produced by MetK, the methionine 
adenosyltransferase (Markham, et al., 1980). 
 H2 production in the anaerobic metabolism of E. coli 1.6
 Mixed Acid Fermentation in E. coli 1.6.1
1.6.1.1 Glycolysis 
Hydrogen production from the oxidation of formate, catalysed by the FHL complex, is one of 
the final steps in mixed-acid fermentation in E. coli. Essentially mixed-acid fermentation can be 
divided into two half pathways: (1) glycolysis, where glucose or other carbon sources are 
oxidised to pyruvate, thus producing ATP; and (2) the reduction of pyruvate to a variety of 
reduced fermentation products, including organic acids, ethanol, CO2 and H2, in order to 
consume reducing equivalents and maintain a redox balance. The reactions of mixed-acid 
fermentation proceed according to a small set of basic biochemical rules: the thermodynamic 
favourability of individual reactions; the availability of enzymes capable of catalysing a specific 
chemical reaction; and the physiochemical properties of intermediate/final metabolites 
produced during fermentation (reviewed in Bar-Even, et al., 2012).  
Glycolysis is essential for all chemoheterotrophs. E. coli primarily uses the Embden-Mayerhoff-
Parnas (EMP) glycolytic pathway to oxidise glucose to pyruvate (Figure 1.11) (reviewed in 
Fraenkel, 1996). Glycolysis can be thought of as the thermodynamically favourable 
rearrangement of electrons in order to release chemical energy, ATP (reviewed in Bar-Even, et 
al., 2012). The oxidation of glucose via the EMP pathway results in a net production of two ATP 
molecules per molecule of glucose. The glucose is transported into the cell by the PEP-
dependent phosphotransferase system (PTS), which results in the consumption of one ATP 
molecule and concurrent phosphorylation of glucose to glucose 6-phosphate. The addition of a 
charged phosphate moiety to substrates is common during glycolysis, as it both reduces the 
permeability of small uncharged molecules (thus preventing leakage through cytoplasmic 
membrane and loss of C and energy sources) (Westheimer, 1987) and often increases the 
affinity of an enzyme for a particular substrate (Bar-Even, et al., 2011). Glucose 6-phosphate is 
first isomerised to fructose 6-phosphate by phosphohexose isomerase (Pgi) before fructose 6-
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phosphate is then further phosphorylated resulting in fructose 1,6-biphosphate by 
phosphofructokinase (PfkA). the 6-carbon fructose 1,6-biphosphate is then split into two 3-
carbon molecules by fructose 1,6-phosphate aldolase (FbaB), yielding one molecule of 
glyceraldehyde 3-phosphate and one molecule of dihydroxyacetone phosphate. 
Dihydroxyacetone phosphate can be isomerised to glyceraldehyde 3-phosphate by triose 
phosphate isomerase (TpiA).  
The next steps in glycolysis involve the recovery of the energy already invested in the 
phosphorylation events, and the release of maximum energy through additional electron 
rearrangement. Glyceraldehyde 3-phosphate is oxidised and phosphorylated in a complicated 
reaction catalysed by glyceraldehyde 3-phosphate dehydrogenase (GapA). The resulting 1,3-
bisphosphoglycerate molecule is a substrate of phosphoglycerate kinase (Pgk), which 
generates ATP and 3-phosphoglycerate. Phosphoglycerate mutase (GpmA) rearranges 3-
phosphoglycerate into 2-phosphoglycerate, which can be dehydrated by enolase (Eno) 
resulting in phosphoenolpyruvate (PEP). Finally, pyruvate kinase (PykA/PykF) generates 
pyruvate from phosphoenolpyruvate together with a second molecule of ATP.  
Two molecules of 3-carbon glyceraldehyde 3-phosphate are generated in the first half of 
glycolysis (consuming 2 × ATP), and the second half of glycolysis generates 2 × ATP for each 
glyceraldehyde 3-phosphate oxidised to 3-carbon pyruvate, this gives a net gain of 2 ATP for 
every 6-carbon glucose molecule consumed. 
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Figure 1.11 The Embden-Mayerhoff-Parnas pathway of glycolysis, typical of Escherichia coli and Salmonella. 
Enzyme abbreviations: PtsG & Crr: components of the PEP-dependent phosphotransferase system; Pgi: 
phosphoglucose isomerase; PfkA: phosphofructokinase; FbaB: fructose biphosphate aldolase; TpiA: triose 
phosphate isomerase; GapA: glyceraldehyde 3-phosphate dehydrogenase; Pgk: phosphoglycerate kinase; GpmA: 
phosphoglycerate mutase; Eno: enolase; PykA/F: pyruvate kinase. The reduction of NAD+ is highlighted in the 
dashed oval. Two glyceraldehyde 3-phosphate molecules are oxidised per molecule of glucose consumed. 
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Alternatives to the EMP pathway of glycolysis are also found in E. coli. Sugar acids such as 
gluconate and glucuronate, which are often found in the intestine, are oxidised via the Entner-
Doudoroff (ED) pathway (Peekhaus and Conway, 1998). The ED pathway is thought to predate 
the EMP pathway (Romano and Conway, 1996) and is highly conserved in prokaryotes. In the 
ED pathway, substrates such as gluconate are only phosphorylated once (instead of twice in 
EMP pathway), converted to 2-keto-3-deoxy-6-phosphogluconate (KDPG) by 6-
phosphogluconate dehydratase (Edd), which is then cleaved into one pyruvate molecule and 
one glyceraldehyde-3-phosphate molecule by KDPG aldolase (Eda). As only G3P (and not 
pyruvate) can be used for substrate-level phosphorylation, the net production from the ED 
glycolysis pathway is only one ATP molecule per gluconate oxidised, instead of two from the 
EMP pathway (Flamholz, et al., 2013). 
In addition to energy conservation through ATP formation during glycolysis, some carbon flux 
must also flow through the pentose phosphate pathway in order to produce essential 
precursor metabolites and supply the reducing equivalent NADPH (Kruger and von Schaewen, 
2003). Substrates for the essential pentose phosphate pathway can originate from either the 
EMP pathway (glucose/fructose 6-phosphate) or from the ED pathway (gluconate 6-
phosphate) and intermediate metabolites can also be redirected back into the ED/EMP 
pathways of glycolysis if required (Sprenger, 1995; Kruger and von Schaewen, 2003). 
1.6.1.2 Reduction of pyruvate and organic acid production 
Glycolysis generates reducing equivalents, in the form of two NADH molecules per glucose, 
which act as electron carriers. These must be re-oxidised in order to re-generate NAD+ so that 
glycolysis can continue.  E. coli deals with this by reducing pyruvate and excreting the final 
products out of the cell (reviewed in Böck and Sawers, 1996) (Figure 1.12). The first step of 
pyruvate metabolism during mixed-acid fermentation can proceed in one of two different 
directions. First, pyruvate can be cleaved to formate and acetyl-CoA, which is catalysed by the 
pyruvate formatelyase (Pfl) complex and, unlike the aerobically-expressed pyruvate 
dehydrogenase (PDH), results in no NADH production (Knappe and Sawers, 1990). 
Alternatively, pyruvate can be reduced to lactate by an NADH-dependent lactate 
dehydrogenase (LdhA), an enzyme that is produced during the late exponential and stationary 
phases of growth.  
Formate is the sole precursor for H2 production, which is catalysed by the FHL complex 
(Section 1.5.3). Acetyl-CoA itself can be further metabolised to produce two different 
fermentation products: acetate and ethanol, each with their own distinct advantage to the 
fermenting cell. Acetate production occurs through the reversible phosphotransacetylase 
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(PTA) - acetate kinase (Ack) pathway. Phosphotransacetylase (Pta) forms a homohexameric 
complex (Campos-Bermudez, et al., 2010) and catalyses the reaction: Acetyl-CoA + Pi ↔ 
Acetyl-phosphate + CoA. It is allosterically regulated by pyruvate and PEP, which ensures the 
reaction proceeds in the forward direction (acetyl-phosphate synthesis) (Campos-Bermudez, et 
al., 2010). Acetate kinase has been purified as a homodimer (Fox and Roseman, 1986) and due 
to its lower Km for acetyl phosphate, preferentially catalyses the production of acetate and the 
transfer of the phosphate group to ADP yielding one molecule of ATP per molecule of 
pyruvate. No NADH reducing equivalents are consumed however during acetate production. 
The main mechanism for consumption of these reducing equivalents occurs as a result of the 
reduction Acetyl-CoA to ethanol via acetylaldehyde. In E. coli this reaction is catalysed by one 
enzyme in alcohol dehydrogenase (AdhE), a multimeric enzyme complex (20 - 60 subunits, 
each 96 kDa) (Kessler, et al., 1991). NADH is the electron donor for both of these reactions, 
with one NADH molecule being oxidised to NAD+ at each step. Housing both reactions in one 
enzyme helps prevent release of potentially toxic acetaldehyde (ethanal) into the cell 
cytoplasm. Ethanol is the most highly reduced fermentation product and is released into the 
extracellular melieu. Its essential role in NAD+ regeneration can be demonstrated by the fact 
that ∆adhE mutants are unable to grow fermentatively (Lorowitz and Clark, 1982; Cunningham 
and Clark, 1986). The expression of adhE is regulated by anaerobiosis and, in particular, the 
redox state of the cell. The expression of adhE seems to correlate with the concentration of 
cellular NADH concentration (Leonardo, et al., 1993). 
The other possible routes for the consumption of NADH generated during glycolysis are 
through the production of lactate and succinate, however these are generally secondary to 
ethanol production. Lactate production occurs during late stationary phase of fermentation 
cultures, thus is not the main mechanism of NAD+ regeneration. Only one of the three lactate 
dehydrogenase expressed in E. coli are involved in mixed-acid fermentation, D-(-)-nLDH/LdhA. 
This soluble lactate dehydrogenase with a molecular mass of 115 kDa, binds pyruvate at two 
sites: the catalytic active site; and a site for allosteric control (Tarmy and Kaplan, 1968a; Tarmy 
and Kaplan, 1968b). Indeed, LdhA is only activated upon pyruvate binding , which cannot occur 
unless the cytoplasmic concentration of pyruvate is higher than 7 mM (Km for pyruvate: 7 mM) 
(Tarmy and Kaplan, 1968a). This only occurs late in fermentation when the high extracellular 
concentrations of acetate, formate and ethanol slow these pathways and pyruvate 
accumulates (Clark, et al., 1988). NADH is the reducing agent and is oxidised to NAD+. Its non-
essential role in E. coli mixed-acid fermentation was shown by the fact that ∆ldhA mutants are 
not necessary for fermentative growth (Clark, et al., 1988). 
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The other normally minor contributor to NADH reoxidation occurs during succinate 
production, which normally accounts for only 5 – 10% of total fermentation products 
(reviewed in Böck and Sawers, 1996). PEP (not pyruvate) is the substrate for succinate 
production during mixed-acid fermentation and perhaps this is why succinate production is 
only a minor fermentation product, as its overproduction would yield less ATP per molecule of 
glucose oxidised. Indeed many biotechnological approaches to increase succinate production 
by E. coli during mixed-acid fermentation rely on the introduction of an ATP production step 
into the succinate production pathway (Zhang, et al., 2009a; Zhang, et al., 2009b). PEP is 
carboxylated to oxaloacetate using the CO2 produced during fermentation by FHL, the 
availability of which also limits succinate production. Oxaloacetate is further reduced via 
malate dehydrogenase & fumarate reductase, consuming one NADH molecule, resulting in 
succinate (Zhang, et al., 2009a; Zhang, et al., 2009b). 
 
  
Figure 1.12 The reductive pathways of mixed-acid fermentation in E. coli. Enzyme abbreviations: PykA/F: 
pyruvate kinase; LdhA: lactate dehydrogenase; Pta: phosphotransacetylase; AdhE: alcohol dehydrogenase; Pfl: 
pyruvate formate lyase; Ppc: phosphoenolpyruvate carboxylase; Mdh: malate dehydrogenase; FumABC: 
fumarase; and FrdABC: fumarate reductase. The oxidative pathway of the TCA cycle halting at α-ketoglutarate is 
not shown for simplicity 
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1.6.1.3 Alternative carbon sources as substrates for mixed-acid fermentation 
The end products of mixed-acid fermentation have different oxidation states (or degrees of 
reduction), which is the hypothetical charge a compound would have if all bonds were ionic. 
Carbon compounds also have varying degrees of reduction/oxidation states. As mixed-acid 
fermentation is a redox neutral process, E. coli can adjust the amount of each fermentation 
product to maintain redox balance (Alam and Clark, 1989). However a trade-off between 
NADH oxidation and ATP production always exists. For example, more reduced sugars and 
sugar alcohols (relative to glucose) may be fermented by E. coli, however these must be 
oxidised before they can enter glycolysis, resulting in the production of one more molecule of 
NADH, which is then balanced by the production of more ethanol or lactate, which results in 
less acetate being produced during sugar alcohol fermentations and hence less ATP. On the 
other hand, more oxidised sugars, such as gluconate, can be fermented by E. coli with less 
NAD+ regeneration required and hence more acetate and ATP is produced. These substrates 
however, enter lower glycolysis through the ED pathway, meaning a net production of only 
one ATP per glucose instead of two in the EMP pathway (Flamholz, et al., 2013). 
It has also been shown that the efflux of one of these organic acids, lactate, from the bacterial 
cytoplasm to the extracellular medium can be coupled to the symport of protons, thus 
generating an electrochemical proton gradient (Ten Brink and Konings, 1980; Verdoni, et al., 
1990), which can be used to drive ATP synthesis. A similar system is proposed for formate 
through the FocA channel (Suppmann and Sawers, 1994), although this formate:proton 
symport may only operate during formate uptake (thus actually collapsing the proton gradient) 
(Lu, et al., 2011). If the concentration of extracellular organic acid was reduced, for example 
through syntrophic consumption by another organism (McInerney, et al., 2009), this could 
allow for sustained organic acid efflux and therefore allow even greater yields of ATP to be 
generated. 
 Fermentation in other organisms 1.6.2
Other members of the Enterobacteriaceae are capable of alternative forms of fermentation. 
Klebsiella oxytoca for example is capable of fermenting glycerol (Lin, 1976), something E. coli is 
thought unable to do. Certain Klebsiella spp. and Clostridia spp. are known to perform a type 
of fermentation called acetone-butanol fermentation, whereby they produce 2,3-butanediol as 
the predominant electron sink for the regeneration of NAD+ and NADP+ (Jones and Woods, 
1986; Böck and Sawers, 1996). Amongst many of the differences between mixed-acid 
fermentation in E. coli and the Clostridial acetone-butanol fermentation is the existence of a 
pyruvate:ferredoxin oxidoreductase instead of pyruvate formatelyase, which both oxidises 
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pyruvate to acetyl-CoA and reduces ferredoxin, which is then used as the electron donor for 
hydrogen production (Jones and Woods, 1986). 
 Biohydrogen production during mixed-acid fermentation 1.6.3
For every mol of glucose hydrolysed, 12 mol of H2 could potentially be produced (C6H12O6 + 
6H2O ↔ 6CO2 + 12H2). However, much more typical yields of 2 – 4 mol of H2 per mol of 
glucose are usually observed  in H2-producing organisms (Davila-Vazquez, et al., 2008). This is 
close to the theoretical maximum of 4 mol H2 per mol of glucose oxidised (1/3 of pyruvate 
generated during glycolysis converted into formate), if acetate is the sole end product: C6H12O6 
+ 2H2O → 2CH3COOH + 4H2 + 2CO2. Of course this theoretical maximum is never achieved in 
native strains as acetate is never the sole fermentation product and some carbon must be 
assimilated into biomass. Furthermore factors such as the pH2 can have inhibitory effects on 
hydrogenase activity (Chong, et al., 2009), thus creating a bottleneck in metabolic flux through 
these enzymes, which is relieved by producing other fermentation products. 
It has been suggested that in order for biohydrogen to become commercially viable, yields of 
H2 must reach 60-80% efficiency, which is equivalent to over 7 mol H2 per mol of glucose 
(Benemann, 1996). Other studies have focussed on the rate of H2 production necessary and 
therefore the size of a reaction vessel that would be necessary to power a PEM fuel cell large 
enough to power an average house (Levin, et al., 2004). They concluded that a 10-fold increase 
in the rate of H2 production would allow a home to store a reasonably-sized bioreactor (e.g. 
one that could fit comfortably in the basement) to supply such a PEM fuel cell (Levin, et al., 
2004). 
 Synthetic biology  1.7
 An overview of synthetic biology and the development of tools for synthetic biology 1.7.1
projects 
Synthetic biology encompasses the design and engineering of novel biological parts as well as 
the reengineering of existing biological parts, which are then combined to construct new 
synthetic devices and systems. The use of the word engineering in this definition is significant 
as in addition to a “drive to make” (Schyfter, 2013), a central aim of synthetic biology is to 
standardise biological parts so they be exchanged in a “plug and play” fashion. Biological parts 
are physical DNA sequences such as transcriptional promoters, ribosome-binding sites, 
linker/insulator sequences between parts, polypeptide coding sequences, non-polypeptide 
coding sequences (e.g. sRNA regulatory sequences, ribosome encoding sequences etc.) and 
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transcriptional terminators. These parts can then be combined to construct devices/systems in 
a chosen host organism, termed a chassis. Synthetic biology projects therefore often overlap 
with aspects of metabolic engineering, protein engineering and pathway engineering, which 
has led to some disputes over its definition (Stephanopoulos, 2012), however many 
researchers in the field now happily group these fields under the umbrella of synthetic biology 
(Nielsen and Keasling, 2011). 
Technologies developed through synthetic biology research and industries that service this 
sector already generate significant revenue, the value of which is expected to reach $10.8 
billion by 2016 (Kitney and Freemont, 2012). One could argue that synthetic biology is a 
rebranding of a number of fields that have suffered from bad publicity over the last twenty 
years, including genetically modified organisms (GMOs) and nanotechnology. In an attempt to 
pro-actively engage with the public and hopefully generate public backing for new 
technologies that emerge from synthetic biology, a large section of the synthetic biology 
community are engaged in “human practices” research (Brown, 2009). A related motivation 
sees an increased emphasis on building in safety and control mechanisms to any new synthetic 
system or organism (Moe-Behrens, et al., 2013).  
An idealised synthetic biology project can be divided into a number of steps (Figure 1.13) 
(Arpino, et al., 2013). It starts with the in silico design of the desired parts, pathways and 
overall synthetic system, which can be followed by modelling studies on the hypothetical 
pathways and system, the results of which should guide further refinement of the individual 
parts.. The next step involves the in vitro construction of each individual part and the 
combination of these parts to assemble in the final synthetic pathways and systems. Finally the 
performance of these parts, pathways and systems can be tested and fully characterised both 
in vitro and in vivo and if required, further refinement of non-optimal parts performed. In 
order for these processes to become easy, quick and affordable, many tools are being 
developed to assist in silico design of parts and devices and the in vitro construction and 
combination of large sequences of DNA, as well as the construction of vast libraries of 
individual parts with specific characteristics. 
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Many computer-aided design (CAD) tools specifically for synthetic biology have been 
developed to allow in silico part, pathway and system design and modelling. Programs such as 
J5 Device Editor (Hillson, et al., 2012) facilitate the automated design of DNA assembly and 
part manipulation. Other programs, such as PIGEON, allow the visualisation of constructs with 
combinations of individual parts (Bhatia and Densmore, 2013). EUGENE allows for the 
construction of synthetic devices (pathway/system) from a wide selection of defined parts, 
based on constraints set by the individual user (e.g. level of output signal etc.) (Bilitchenko, et 
al., 2011). The ribosome-binding site calculator developed by Salis and Voigt is an invaluable 
tool for the design (or testing) of ribosome-binding sites with defined translation initiation 
rates, based on the surrounding DNA sequence (Salis, 2011). A final example of a synthetic 
biology CAD tool is TinkerCell (Chandran, et al., 2009), which allows the design and testing of 
intricate genetic circuits and synthetic devices. This software also allows the integration of 
modelling programs into its interface and also guides the final construction of the individual 
DNA sequences. A standardised visual language for synthetic parts, the Synthetic Biology Open 
Language (SBOL), has also been developed and has widely adopted (Galdzicki, et al., 2011). 
The construction of vast libraries of useful biological parts, many of which are stored in a 
central “Biobrick” repository (Registry of standard biological parts, Cambridge, Massachusetts) 
and available to synthetic biology researchers is both noble and invaluable. Libraries of 
synthetic promoters have been constructed and their strength of transcriptional initiation 
characterised (Davis, et al., 2011; Brewster, et al., 2012; Pasotti, et al., 2012; Temme, et al., 
Figure 1.13 A theoretical workflow chart for a typical synthetic biology project. In silico, in vitro and in vivo 
approaches are combined and at each stage, redesign and optimisation may be required. 
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2012). Similar libraries of synthetic ribosome-binding sites have also been developed with 
translation initiation rates measured in combination with a wide variety of promoters and 
coding sequences (Salis, et al., 2009; Temme, et al., 2012). Transcriptional terminators have 
also been developed (Temme, et al., 2012; Chen, et al., 2013) as well as insulating (linker) 
sequences between individual parts, to ensure minimal interference with promoters, RBSs and 
terminators (Lou, et al., 2012). Libraries of expression vectors have also been constructed 
specifically for biobrick cloning compatibility (Lee, et al., 2011), while other researchers are 
developing a standard European vector, pSEVA, which would allow exchange of modular parts 
(selection markers, origins of replication, multiple cloning sites etc.), which looks promising 
(Silva-Rocha, et al., 2013). As a last example of synthetic parts many researchers have 
developed libraries of polymerase-encoding genes, which when combined with promoter 
libraries allow for fully tunable levels of gene expression (Shis and Bennett, 2013). 
The greatest revolution, and possibly the driving force, behind synthetic biology has been the 
development of cheaper high-throughput DNA synthesis (<$0.28 per base pair) and assembly 
technologies (Carlson, 2009). Synthetic DNA constructs can now be designed in silico, based on 
the vast amount of genomic information available, ordered and assembled in days. Assembly 
methods such as the Biobrick assembly standard (Knight, 2003) are now being replaced with 
high-throughput one-step assembly methods such as Gibson assembly (Gibson, 2009) and 
Golden-Gate assembly (Engler, et al., 2009). New techniques allowing rapid recombination and 
DNA shuffling (Coco, et al., 2001; Bloom, et al., 2005; Edwards, et al., 2008; Bloom and Arnold, 
2009; Wang, et al., 2012) and microfluidics based DNA mutant library construction (Szita, et 
al., 2010), mean it is possible to construct novel synthetic parts with completely new functions 
(Altamirano, et al., 2000). These technologies also enable expression of metagenomic 
sequences in a chassis such as E. coli. 
 Construction of synthetic genetic circuits 1.7.2
A longstanding aim of many in the field of synthetic biology is to construct synthetic genetic 
circuits where the expression of specific genes is regulated in response to specific inputs 
(Hasty, et al., 2002). Riboswitches are small regulatory RNAs (aptamers) that can bind specific 
DNA or RNA sequence, thus inhibiting transcription or translation of these sequences, and 
whose action is controlled allosterically through the binding of a specific metabolite or ions 
(Hollands, et al., 2012). Synthetic riboswitches have been constructed to control 
transcription/translation of any desired sequence (Bayer and Smolke, 2005; Wachsmuth, et al., 
2013). Riboswitches, recombinases, repressors, libraries of promoters and terminators, have 
been combined in the construction many interesting genetic circuits in bacteria and yeast, 
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such as synthetic circuits with the ability to count the application of a specific input (Friedland, 
et al., 2009) or genetic circuits/toggle switches that can oscillate gene expression over multiple 
cycles (Elowitz and Leibler, 2000; Gardner, et al., 2000; Atkinson, et al., 2003; Fung, et al., 
2005). Decision making capabilities in the form of artificial logic gates that can respond to a 
variety of inputs have been constructed and can be orthologous or modular in nature 
(Yokobayashi, et al., 2002; van Hijum, et al., 2009). More complicated genetic circuits that can 
both record and store information over many generations (Bonnet, et al., 2012) and the 
combination of synthetic biological logic gates and synthetic DNA data storage (Siuti, et al., 
2013) have also been developed. 
 From synthetic circuits to synthetic organisms 1.7.3
Synthetic genetic circuits to date focus on a maximum of two inputs to control the expression 
a small number of output genes and have mostly been used as proofs of principle in synthetic 
biology. More complex synthetic biology projects have also been carried out. The expansion of 
the genetic code is one of the most impressive and ground-breaking achievements of synthetic 
biology to date, allowing the in vivo, site-specific incorporation of non-natural amino acids into 
a wide variety of proteins and is being used in many areas of fundamental biological research, 
as well as the construction of new functional proteins and bio-materials (Davis and Chin, 
2012). The Schultz lab were the first to successfully construct DNA sequences encoding many 
useful non-natural amino acids, through the construction of unique tRNA/tRNA synthetase 
pairs (Wang, et al., 2001; Chin, et al., 2002a; Chin, et al., 2002b; Santoro, et al., 2002; Wang, et 
al., 2002; Zhang, et al., 2002). Synthetic orthogonal ribosomes were developed by the Chin lab, 
which recognise alternative Shine Dalgarno sequences to that recognised by the native 
ribosome (Rackham and Chin, 2005). This allows polypeptides with non-natural amino acids to 
be synthesised independently to native protein production (reviewed in Chin, 2011). The 
expansion of the genetic code took another huge leap forward with the development of a 
synthetic form of nucleic acid known as XNA by the Holliger lab (Pinheiro, et al., 2012; 
Pinheiro, et al., 2013). 
Synthetic spatial organisation of cellular enzymes is another exciting area of research in 
synthetic biology. A variety of scaffolds have been constructed to bring enzymes closer 
together in order to increase reaction rates. These include various protein scaffolds (Dueber, et 
al., 2009; Agapakis, et al., 2010) as well as RNA scaffolds (Delebecque, et al., 2011; reviewed in 
Thodey and Smolke, 2011). Empty proteinaceous bacterial microcompartments, such as that 
used in the propanediol utilisation (Pdu) pathway of Salmonella have been synthetically 
expressed in a variety of chasses and a variety of proteins can be targeted into this 
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microcompartment using a short signal peptide (reviewed in Parsons, et al., 2010; Frank, et al., 
2013). Another bacterial microcompartment, the CO2 fixing microcompartment (carboxysome) 
from Thiobacillus neapolitanus has been heterologously expressed in an E. coli chassis and is 
functional at CO2 fixing both in vivo and in vitro (Bonacci, et al., 2012).  
The next development in synthetic biology is sure to be the construction of a fully synthetic 
organism. An extremely well-publicised first attempt in the “creation” of a synthetic bacterium 
was recently published (Gibson, et al., 2010). This team assembled a stripped down version of 
the Mycoplasma mycoides genome, both to understand the minimal set of genes required for 
life and to provide an ideal and robust platform for future synthetic biology devices (Gibson, et 
al., 2010). This project also led to the development of the high-throughput DNA assembly 
method known as Gibson assembly (Gibson, 2009). Recently a number of groups have started 
engineering the Gram-negative soil bacterium Pseudomonas putida as a specialised synthetic 
biology chassis (Poblete-Castro, et al., 2012). 
  
39 
 
 Aims 1.8
The aim of this thesis was to explore different approaches to enhancing biohydrogen 
production in E. coli. This will involve combining modern synthetic biology concepts with 
traditional molecular biology and metabolic engineering technologies. The research has the 
following specific objectives. 
1. To design, construct and characterise a synthetic [FeFe]-hydrogenase 
2. To integrate a synthetic NADH-dependent hydrogenase into the central metabolism of E. 
coli 
3. To re-purpose E. coli Hyd-2 for respiratory H2 production using chimeric enzymes 
4. To examine the use of glycerol as substrate for H2 production by E. coli 
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2. In vitro characterisation 
of a synthetic [FeFe]-
hydrogenase 
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 Introduction  2.1.1
2.1.1.1 Heterologous expression of hydrogenases to increase H2 production 
In order for biohydrogen production to become commercially viable, H2 yields must be 
increased to close to the maximum theoretical yield of H2. Heterologous expression of 
hydrogenases from other H2-producing organisms is an attractive strategy to improve H2 
yields. Non-native hydrogenases with alternative catalytic properties, cellular localisations, or 
substrate specificities may offer an advantage over native hydrogenases. [FeFe]-hydrogenases 
have H2-production activities that are 10 – 100 times greater than [NiFe]-hydrogenases and are 
therefore attractive candidates for enhanced H2 production projects (Adams, 1990; Frey, 
2002). Recent identification and elucidation of the roles of each of the [FeFe]-hydrogenase 
accessory maturases, HydE, HydF, and HydG (Posewitz, et al., 2004), has allowed successful co-
expression of these maturases and a variety of non-native [FeFe]-hydrogenases in E. coli, 
resulting in active enzyme (Posewitz, et al., 2004; King, et al., 2006). Most of these studies 
were, however, designed to investigate the H-cluster maturation proteins and used 
hydrogenases such as those from Clostridium acetobutylicum or Chlamydomonas reinhardtii, 
whose natural electron donor is reduced ferredoxin. Ferredoxin is an electron carrier that does 
not appear to form a central part of E. coli metabolism. NAD+/NADH are the main electron 
carriers used by E. coli during glycolysis and fermentation and a hydrogenase that could accept 
electrons from NADH would therefore be desirable. 
2.1.1.2 An NADH-dependent [FeFe]-hydrogenase with high specific activities 
Thermoanaerobacter tengcongensis (Tte; recently reclassified as Caldanaerobacter 
tengcongensis) is a thermophilic Gram-negative bacterium found in hot springs in China (Xue, 
et al., 2001) that expresses two hydrogenases, one of which has been described as a soluble 
[FeFe]-hydrogenase that produces H2 with NADH as the sole electron donor (Soboh, et al., 
2004). The enzyme was originally purified under anaerobic conditions and consisted of a four 
subunit complex: HydA; HydB; HydC and HydD. The genes encoding these products were 
identified and were found to be organised a single gene cluster: TTE0890-TTE0894, which 
corresponds to: hydC; a gene of unknown function – product not found in purified enzyme; 
hydD; hydB; and hydA, respectively. HydA is the large 64 kDa H-cluster-containing catalytic 
subunit predicted to contain an additional three [4Fe-4S] clusters and one [2Fe-2S] cluster. 
HydB is a large 65 kDa diaphorase subunit, with sequence similarity to NADH dehydrogenases 
and 65% overall sequence identity with HydB from Thermotoga maritima (Verhagen, et al., 
1999). It is thought to contain a flavin a part of the NAD(H)-binding site, three [4Fe-4S] clusters 
and one [2Fe-2S] cluster. HydC has a molecular mass of 20 kDa and shares 47% overall 
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sequence identity to HndA of Desulfovibrio fructosovorans and is thought to ligate a single 
[2Fe-2S] cluster. HydD has a molecular mass of 14 kDa and shares 36% sequence identity with 
HndB of Desulfovibrio fructosovorans and is likely to ligate an FeS cluster (Soboh, et al., 2004). 
The purified enzyme displayed high H2 oxidation and production rates with methyl viologen 
(MV) as the artificial electron acceptor/donor (both at 1700 U; 1U = µmol H2 min-1 mg-1) and 
with NAD+/NADH as electron acceptor/donor (5/10 U respectively). The purified enzyme was 
found to contain FMN at the ratio of 1 mol FMN per mol enzyme and an excess of FMN was 
required in all buffers during purification for significantly-increased hydrogenase activity 
(Soboh, et al., 2004). 
 
 
 
 
  
Figure 2.1 Schematic of Ca. tengcongensis NADH-dependent [FeFe]-hydrogenase. The exact type of FeS 
cluster in HydD is still unknown but shown here as [2Fe-2S] cluster. 
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 Aims 2.2
This Chapter aims to construct, express and characterise a synthetic NADH-dependent H2-
producing [FeFe]-hydrogenase. This requires design of a synthetic operon encoding the 
hydrogenase structural genes, as well as provision of essential maturation proteins that will 
help build the [FeFe] catalytic centre in an E. coli chassis. Full comprehensive characterisation 
of each synthetic construct is planned, including both physical characterisation of all parts as 
well as functional characterisation of the synthetic hydrogenase enzyme. 
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 Results 2.3
 The design, construction and expression of a synthetic [FeFe]-hydrogenase operon 2.3.1
As a starting point, the soluble, thermostable NADH-dependent [FeFe]-hydrogenase operon of 
Thermoanaerobacter tengcongensis (Tte; recently reclassified as Caldanaerobacter 
tengcongensis) was chosen (Soboh, et al., 2004). The constituent parts chosen to build a 
synthetic operon were the five genes hydC, TTE0891, hydD, hydB, and hydA. The primary 
amino acid sequences were back translated into DNA sequence, which was then codon 
optimised to ensure efficient translation in an E. coli chassis using the OPTIMIZER software 
(Puigbo, et al., 2007). This gave final codon adaptation indices (CAIs), which is a comparison 
between the codon usage in a given DNA sequence and a reference set of highly expressed 
genes from the same species (Sharp and Li, 1987), for each gene  of 0.759 for hydC; 0.742 for 
tte0891; 0.796 for hydD; 0.768 for hydB; and 0.747 for hydA (for comparison, a score of 0 = 
very different and unlikely to be translated in new host, while a score of 1 = identical to codon 
usage of new host and very likely to be translated). This indicates that heterologous expression 
of all synthetic genes should be successful in an E. coli K-12 chassis based on known tRNA 
abundances. In addition, sequences were designed so that commonly-used restriction sites 
were omitted.  
A synthetic RBS and spacer sequence was included upstream of each synthetic gene: 
AGGAGGAAAAAAA. This sequence (along with the sequence upstream of the RBS and spacer, 
and the coding sequence itself) was analysed using the RBS CALCULATOR software (Salis, et al., 
2009), which allows the efficiency of translation initiation to be predicted. This software uses a 
thermodynamic model to quantify the free energies involved in the rate limiting step of 
translation initiation (calculated from the Gibbs free energies associated with mRNA secondary 
structure, 16S rRNA binding, etc.). The translation initiation rates (based on experimental 
validation of predictive model with transcriptional fusions of a library of RBSs to rfp; given in 
fluorescence units) and the ∆Gtotal (the difference in Gibbs free energies between the separate 
mRNA transcript and free 30S complex and the 30S assembled pre-initiation complex on the 
mRNA transcript; measured in kcal/mol) are shown in Table 2.1. All genes except hydB show 
strong translation initiation rates and very favourable ∆Gtotal values, indicating that this 
synthetic construct should be translated efficiently in E. coli. The hydB gene sequence appears 
to suffer from very strong mRNA secondary structure. These results show the sequence 
upstream of the RBS as well as the coding sequence itself can affect translation initiation. 
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The five synthetic sequences were then brought together to form a synthetic operon in which 
the natural gene order (hydC, TTE0891, hydD, hydB, and hydA) was maintained. Finally, unique 
restriction site sequences were chosen to separate each gene at which point the design phase 
was considered complete (Figure 2.2). The complete 5,104 bp operon was then synthesised 
and assembled as a service by Biomatik Corp (USA). 
 
Once complete, the synthetic operon was subcloned into the E. coli expression vector, pUNI-
PROM (Jack, et al., 2004), which contains both the commonly used inducible T7 promoter 
(PT7lac) and the constitutive promoter of the E. coli tat operon (Ptat) giving the final construct 
pUNI-Tte-Hyd (Figure 2.3A). The tat promoter is a well characterised promoter that conveys 
constitutive expression of genes under its regulation in both aerobic and anaerobic respiratory 
conditions (900 Miller units when studied in situ with a RBS and spacer sequence 
AGAGGAACATGT and the lacZ reporter gene placed downstream) as well as under 
fermentative conditions (430 Miller units) (Jack, et al., 2001). 
Table 2.1 Analysis of the RBS and spacer used upstream of each gene in synthetic hydrogenase operon using 
RBS CALCULATOR. Translation initiation rate is based on experimental validation with transcriptional fusion of 
a library of RBSs to rfp of predictive model. ∆Gtotal shows how energetically favourable the formation of the 
pre-initiation complex is. ∆GmRNA:rRNA shows how energetically favourable the binding of the 16S rRNA is. 
∆GmRNA shows how strong the secondary structure mRNA transcript is folded. The same RBS and spacer 
sequence was used before each gene, AGGAGGAAAAAAA. RBS CALCULATOR was published by (Salis, et al., 
2009) 
 Translation initiation rate (Au) 
∆Gtotal 
(kcal/mol) 
∆GmRNA:rRNA 
(kcal/mol) 
∆GmRNA 
(kcal/mol) 
hydC 51287.28 -6.71 -11.98 -5.79 
TTE0891 129028.73 -8.76 -13.38 -5.14 
hydD 258037.37 -10.30 -17.38 -7.60 
hydB 1778.21 0.76 -12.38 -13.66 
hydA 30703.96 -5.57 -12.38 -7.33 
Figure 2.2 The final synthetic construct encoding the Ca. tengcongensis [FeFe]-hydrogenase. Each gene in the 
native TTE0890-0894 operon was codon-optimised for expression in E. coli and has its own upstream synthetic RBS 
and spacer. Unique restriction enzyme sites were inserted to allow simple subcloning. 
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In order to validate that each gene in the synthetic operon was being correctly transcribed and 
translated the engineered restriction sites were used to modify the pUNI-Tte-Hyd plasmid. A 
bank of six new plasmids were constructed each carrying specific gene deletions. These were 
termed pUNI-Tte-Hyd∆hydC, pUNI-Tte-Hyd∆TTE0891, pUNI-Tte-Hyd∆hydD, pUNI-Tte-
Hyd∆hydB, pUNI-Tte-Hyd∆hydA, and pUNI-Tte-Hyd∆hydAB. The seven synthetic constructs 
were next used in 35S-Methionine radiolabelling experiments. E. coli strain K38 (containing 
plasmid pGP1-2, a temperature-sensitive plasmid that encodes T7 polymerase) was 
transformed separately with pUNI-Tte-Hyd, pUNI-Tte-Hyd∆hydC, pUNI-Tte-Hyd∆tte0891, 
pUNI-Tte-Hyd∆hydD, pUNI-Tte-Hyd∆hydB, pUNI-Tte-Hyd∆hydA, and pUNI-Tte-Hyd∆hydAB 
respectively. Cultures of M9 minimal medium lacking cysteine and methionine were labelled in 
vivo for 15 min by the addition of 35S-methionine. Samples were then analysed by SDS-PAGE 
(12% w/v polyacrylamide gels), fixed, and visualised by autoradiography. Clear, radiolabelled 
protein bands could be assigned to each synthetic gene product (Figure 2.3B), confirming both 
transcription and translation of each gene in the E. coli chassis. 
  
B 
A 
Figure 2.3 35S-methionine radiolabelling confirms production of all gene products from the synthetic 
operon. E. coli strain K38/pGP1-2 was transformed with plasmids: pUNI-Tte-Hyd; pUNI-Tte-Hyd∆hydC; 
pUNI-Tte-Hyd∆tte0891; pUNI-Tte-Hyd∆hydD; pUNI-Tte-Hyd∆hydB; pUNI-Tte-Hyd∆hydA; and pUNI-
Tte-Hyd∆hydAB and minimal M9 cultures lacking cysteine and methionine were labelled for 15 min by 
the addition of 35S-methionine. Protein samples were then separated by SDS-PAGE (12% w/v 
polyacrylamide), fixed, and visualised by autoradiography. 
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 The design, construction & expression of a synthetic [FeFe] active-site maturase 2.3.2
operon 
A complex suite of maturation proteins are required in order to both assemble and insert the 
[FeFe] active site into the large catalytic subunit of HydA. While the Hyp accessory proteins, 
required for assembly of the [NiFeCO2CN] cofactor in a [NiFe]-hydrogenase, appear to the 
species-specific the same cannot be said of the genes required for H-cluster assembly. The γ-
Proteobacterium Shewanella oneidensis is closely related to E. coli but encodes a periplasmic 
[FeFe]-hydrogenase in its genome. Co-expressed with the [FeFe]-hydrogenase structural genes 
are four open reading frames SO_3923 (hydG), SO_3924 (a gene of unknown function – hydX), 
SO_3925 (hydE), and SO_3926 (hydF), that are thought to encode maturation proteins for H-
cluster assembly. Indeed, during the course of this work, Sh. oneidensis and its hydGXEF genes 
have been successfully used in heterologous expression studies of [FeFe]-hydrogenases 
(Kuchenreuther, et al., 2010). 
Initially, the codon usage of the native Sh. oneidensis hydGXEF genes was analysed using 
OPTIMIZER (Puigbo, et al., 2007). The codon adaptation indices for hydG, hydX, hydE, and hydF 
were all above the lower threshold figure of 0.3 (0.413; 0.337; 0.319; and 0.323 respectively), 
meaning all genes could be translated in E. coli. The four gene operon containing SO_3923 
(hydG); SO_3924 (hydX); SO_3925 (hydE) and SO_3926 (hydF) was amplified by PCR from Sh. 
oneidensis genomic DNA and subsequently cloned directly into pUNI-PROM (AmpR; PT7lac; Ptat) 
and pSU-PROM (KanR; Ptat) (Jack, et al., 2004), with only one engineered RBS and spacer before 
the first gene in the operon, to give the plasmids pUNI-Sh-EFG and pSU-Sh-EFG (Figure 2.4A). 
To examine the translational efficiency of the cloned genes, the pUNI-Sh-EFG plasmid was used 
in a radiolabelling experiment in the E. coli chassis. Unfortunately, not all gene products could 
be confidently identified using this method. Only two prominent bands were evident migrating 
at 52 and 43 kDa (Figure 2.4B). In comparison, the predicted sizes of the hydGXEF gene 
products are 52 kDa, 23.5, 39.5 and 43 kDa respectively. 
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In an attempt to identify which genes were being translated a set of restriction digests were 
performed. The pUNI-Sh-EFG vector was digested with XhoI, which will remove a portion of 
the final gene in the operon SO_3926 (hydF). Subsequent radiolabelling experiments 
established that the prominent band migrating at 43 kDa was HydF. Next, the pUNI-Sh-EFG 
vector was digested with SacI, which will remove a portion of the first gene in the operon 
SO_3923 (hydG). In this case the prominent band migrating at 52 kDa was identified as HydG. 
Interestingly, therefore, despite transcription being driven from a single T7 promoter in this 
experiment, it is the first and last genes of the four-cistron operon that are most efficiently 
translated and the most stable in the cell. Expression of neither SO_3924 (hydX) nor SO_3925 
(hydE) could be confirmed by this method (Figure 2.5). 
 
Figure 2.4 35S-methionine radiolabelling indicates problems with translation of 
Shewanella genes in E. coli. E. coli strain K38/pGP1-2 was transformed with pUNI-Sh-EFG 
and cultures of M9 minimal medium lacking cysteine and methionine were labelled for 15 
min by the addition of 35S-methionine. Protein samples were then separated by SDS-PAGE 
(14% w/v polyacrylamide), fixed, and visualised by autoradiography. HydG has a predicted 
molecular mass of 52 kDa, HydF has a predicted molecular mass of 43 kDa. HydE has a 
predicted molecular mass of 39.5 kDa and HydX has a predicted molecular mass of 23.5 
kDa. 
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Figure 2.5 The hydE gene is not translated efficiently in the E. coli chassis. E. coli strain 
K38/pGP1-2 was transformed with plasmids: pUNI-Sh-EFG; pUNI-Sh-EFGSacI; pUNI-Sh-EFGClaI; pUNI-
pUNI-Sh-EFGXhoI; pUNI-Sh-EFGNcoI and minimal M9 cultures lacking cysteine and methionine were 
labelled for 15 min by the addition of 35S-methionine. Protein samples were then separated by 
SDS-PAGE (14% w/v polyacrylamide), fixed, and visualised by autoradiography. pUNI-Sh-EFGXhoI 
allows identification of HydF (predicted molecular mass of 43 kDa). pUNI-Sh-EFGSacI and pUNI-Sh-
EFGNcoI allows identification of HydG (predicted molecular mass of 52 kDa). pUNI-Sh-EFGClaI allows 
identification of HydE (predicted molecular mass of 39.5 kDa). HydX has a predicted molecular 
mass of 23.5 kDa but could not be identified. 
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 Optimising expression of the H-cluster maturation genes 2.3.3
Although HydG and HydF are being produced from the pUNI-Sh-EFG vector, this is unlikely to 
be sufficient to assemble the active site H-cluster. The activity of HydE is essential for 
maturation, as mutation of its three anion-binding residues reduced [FeFe]-hydrogenase 
activity (Nicolet, et al., 2008) and its similarity to other AdoMet radical proteins suggests it is 
responsible for the synthesis of the bridging aminedithiolate ligand on the 2Fe scaffold of HydF 
(Nicolet, et al., 2010; Peters and Broderick, 2012). In an attempt to induce expression of hydE, 
and remove some of the native regulatory elements possibly hidden in the native Sh. 
oneidensis operon structure, it was decided to clone both halves of the operon (hydGX and 
hydEF) separately into the dual expression vector pACYC-Duet. The pACYC-Duet vector has two 
multiple cloning sites both under the control of separate PT7lac promoters and also contains 
lacI, encoding the repressor of the lac operon. Each half-operon was amplified by PCR and 
cloned with the initial gene in each half enjoying the same RBS and spacer sequence 
(AGGAGGAAAAAAA). The resultant plasmid, pDuet-Sh-GX-EF, was then analysed by 35S-
Methionine radiolabelling experiments. In this case, crucially, all the major maturation genes 
were found to be transcribed and translated (Figure 2.6). 
Next, the entire RBS–spacer-hydGX-TermT7-hydEF DNA fragment from pDuet-Sh-GX-EF was 
subcloned into pSU23 (Bartolome, et al., 1991), which, unlike pACYC-Duet, does not encode 
the LacI repressor. This lead to increased expression levels relative to pDuet-Sh-GX-EF as 
observed by radiolabelling experiments (Figure 2.6). Finally, as repression or careful induction 
of expression of S. oneidensis operon was not thought to be required, the E. coli tat promoter 
(Ptat) was introduced upstream of the first gene to yield pSUtat-Sh-GX-EF. This removed the 
need to co-express with a plasmid encoding T7 polymerase (e.g. pGP1-2),  
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Figure 2.6 35S-methionine radiolabelling confirmed the production of each maturation gene after 
optimisation. E. coli strain K38/pGP1-2 was transformed with plasmids: pDuet-Sh-GX-EF; pSU23-Sh-
GX-EF and minimal M9 cultures lacking cysteine and methionine (supplemented with 10 mM IPTG; 
necessary to induce expression of genes on pDuet-Sh-GX-EF plasmid; not necessary for pUNI-Sh-EFG or 
pSU23-Sh-GX-EF however) were labelled for 15 min by the addition of 35S-methionine. Protein samples 
were then separated by SDS-PAGE (14% w/v polyacrylamide), fixed, and visualised by autoradiography. 
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 Purification and structural characterisation of a synthetic hydrogenase complex 2.3.4
To facilitate in vitro characterisation of the synthetic Ca. tengcongensis  [FeFe] hydrogenase 
complex, the plasmid pUNI-Tte-HydhisC was constructed, which is identical to the pUNI-Tte-Hyd 
vector except  that it encodes a version of HydC that carries an N-terminal hexa-Histidine tag. 
In theory, any intact complex could then be easily purified using immobilised metal affinity 
chromatography (IMAC). During the course of this work, an increase in the activity of a 
heterologously-expressed [FeFe]-hydrogenases has been reported when expressed in an E. coli 
iscR mutant (Kuchenreuther, et al., 2010). As a result the E. coli strain PK4854 (as MG1655 
∆iscR) was chosen as the host strain for all subsequent experiments.  
PK4854 was transformed with pSUtat-Sh-GX-EF and pUNI-Tte-HydhisC and this was used to 
inoculate 5 litre anaerobic LB cultures supplemented with 0.4 % (w/v) glucose, 2 mM cysteine, 
2 mM ferric ammonium citrate and the appropriate antibiotics. The cultures were incubated at 
37 °C for ~16 hours before the cells were harvested and then lysed using either BPER (contains 
detergent) or sonication. The resultant crude cell extract was loaded to a Ni2+ Sepharose™ high 
performance column (GE Healthcare), washed and bound proteins eluted by the application of 
an imidazole gradient. As [FeFe]-hydrogenases are notoriously sensitive to irreversible 
inactivation by O2, all buffers were maintained as anaerobic as possible by degassing and 
constant bubbling with N2. In addition, cell pellets and crude extracts were flushed with Ar 
throughout the purification protocol. Aliquots of individual peak fractions were immediately 
flushed with Ar, aliquoted and flash frozen in liquid N2 before being stored under Ar at -80 °C. 
Individual peak aliquots were analysed by SDS-PAGE (Figure 2.9). Strong bands corresponding 
to the expected sizes of each of the four subunits of the synthetic [FeFe] hydrogenase were 
observed and the identification of each subunit was further confirmed by tryptic peptide mass-
fingerprinting (HydA, HydB and HydD). The identification of HydC was confirmed by western 
immunoblotting using an α-pentaHis antibody (Figure 2.8).  
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Figure 2.7 Visible-light spectroscopy of purified enzyme shows characteristic FeS-cluster shoulders at 420 
and 450 nm. Purified enzyme was diluted 1:1 with 100 mM sodium phosphate buffer pH 6.0 and analysed 
over wavelengths from 330 to 710 nm. 
 
Figure 2.9 Purification of synthetic [FeFe]-hydrogenase using IMAC. E. coli strain PK4854 
(∆iscR) was transformed with plasmids: pUNI-Tte-HydhisC and pSUtat-Sh-GX-EF. This was 
used to inoculate 5 litre overnight, anaerobic cultures of L.B. supplemented with 0.4 % 
(w/v) glucose, 2 mM cysteine, 2 mM ferric ammonium citrate and the appropriate 
antibiotics. Cells were harvested and lysed using sonication. Crude cell extract was loaded 
onto a HisTrap™ HP column and eluted by an imidazole gradient (buffer B: 1 M imidazole). 
All steps were carried out under Ar. Peak fractions were collected, separated on 14% SDS-
PAGE gel and visualised after staining with Coomassie Blue. Each subunit was identified 
using tryptic peptide mass fingerprinting. 
Figure 2.8 Identification of HydC confirmed by α-His 
immunoblotting. Purified hydrogenase was separated on a 
14% SDS-PAGE gel, followed by a semi-dry transfer to 
nitrocellulose membrane and the band corresponding to 
HydC confirmed by immunoblotting using an α-pentaHis 
antibody. 
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A collaboration with Prof. Bill Hunter’s Structural Biology group at the University of Dundee 
was initiated to investigate the structure of the synthetic hydrogenase. A number of 
purifications, followed by size-exclusion chromatography (S.E.C.) and crystallisation screens 
with a wide variety of conditions were performed, however no crystals were obtained. 
During S.E.C. the enzyme complex was observed to elute at a volume indicating it had a 
molecular mass of approximately 320 kDa, which was approximately double the expected 
molecular mass of the four subunit enzyme. This merited further investigation. Size-exclusion 
chromatography – multi-angle laser light scattering (SEC-MALLS) experiments were carried out 
on purified enzyme from cells that had been lysed using the BPER chemical cocktail. The 
protein was concentrated and resolved on a MAbPac SEC– 1 (Dionex). The column was linked 
in series to two detectors: a laser photometer that continuously fires a laser at the eluent, thus 
scattering the beam and measuring the intensity of the scattered beam at different angles; and 
a refractive-index detector that determines accurate relative sample concentration. This allows 
information such as molecular mass, polydispersity and the radius of the complex to be 
accurately calculated. The purified enzyme appeared to form a stable large monodisperse 
complex containing each of the four subunits (confirmed by SDS-PAGE; Figure 2.11). The 
enzyme purified using the BPER lysis method, forms a monodisperse complex with a molecular 
weight of 325 kDa (±0.1%) and has a radius of 11.9 nm (±3.3%) (Figure 2.10). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10 SEC-MALLS analysis of the purified synthetic hydrogenase complex. After Ni-IMAC, 
1 mg of enzyme purified using the BPER method of lysis was loaded onto a MAbPac SEC– 
1 (Dionex) column. The molar mass of the eluent was calculated from light-scattering and 
differential refractive index measurements. The continuous line represents the absorbance at 
280 nm of the eluent against time and the dotted line represents the weight-average molecular 
weight of the species in the eluent. The purified enzyme forms a monodisperse complex 
containing all four subunits, with a radius of 11.9 nm. 
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Figure 2.11 SDS-PAGE analysis of the synthetic enzyme 
following SEC-MALLS. The peak fraction from SEC-MALLS 
analysis was collected, concentrated and separated on 
12% SDS polyacrylamide gel, followed by staining with 
Instant Blue™ Coomassie stain. 
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 Purified synthetic hydrogenase displays H2-oxidation and H2-reduction activity in 2.3.5
vitro 
The next stage in the functional characterisation of the synthetic hydrogenase was to assay its 
ability to either oxidise or evolve H2 with an artificial electron acceptor or donor. Benzyl 
viologen (BV) was chosen as the electron acceptor as its standard reduction potential (E0’ -348 
mV) is above that of the H+/½ H2 redox couple (E0’ -420 mV) and methyl viologen (MV) as the 
electron donor (E0’ -443 mV) as it is a stronger reducing agent. For BV reduction, one activity 
unit (U) is defined as 1 µmol BV reduced min-1 mg-1 cells. For MV-dependent H2 production, 
one unit (U) is defined as 1 µmol H2 evolved min-1 mg-1 cells. 
Synthetic enzyme purified from cells co-expressing pSUtat-Sh-GX-EF and lysed by sonication, 
catalysed the reduction of BV with H2 as the electron donor, with a specific activity of 38 U 
(when assayed in pH 8.0 Tricine buffer) or 24 U (pH 8.0 Tris HCl) (Figure 2.12B). This was >40 
times higher (0.6 U) than enzyme purified from cells co-expressing the pSU23-Sh-GX-EF (and 
T7 polymerase-encoding pGP1-2) lysed using BPER, even when all steps were performed in an 
MBraun Labstar™ anaerobic glove box. Trace activity was observed when enzyme was purified 
from cells co-expressing the original Sh. oneidensis accessory plasmid, pSU-Sh-EFG (0.01 U). 
Synthetic Ca. tengcongensis [FeFe]-hydrogenase purified using the sonication method also 
demonstrated good H2-evolution activity with reduced MV as the artificial electron donor (5 U) 
(Figure 2.12A). Again, this was much higher than the rate observed for enzyme purified from 
cells lysed with BPER and co-expressing the original Sh. oneidensis accessory plasmid, pSU-Sh-
EFG (0.8 U). 
Disappointingly, no NADH-dependent production of H2 was observed under a number of 
different assay conditions, despite H2 production with the artificial electron donor MV being 
demonstrated. Synthetic Ca. tengcongensis [FeFe]-hydrogenase was also unable to catalyse 
the oxidation/reduction of NADH/NAD+ during spectroscopic experiments (absorbance of 
NADH monitored at 340 nm). 
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Figure 2.12 Purified synthetic [FeFe]-hydrogenase displays hydrogenase 
activity in vitro . After Ni-IMAC, purified enzyme from cells coexpressing one of 
the three accessory plasmids: pSU-Sh-EFG; pSU23-Sh-GX-EF; or pSUtat-Sh-GX-
EF, and lysed either by sonication or using Bacteria Protein Extraction Reagent 
(BPER) was assayed for hydrogenase activity. (a) Methyl viologen (MV)-
dependent H2 production was measured in a modified Clark-type electrode. 
100 mM sodium phosphate buffer pH 6.0 was added to the reaction chamber, 
to which 12.5 mM MV and 650 µM sodium dithionite was added. The reaction 
was initiated by the addition of 10 µg of purified Tte enzyme. (b) Benzyl 
viologen (BV) reduction (H2 oxidation) was monitored at 578 nm in a UV-vis 
spectrometer. 1 ml quartz cuvettes were filled with H2-saturated buffer (50 
mM Tris HCl pH 8.0 or 50 mM Tricine pH 8.0) and 13 mM BV. This was titrated 
with sodium dithionite to an absorbance of 0.4 - 0.7 and the reaction started 
by the addition of 20 µg of purified Ca. tengcongensis enzyme. Error bars 
represent the standard error of three independent experiments. 
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 Investigation of possible bifurcating mechanism of Ca. tengcongensis hydrogenase 2.3.6
It was recently shown that the soluble [FeFe]-hydrogenase from Thermotoga maritima has an 
interesting bifurcating mechanism of hydrogen production, where it uses reduced ferredoxin 
in combination with NADH, synergistically, as electron donors for H2 (Schut and Adams, 2009). 
The reduced ferredoxin is a product of the oxidation of pyruvate to acetyl-CoA catalysed by the 
pyruvate ferredoxin oxidoreductase. 
Pyruvate (CH3COCOO-) + CoA + 2Fdox ↔ acetyl-CoA + CO2 + 2H+ + 2Fdred 
Indeed, in the course of this research a number of other studies have described or suggested a 
bifurcating mechanism of H2 metabolism in certain [FeFe]-hydrogenases (Huang, et al., 2012; 
Rydzak, et al., 2012; Schuchmann and Muller, 2012). 
The three subunits HydA, B and C of the Th. maritima [FeFe] hydrogenase share high sequence 
identity and similarity to the Ca.tengcongensis hydrogenase subunits (HydA, B and C):  Ca. 
tengcongensis HydA has 43% overall sequence identity and 59% overall similarity with Th. 
maritima HydA; Ca.tengcongensis HydB shares 56% identity and 71% similarity with Th. 
maritima HydB; and Ca. tengcongensis Hyd C shares 48% identity and 70% similarity with Th. 
maritima HydC. It was therefore decided to investigate whether a similar mechanism was 
involved in H2 production by the Ca.tengcongensis enzyme. 
The gene TM0927 (encoding a ferredoxin (Fd)) and the operon TM0015-TM0018 (encoding the 
γ, δ, α & β subunits of a pyruvate-ferredoxin oxidoreductase (POR)) were cloned from Th. 
maritima genomic DNA into pUNI-PROM expression vectors. Successful heterologous 
expression of both the Th. maritima ferredoxin-encoding gene and the POR-encoding operon 
was confirmed using 35S-methionine radiolabelling (Figure 2.13A). Both pyruvate-ferredoxin 
oxidoreductase and ferredoxin were purified using IMAC and the pyruvate-
oxidation/coenzymeA-acetylation activity of POR was assayed (2 µmol BV reduced min-1 mg-1). 
Furthermore, size-exclusion chromatography (and SDS-PAGE analysis) of the purified His-
tagged POR complex on its own (Figure 2.13 B and C) and when co-expressed with a non-
affinity-tagged Fd (Figure 2.13 B and D) indicated a probable interaction between the 
heterologously-expressed POR and Fd. In vivo assays where the Ca.tengcongensis hydrogenase 
and the Th. maritima POR/Fdred system were combined to test for H2 production in a 
bifurcating-dependent manner were initiated, but were inconclusive upon cessation of 
experimental work.  
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Figure 2.13 Heterologous expression, purification and characterisation of Th. maritima POR and Fd. A. 35S 
Methionine radiolabelling of pUni-Tma-POR and pUNI-Tma-Fd6 followed by SDS-PAGE and autoradiography. B. 
Size-exclusion chromatography of Ni2+-IMAC purified POR enzyme (black dashed lines) and POR & Fd (grey dashed 
lines) indicates that POR complex purifies as a dimer of the four subunits and also indicates that this POR dimer 
interacts with 4 Fds. C. SDS-PAGE analysis of the peak fraction from size-exclusion chromatography of POR. Each of 
the four subunits was identified by tryptic-peptide mass fingerprinting. D. SDS-PAGE analysis of the peak fraction 
from size-exclusion chromatography of POR. The band at approximately 16 kDa could be the Fd in complex with 
POR. 
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 Discussion 2.4
 Standardisation of characterisation of parts and systems in synthetic biology 2.4.1
Standardisation in the field of synthetic biology is a major focus of current discussion. The 
famous “Biobrick” standard developed by the Knight lab has gained most traction in the drive 
to standardise the construction of standardised genes, promoters, RBSs, etc., in order to 
permit the true engineering of biology (Shetty, et al., 2008). Standard cloning and expression 
vectors (Silva-Rocha, et al., 2013) and even standard minimal organisms/chasses (Gibson, et 
al., 2010) are also under construction. 
The standardisation of the characterisation of biological parts and synthetic systems however, 
is a much more difficult ambition to realise. It has been suggested that a concerted effort to 
standardise the way synthetic parts, pathways, systems and organisms are characterised 
would lead to more predictable and effective construction of synthetic pathways and systems. 
This would allow for true modularity (“plug and play”) of biological parts, in much the same 
way that engineering device standards allow an engineer to evaluate a particular part in the 
design of predictable complex systems (Arkin, 2008). In synthetic biology however, it is 
extremely difficult to work out what the “proper characterisation” of a part/system means. 
Variables such as the plasmids used, the type of growth media used, the temperature the cells 
were grown at and whether a part has been chromosomally integrated or introduced on 
expression vectors have to be taken into consideration. More complex systems such as 
synthetic secretion systems and redox enzyme systems will always require massive tinkering in 
order to optimise their activity, and this makes standardisation extremely difficult to 
implement (Arkin, 2008). In addition to these technical obstacles to standardisation, it’s very 
possible that “over-standardisation” could lead to a lack of innovation, where exciting and 
important serendipitous results/breakthroughs are missed. 
Standardisation of characterisation until now has been mostly limited to biological parts that 
control gene expression/translation, i.e. promoter libraries, RBSs, negative/positive gene 
expression feedback loops. They typically involve the transcriptional fusion of a promoter/RBS 
to GFP/RFP/LuxR and in these situations quantitative characterisation of these parts is 
possible. There are huge limitations and flaws with this type of approach as when these same 
parts are subsequently placed upstream of another gene, perhaps encoding a structural 
protein or an enzyme, the codon usage, length and secondary structure of the mRNA 
transcript is completely different to that of GFP/RFP etc.  
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Possibly for this reason and others, characterisation of the activity of a more complex system 
usually relies upon a qualitative yes/or observation of the whole system, rather than true 
biochemical characterisation of each individual step. Indeed, although in vitro reconstruction 
of a synthetic metabolic pathway is recognised as essential for true meaningful 
characterisation of a synthetic system (Bayer, 2010), very few synthetic biology studies take 
this approach. One excellent recent paper outlining this kind of comprehensive approach to 
the in vitro characterisation of each step in a metabolic pathway, was the refactoring of the 
nitrogen fixation gene cluster performed by the Voigt lab at MIT (Temme, et al., 2012). 
Building on preliminary work where they constructed huge libraries of promoters and RBSs 
(characterised using fusions to GFP/RFP etc.), individual refactored (randomised DNA; removes 
native internal regulation) operons were put under the control of a series of promoters with 
increasing strength and the activity of the products of each operon measured relative to the 
WT operons. Through this meticulous method the optimum level of expression for each 
refactored operon was identified and then operons were combined to construct the final 
complex synthetic metabolic pathway and the final enzymatic activity measured (Temme, et 
al., 2012). 
Perhaps at this stage of synthetic biology, a more useful standardisation of characterisation 
would be the comprehensive documentation of both the physical characteristics of constructs 
(e.g. a detailed file including sequenced constructs with full decoration of features such as 
promoters, RBSs, ORFs, terminators etc.) and performance characteristics such as expression 
data (e.g. qPCR or in the near future, RNA sequencing), in vitro biochemical characterisation 
(protein levels, localisation etc.) as well as performance measurements of individual parts 
(enzymatic activity) and the entire synthetic system. A similar system is proposed by the Endy 
lab at Berkeley, where the publication of new synthetic systems would require an 
accompanying datasheet (Canton, et al., 2008). 
In the future perhaps a standard growth media, expression plasmid, environmental conditions, 
buffers and even enzymatic assays can be agreed upon amongst researchers working in a 
particular field (e.g. secretion, nitrogen fixation, long-chain biofuel fields etc.) and these 
standards could then be performed as a mandatory yet supplementary standard 
characterisation. 
 Design and comprehensive testing of a synthetic hydrogenase 2.4.2
In this study a synthetic operon encoding an alien [FeFe]-hydrogenase was constructed and 
introduced into an E. coli chassis. An operon encoding the essential H-cluster maturation 
proteins was also constructed and its heterologous expression improved. Bioinformatics and 
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biochemical characterisation of the individual biological parts as well as the overall synthetic 
system was integral to this project. 
A well-characterised promoter (Ptat), whose activity under a number of relevant physiological 
conditions has already been measured, was chosen to provide constitutive expression of both 
constructs (hydrogenase and maturation). A RBS and spacer with strong 16S rRNA binding was 
used in front of each structural gene, as well as each half of the maturation gene operon, and 
the successful translation of each hydrogenase subunit predicted. Codon usage of the 
synthetic hydrogenase operon was optimised for the E. coli chassis and the codon usage of the 
Sh maturation genes was assessed for heterologous expression.  In vivo transcription and 
translation was tested using radiolabelling experiments and this characterisation data used to 
improve the expression of the maturation genes in E. coli. This data shows the importance of 
measuring the levels of full length functional proteins and not just rely on the results of 
transcriptional/translational fusions to fluorescent proteins. 
The synthetic hydrogenase enzyme was isolated from its E. coli chassis and a number of in vitro 
experiments performed to further characterise it. Basic structural information on the size and 
molecular weight of the enzyme complex as well as its stability was obtained. Finally, 
enzymatic activity assays of the purified enzyme were performed to characterise its 
performance in both catalytic directions (H2 oxidation and H2 production). This detailed 
biochemical characterisation allows each step to be tested and if necessary corrected so that 
the activity of the final overall synthetic system can be confidently investigated. 
 Possible reasons behind the lack of NADH-dependent H2 production? 2.4.3
Disappointingly, no NADH-dependent production of H2 was observed under a number of 
different assay conditions, despite H2 production with the artificial electron donor MV being 
demonstrated. NADH oxidation when incubated with purified enzyme was also not detected. 
This clearly does not match the published data on enzyme purified from the native organism 
(Soboh, et al., 2004). 
As the synthetic [FeFe]-hydrogenase, POR and Fd are all extremely sensitive to O2, perhaps 
these purifications need to be performed in fully anaerobic conditions to determine if this 
complex redox reaction occurs. 
In the original Tte hydrogenase paper (Soboh, et al., 2004), 1 mM Ti(III)citrate was added to 
the NADH-dependent H2 production assay. Ti(III)citrate is a powerful reducing agent (E°’pH7.5 = -
500 mV), more than powerful enough to replace Fdred as electron donor (E°’pH7.5 = -430 mV) in a 
bifurcating H2-production mechanism similar to that of Th. maritima (Schut and Adams, 2009) 
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(Error! Reference source not found.). Perhaps this is why H2 production from NADH was 
observed in the original assay. Interestingly, it was noted in the original paper that the rate of 
electron transfer from the diaphorase (NADH-oxidising) subunit to the H-cluster was likely to 
be the rate-limiting factor (Soboh, et al., 2004). The physiological role of the closely related 
NADP-reducing hydrogenase from Desulfovibrio fructosovorans, HndABCD, was suggested to 
be H2-dependent NADP reduction, but this has only been demonstrated in crude D. 
fructosovorans cell extracts (containing this hydrogenase and any possible interacting partners, 
electron carriers etc.) (Malki, et al., 1995; Malki, et al., 1997). When heterologously expressed 
in E. coli, crude cell extracts displayed H2-dependent MV reduction (de Luca, et al., 1998) but 
no H2-dependent NADP reduction (or H2 production) has been observed from purified enzyme 
alone has been observed. It is possible this enzyme also requires Fd for NADP reduction in its 
native organism as has been seen in other [FeFe]-hydrogenases (Huang, et al., 2012; Rydzak, et 
al., 2012; Schuchmann and Muller, 2012). 
 
 
 
 
Figure 2.14 Possible bifurcating mechanism of Ca tengcongensis [FeFe]-hydrogenase: HydABCD. The 
reduced ferredoxin (Fdred) donates electrons in addition to NADH in order to drive the energetically 
unfavourable production of H2 from NADH. These electrons from Fdred may enter the hydrogenase 
complex via HydC or HydD (shown here as HydD) 
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Flavin mononucleotide (FMN) (and not FAD) was identified as the type of flavin cofactor of the 
Ca.tengcongensis NADH-dependent [FeFe]-hydrogenase (Soboh, et al., 2004). Here, FMN (2 
mM) was added to lysis buffer, during purification, and to the buffers used during H2 
production assays with NADH as the sole electron donor, and during NADH oxidation assays. If 
FMN is indeed the correct flavin cofactor, then this is unlikely to be a possible reason for the 
lack of NADH-dependent H2 production. 
In this Chapter, all assays were performed at ambient temperature (25 – 30 °C). T. 
tengcongensis is a thermophilic bacterium found at 70 °C. Therefore it is also possible that the 
lack of NADH-dependent H2 production observed in this chapter is a result of the lower 
temperatures used during all hydrogenase assays. Thermophilic enzymes are stable at higher 
temperatures as a result of increased rigidity and stability in the protein backbone. This 
increased rigidity has been shown to result from extra structurally-stabilising interactions 
compared to mesophilic homologues, including disulphide bonds (Beeby, et al., 2005) and salt 
bridges (Lam, et al., 2011), as well as the replacement of certain amino acids with larger 
residues (Tomazic and Klibanov, 1988). This increased rigidity and stability is inversely 
proportional to activity of these enzymes at lower temperatures, where increased flexibility 
allows for greater catalytic activity (Beadle and Shoichet, 2002). In this project, no melting 
curve could be obtained when standard thermofluor experiments were performed using the 
purified synthetic enzyme (data not shown), indicating stability of this enzyme at high 
temperatures. 
Interestingly, a huge increase (40 times) in in vitro hydrogenase activity was observed when 
the enzyme was purified from sonicated cell extracts, rather than when BPER was used to lyse 
the cells. 
The SEC-MALLS analysis of the purified enzyme complex indicated that the enzyme purified as 
a monodisperse dimer of the four subunits. This could be investigated further using analytical 
ultracentrifugation (AUC). 
 Electrochemical results of purified enzyme 2.4.4
In collaboration with Alison Parkin (University of York) electrochemical experiments were also 
performed to allow further in vitro characterisation of this anaerobically-purified enzyme. 
Protein-film voltammetry (PFV) is a powerful tool in the study of redox enzymes. Protein 
molecules are immobilised on a graphite electrode to create a film, varying potentials are 
applied and any resulting current is measured. Variables such as temperature, pH and 
substrate concentrations can be sensitively controlled throughout these experiments. 
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Hydrogenase activity assayed through protein-film voltammetry is substrate independent and 
[FeFe]-hydrogenases are thought to act bidirectionally (i.e. can carry out both H2 oxidation and 
evolution). 
Initial protein-film voltammetry experiments performed with the purified synthetic Ca. 
tengcongensis [FeFe]-hydrogenase were unsuccessful, probably due to the incorrect 
orientation on the graphite electrode to allow electron transfer. In an attempt to improve its 
orientation on the electrode and allow easier access to an FeS cluster for electron transfer, a 
∆hydD version of the pUNI-Tte-HydhisC was constructed and this enzyme was purified. This 
enzyme displayed H2-dependent BV reduction activity of 561 nmol H2 oxidised min-1 mg-1. 
Electrochemical characterisation of this enzyme was possible, but hydrogenase activity was 
still low compared to other hydrogenases from other organisms described previously. 
In protein-film electrochemistry (PFE) positive current arising from enzymatic processes 
indicates oxidation activity, while negative current is proportional to the rate of 
electrochemical reduction. When an electrode is modified with a layer/film of adsorbed Ca. 
tengcongensis enzyme, H2 oxidation (100% H2) is observed but no H2 production (100% Ar) 
(Figure 2.15A). The high potential H2-oxidation activity of the enzyme titrates with pH (Figure 
2.15B). As observed with other [FeFe]-hydrogenases, in more alkaline buffer solutions there is 
a greater proportion of current-loss at potentials more positive than 0 V. This shows that 
increasing the concentration of hydroxide ions causes a greater amount of anaerobic 
oxidative-inactivation (formation of the Hoxinact state). Lowering the scan rate from 1 mV/s to 3 
mV/s allowed the easier observation of the reversible inactivation-reactivation process which 
occurs at high potential (Figure 2.16A), because the inactivation occurs on a timescale which is 
too slow to be fully probed at rapid rates. Since Ca. tengcongensis is a thermophilic bacterium, 
the impact of temperature on enzymatic activity was also tested. An increase in H2 oxidation 
was observed at the higher temperature of 80 °C (Figure 2.16B). 
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Figure 2.15 Basic electrochemical characterisation of the catalytic activity of purified ∆HydD 
enzyme. (A) The impact of hydrogen partial pressure on enzymatic activity: a 3 mV/s cyclic 
voltammogram was recorded at pH 6 under a gas atmosphere of Ar, as shown in grey. Hydrogen 
was then flowed through the electrochemical cell and after an equilibration time of 600 s the black 
scan was measured at the same scan rate. (B) The impact of pH on enzymatic activity: (i) a 3 mV/s 
cyclic voltammogram was recorded at pH 6 under a gas atmosphere of 100% H2, as shown in black. 
The buffer solution was then exchanged for pH 4 solution and the grey scan was measured at the 
same scan rate. (ii) a comparison of 1 mV/s voltammograms measured at pH 8 and pH 6. 
Experimental conditions common to all plots: temperature 60 °C and electrode rotation rate 1000 
rpm 
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Figure 2.16 (A) The effect of decreasing the scan rate from 3 to 1 mV/s on the voltammogram 
shape produced by an adsorbed film of ∆HydD enzyme at pH 6 and pH 8. The same enzyme film 
was used for experiments measured at the same pH. Other experimental conditions: temperature 
60 °C, gas atmosphere 100% H2 and electrode rotation rate 1000 rpm. (B) Two 3 mVs
-1 scans of a 
∆HydD enzyme “film” to compare the enzymatic activity at 60 and 80 °C under an atmosphere of 
100% H2. The graphite electrode modified with enzyme remained sealed in the electrochemical cell 
while a measurement was first made at 60 °C, the potentiostat was then paused at -0.56 V while 
the temperature of the external water circulator was raised to 80 °C and then the scan was then re-
commenced. Other conditions: pH 6, electrode rotation rate of 1000 rpm 
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 Future improvements to the synthetic [FeFe]-hydrogenase expression and 2.4.5
maturation system 
2.4.5.1 Genetic manipulation of native Sh. oneidensis maturation gene operon 
The correct expression and therefore maturation activity of the cloned Sh. oneidensis 
accessory genes required significant genetic manipulation (Figure 2.6). The hypothesis was 
that the Sh. oneidensis RBS was ineffective at initiating translation in E. coli and therefore an 
optimised Shine-Dalgano sequence and linker was introduced upstream of the hydE gene, 
which rescued translation in E. coli. It is also possible that the re-cloning removed some 
internal transcriptional or translational regulation. The full length Sh. oneidensis accessory 
operon SO_3923 – SO_3926 was analysed using the Softberry™ BPROM software for putative 
promoters and ten predicted internal promoters were identified, including well studied 
promoters such as lexA, fur, and rpoD16 & 18 promoters. Six of the ten predicted promoters 
were had linear discriminant function (LDF) scores that were 10 times over the minimum 
promoter threshold, indicating the strong likelihood of transcription initiation. Separating the 
operon into two halves, with the addition of a T7 transcriptional terminator between each half, 
likely stopped the read through of many of these short transcripts. Alternatively, multiple RBSs 
or indeed multiple translational start sites might account for the numerous truncated proteins 
observed in the original radiolabelling experiment (Figure 2.4). Using the EXPASY Translate 
Tool, over 30 possible ORFs can be identified in the 5’-3’ direction alone. The complete 
removal of spurious internal transcription or translation initiation sites would require the full 
refactoring (randomisation of codon usage) of the four genes, as performed in the 
reconstruction of the nitrogen fixation pathway of Klebsiella (Temme, et al., 2012). 
The function of HydX is still unknown, although it does share 35% sequence identity and 54% 
sequence similarity with conserved proteins of unknown function in Desulfovibrio vulgaris (and 
other species of this genus), which also encodes an [FeFe]-hydrogenase. HydX shares 30% 
sequence identity and 47% sequence similarity with a chloroplast phytoene synthase from 
Sorghum bicolor. These are transferase enzymes, involved in the biosynthesis of carotenoids. 
Perhaps HydX is involved in an additional, previously unreported modification of the H-cluster 
and/or [FeFe]-hydrogenase complex in Sh. oneidensis. In Figure 2.6, a band corresponding to 
approximately 23 kDa can be observed in the pSU-Sh-GX-EF lane. This band might correspond 
to HydX, however as in vitro hydrogenase activity was observed, no further investigation was 
deemed necessary. 
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2.4.5.2 A direct [FeFe]-maturation activity assay 
Successful improvement in the expression/translation or even direction evolution of the [FeFe] 
maturation genes/enzymes can be assessed indirectly by assaying in vivo/in vitro hydrogenase 
activity, as carried out in this chapter and used in other previous studies (Brazzolotto, et al., 
2006; Nicolet, et al., 2008; Shepard, et al., 2010b). However it would be extremely useful to 
develop a quantitative assay to determine maturation activity directly. This would allow levels 
of maturation activity to be optimised precisely, depending on the amount of [FeFe]-
hydrogenase protein produced in the cell. It might also allow further elucidation of the 
fundamental mechanism of these radical SAM and GTPase enzymes in active site construction 
and insertion. Electron paramagnetic resonance (EPR) spectroscopy can be used to identify the 
assembly of the H-cluster precursor on HydF (Shepard, et al., 2010b), however this is neither 
trivial nor high-throughput enough to use as a practical maturation assay. It is now possible 
however, to perform high-throughput Fourier-transform infrared (FTIR) spectroscopy on 
numerous samples using either microfluidics (Chan, et al., 2009) or plate-based spectrometers 
(Thermo Scientific™ Micro Well Plate Reader and Nicolet™ 6700 FT-IR spectrometer). FTIR 
spectroscopic analysis of HydF with a fully formed H-cluster precursor, shows four distinct 
bands, two of which correspond to the CO ligand and the other two corresponding to the CN- 
ligand (Shepard, et al., 2010b). Absorbance at any of these wavenumbers could be monitored 
in a cell-free maturation assay similar to that described previously (Boyer, et al., 2008), 
showing real-time ligand attachment on the 2Fe scaffold and this could then be used as a 
functional H-cluster maturation assay. 
2.4.5.3 Optimising the relative amounts of each hydrogenase subunit and essential 
maturation proteins for maximal hydrogenase activity 
Using either a novel high-throughput [FeFe]-maturation activity assay or indeed by carefully 
monitoring hydrogenase activity in response to levels of HydEFG protein, the levels of 
synHydABCD and ShHydEFG, as well as times of induction of each gene could be tuned to allow 
for maximal hydrogenase activity as well as avoiding issues such as protein toxicity. This could 
be accomplished through a number of means. Alternative promoters with a range of strengths 
of induction and physiological requirements for induction of gene expression could be used to 
control gene expression of each component. Some preliminary work was started towards this 
end with the replacement of the constitutive Ptat promoter on the synthetic [FeFe]-
hydrogenase, with one of: PhybO (promoter region of the E. coli hydrogenase-2 operon; 
upregulated under anaerobic conditions; aerobic repression reduced in ∆iscR strains – 2.6 fold 
increase in expression under aerobic conditions); PfadH (promoter region of the E. coli fadH 
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gene; massively upregulated in ∆iscR strains under anaerobic conditions – 31 fold increase) 
(Giel, et al., 2006); and PadhE (promoter region of the E. coli alcohol dehydrogenase gene; 
upregulated under anaerobic conditions – 10 fold increase relative to aerobic conditions and 
unaffected by deletion of iscR) (Leonardo, et al., 1993). A similar approach could also be taken 
with the Sh. oneidensis maturation gene operon. Unfortunately systematic testing of these 
constructs was not possible due to time constraints. 
Alongside testing a variety of promoters, the RBSs before each hydrogenase subunit gene 
could be changed to normalise the protein levels of each subunit in the cell. This could be 
carried out using the RBS CALCULATOR (as discussed in 2.3.1), which takes the very important 
upstream and mRNA transcript secondary structure into consideration. Alternatively, the 
translation initiation rates for each gene in the synthetic hydrogenase and Sh accessory 
operons could be increased or decreased in order to test for the optimum amount of each 
protein for hydrogenase activity (and cell survival). In particular, the ratio of HydEFG:HydABCD 
could be altered to ensure 100% maturation of all expressed hydrogenase. 
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3. Integration of a synthetic 
[FeFe]-hydrogenase into E. 
coli metabolism 
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 Introduction 3.1
Under fermentative conditions, where respiratory electron transport is at a minimum, E. coli 
faces a constant struggle to regenerate NAD+ for glycolysis to continue. The main mechanism 
for recycling of NAD+ from NADH is through the reduction of acetyl-CoA to ethanol via 
acetylaldehyde (Figure 3.1). In E. coli this reaction is catalysed by one protein, alcohol 
dehydrogenase (AdhE). The other possible routes for the consumption of NADH generated 
during glycolysis are through the production of lactate and malate (as part of reductive branch 
of TCA cycle that leads to succinate production); however this are generally confined to late 
stationary phase and is therefore secondary to ethanol production.  
The AdhE protein is essential for E. coli growth during fermentation in defined media (Lorowitz 
and Clark, 1982; Cunningham and Clark, 1986; Gupta and Clark, 1989) and successfully ensures 
that the cell maintains the correct ratio of NAD+ to NADH (de Graef, et al., 1999). The ratio of 
NADH/NAD+ is highest during glucose fermentation (~0.75), in comparison with anaerobic 
respiratory conditions (~0.6) or during aerobic growth (~0.08) (de Graef, et al., 1999).  
Figure 3.1 The reductive pathways of mixed-acid fermentation in E. coli. Enzyme abbreviations: PykA/F: pyruvate 
kinase; LdhA: lactate dehydrogenase; Pta: phosphotransacetylase; AdhE: alcohol dehydrogenase; Pfl: pyruvate 
formate lyase; Ppc: phosphoenolpyruvate carboxylase; Mdh: malate dehydrogenase; FumABC: fumarase; and 
FrdABC: fumarate reductase. The oxidative pathway of the TCA cycle halting at α-ketoglutarate is not shown for 
simplicity 
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 A synthetic NADH-dependent [FeFe]-hydrogenase pathway in E. coli 3.1.1
Hydrogen production in E. coli is not directly coupled to the regeneration of NAD+, as the 
majority of H2 is generated by the FHL complex. However, a small number of NADH-dependent 
hydrogenases have been described in other microbes. Thermoanaerobacter tengcongensis 
(recently reclassified as Caldanaerobacter tengcongensis) is a thermophilic Gram-negative 
bacterium isolated from a hot spring in China (Xue, et al., 2001). Ca. tengcongensis expresses 
two hydrogenase activities, one of which has been characterised as a soluble [FeFe]-
hydrogenase that produces H2 with NADH as the sole electron donor (Soboh, et al., 2004). In 
this work, a synthetic operon encoding all structural subunits of this Ca. tengcongensis 
hydrogenase has been constructed, expressed and characterised in E. coli (Chapter 2). When 
co-expressed with the essential H-cluster maturation proteins from Sh. oneidensis, (encoded 
on the pSUtat-Sh-GX-EF vector prepared in this work) the isolated enzyme displays H2-
oxidation and H2-production capabilities when assayed in vitro. The Ca. tengcongensis enzyme 
is attractive because, as an [FeFe] hydrogenase, it should be biased towards H2 production, 
and its diaphorase activity could be harnessed in an E. coli chassis. Indeed, it is tempting to 
speculate that coupling a hydrogenase to the essential recycling of NADH during fermentation 
may boost H2 production. 
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 Aims 3.2
This Chapter aims to construct a synthetic NADH-dependent H2-production pathway in an 
engineered E. coli chassis. A strain will be engineered that will express a synthetic, active 
[NADH]-dependent [FeFe]-hydrogenase and metabolic engineering will be performed in order 
to remove competing NAD+ regeneration pathways. The engineered strains will be 
characterised for H2 production and changes in metabolic flux during mixed-acid fermentation.  
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 Results 3.3
 Construction of a synthetic [NADH]-dependent H2-production pathway in E. coli 3.3.1
A synthetic operon encoding the NADH-dependent [FeFe]-hydrogenase from Ca. 
tengcongensis was integrated onto the chromosome of the E. coli strain FTD147 (MC4100 
∆hyaB, ∆hybC, ∆hycE) (Redwood, et al., 2008) in place of adhE using the pMAK705 
homologous recombination protocol (Hamilton, et al., 1989) (Figure 3.2). This precise 
replacement of the adhE gene with the synthetic [FeFe]-hydrogenase was confirmed using 
sequencing. The synthetic operon retains the constitutive tat promoter, but should also be 
driven by the native adhE promoter itself. The new strain was termed FTD147h3  E. coli strains 
used in this section, including those used as controls, are listed in Table 3.1. 
 
  
Strain Name Genotype Reference 
MG1655 wild-type E. coli strain 
F-, λ-, rph-1,  ilvG, rfb-50 
(Blattner, et al., 1997) 
MC4100 F- [araD139]B/r Δ(argF-lac)169 &lambda- e14- 
flhD5301 Δ(fruK-yeiR)725 (fruA25)‡ relA1 
rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1) 
deoC1 
(Casadaban, 1976) 
FTD147 MC4100 ∆hyaB, ∆hybC, ∆hycE (Redwood, et al., 2008) 
Teatotal1 FTD147 ∆adhE This work 
FTD147h3 FTD147 ∆adhE::TtehydC-A This work 
Figure 3.2 A synthetic operon encoding HydC-A of the Ca. tengcongensis NADH-dependent [FeFe]-
hydrogenase. This synthetic operon was integrated onto the chromosome of E. coli strain FTD147 in place 
of adhE, which encodes alcohol dehydrogenase. 1000 bp of flanking sequence to adhE was amplified by 
PCR and used to target the insertion of this synthetic operon by homologous recombination using the 
pMAK705 protocol. 
Table 3.1 Strains used in the characterisation of a synthetic NADH:H2 production pathway in E. coli 
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 Characterisation of FTD147h3: growth in liquid media 3.3.2
The ability of FTD147h3 to grow fermentatively in both rich and minimal media was tested and 
compared with MG1655 and FTD147. Cells were plated freshly from frozen stocks stored at -80 
°C and single colonies used to inoculate 5 ml aerobic overnight cultures. These aerobic 
overnight cultures were used to inoculate (1:1000) 16 ml test tubes filled with L.B. + 0.4% w/v 
glucose (Figure 3.3A) or M9 + 0.4% w/v glucose (Figure 3.3B). These were sealed to induce 
anaerobiosis and incubated at 37 °C without shaking. Samples were taken 3, 6, 9, 11, 13, 17, 21 
and 38 hours after inoculation and optical density at 600 nm measured (Figure 3.3). In minimal 
M9 media supplemented with glucose FTD147h3 did not grow anaerobically, whereas MG1655 
grew to an OD600 of 1.0 after 17 h and then entered stationary phase (Figure 3.3B). FTD147h3 
was capable of anaerobic growth in rich media supplemented with glucose (Figure 3.3A), 
although the final OD600 was approximately half (0.57) that of MG1655 (1.07) and FTD147 
(0.98) over an identical time course.  
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Figure 3.3 FTD147h3 is capable of growing in rich liquid media 
supplemented with glucose under fermentative conditions but not in 
minimal liquid media. Test tubes filled with 16 ml (A) L.B. + 0.4% w/v 
glucose or (B) M9 + 0.4% w/v glucose were inoculated 1:1000 with FTD147, 
FTD147h3 and MG1655 and cultures grown anaerobically. The optical 
density (OD600) of these cultures was recorded at various time points over 
38 h. It was decided not to convert OD600 to log10 values, to better highlight 
differences in final cell densities. 
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 Characterisation of FTD147h3: organic-acid production 3.3.3
The organic-acid acid content of the extracellular media upon completion of growth was 
analysed by high-performance liquid chromatography (HPLC) coupled with UV detection. 
MG1655, FTD147 and FTD147h3 anaerobic cultures of 16 ml LB media supplemented with 0.4 
% (w/v) glucose were grown for 72 h (to ensure sufficient FTD147h3 biomass). Cells were 
harvested by centrifugation and the culture supernatant was passed through a 0.2 µm filter to 
remove any remaining cells or debris. The spent fermentation broth was analysed with an 
Aminex HPX-87H organic-acid column at 0.7 ml min-1 and 55 °C. Organic acids detected by UV 
absorption at 210 nm. A standard curve of organic acid standards was prepared (R2: 99.90%) 
and used to identify and quantify concentrations of pyruvate, succinate, lactate, formate, 
fumarate and acetate. Sample concentrations were normalised by cell pellet wet weight. The 
concentrations of compounds in virgin media (LB + 0.4% (w/v) glucose) were subtracted to 
reveal changes in each metabolite (Figure 3.4). 
The extracellular concentration of pyruvate did not increase greatly in any of the three 
samples tested (Figure 3.4). Succinate concentrations increased slightly in the FTD147h3 
sample compared to both MG1655 and FTD147 samples (Figure 3.4). The concentration of 
lactate also increased relative to the MG1655 sample (Figure 3.4). Formate was not detected 
with the MG1655 samples (Figure 3.4), presumably as all of the formate is converted to H2 and 
CO2 following a 72 hour incubation period. No extracellular fumarate was detected in any of 
the samples (Figure 3.4), however the concentration of acetate increased significantly in both 
the FTD147 (43 mM; P = 0.0002) and FTD147h3 (58 mM; P = 0.0012).  
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Figure 3.4 Organic-acid content of MG1655, FTD147 and FTD147h3 fermentation broths. Test tubes 
filled with 16 ml L.B. + 0.4% (w/v) glucose were inoculated 1:1000 with MG1655, FTD147 and 
FTD147h3 and cultures grown anaerobically. Cells were harvested by centrifugation at 4000 rpm 
before the culture supernatant was passed through a 0.2 µm filter and analysed by HPLC. For HPLC 
analysis, 5 µl of fermentation broth was separated at 0.7 ml min-1 and 55 °C using a Dionex UltiMate 
3000 HPLC system, fitted with an Aminex HPX-87H organic acid column and absorbance monitored 
at 210 nm. Organic acid standards were used all with R2 values greater than 99.90%. Bars represent 
difference in metabolite concentration between media before and after fermentation. Error bars 
represent standard error of three biological replicates. The inset graph represents concentration of 
each metabolite in media before inoculation. 
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 Expression of essential maturation proteins in FTD147h3 does not confer a growth 3.3.4
advantage during fermentative conditions 
Next, FTD147h3 cells were transformed with plasmid pSUtat-Sh-GX-EF (Acc) expressing the H-
cluster maturation proteins and was tested for improved growth in both rich and minimal 
liquid media. No difference was observed between FTD147h3 and FTD147h3 expressing 
pSUtat-Sh-GX-EF (Acc) in anaerobic LB cultures supplemented with glucose (Figure 3.5A & B). A 
similar pattern of growth was obtained for TeaTotal1 (FTD147 ∆adhE) (Figure 3.5B). No 
recovery of growth of FTD147h3 expressing pSUtat-Sh-GX-EF was observed in minimal M9 
media supplemented with glucose (Figure 3.5C). 
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Figure 3.5 A synthetic Ca. tengcongensis hydrogenase provides no growth advantage 
under fermentative conditions. Test tubes filled with 16 ml (A & B) L.B. + 0.4% w/v 
glucose or (C) M9 + 0.4% w/v glucose were inoculated 1:1000 with FTD147, FTD147h3, 
TeaTotal1 and MG1655, grown anaerobically and the optical density (OD600) of these 
cultures was recorded at various time points over 38 h. It was decided not to convert 
OD600 to log10 values, to better highlight differences in final cell concentrations. 
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 Characterisation of FTD147h3: hydrogenase activity when HydEFG are expressed 3.3.5
The next stage in the functional characterisation of FTD147h3 was to assay its ability to either 
oxidise or evolve H2 with an artificial electron acceptor or donor, when transformed with the 
optimised H-cluster-accessory plasmid, pSUtat-Sh-GX-EF. Benzyl viologen (BV) was chosen as 
the electron acceptor as its standard reduction potential (E0’ -348 mV) is above that of the 
H+/½ H2 redox couple (E0’ -420 mV) and methyl viologen (MV) as the electron donor (E0’ -443 
mV) as it is a stronger reducing agent. For H2-dependent BV reduction, one activity unit (U) is 
defined as 1 µmol BV reduced min-1 mg-1 cells. For MV-dependent H2 production, one unit (U) 
is defined as 1 µmol H2 evolved min-1 mg-1 cells. 
FTD147h3 was transformed with pSUtat-Sh-GX-EF and this was used to inoculate 500 ml 
anaerobic LB cultures supplemented with 0.4% (w/v) glucose, 2 mM cysteine, 2 mM ferric 
ammonium citrate and chloramphenicol. The cultures were incubated at 37 °C for ~16 hours 
before the cells were harvested, washed, resuspended in anaerobic buffer and lysed by 
sonication. Cell pellets and crude lysates were flushed with Ar throughout in an attempt to 
maintain anaerobic conditions. The FTD147h3 + Accessory genes (Acc) crude cell lysate 
catalysed the reduction of BV with H2 as the electron donor, with a specific activity of 9 U, 
when assayed in H2-saturated, Tricine pH 8.0 buffer (Figure 3.6B). Assays were repeated in N2-
saturated buffer to confirm H2-specific BV reduction. Intact whole cells (in both H2- and N2-
saturated buffer) were also used as negative controls, as oxidised BV is believed to be 
impermeable to the cytoplasmic membrane and therefore should not react with the 
cytoplasmically-localised [FeFe]-hydrogenase. 
The FTD147h3 + Accessory genes (Acc) crude cell lysate demonstrated H2-evolution activity 
with reduced MV as the artificial electron donor (6 U) (Figure 3.6A). Only a trace of H2-
production activity was observed with cell lysates lacking the accessory plasmid, confirming 
the hydrogenase activity was specific to the chromosomally-encoded [FeFe]-hydrogenase. No 
NADH-dependent production of H2 was observed from the FTD147h3 + Accessory genes (Acc) 
crude cell lysate under a number of different assay conditions. 
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Figure 3.6 FTD147h3 + Acc displays in vitro H2 production and H2 oxidation. 
FTD147h3 cells were transformed with pSUtat-Sh-GX-EF, which encodes 
HydEFG from Sh. oneidensis. Transformants were used to inoculate a 5 ml 
aerobic overnight culture, which was then used to inoculate 500 ml 
anaerobic L.B. cultures supplemented with 0.4% (w/v) glucose, 2 mM 
cysteine, 2 mM ferric ammonium citrate and chloramphenicol. The cultures 
were incubated at 37 °C for ~16 hours, pelleted by centrifugation, washed 
and resuspended in anaerobic buffer. Cell pellets were flushed with Ar 
throughout in an attempt to maintain anaerobic conditions, then lysed by 
sonication and centrifuged to remove cellular debris, resulting in crude cell 
lysate, which was assayed for hydrogenase activity. A. Methyl viologen (MV)-
dependent H2 production was measured in a modified Clark-type electrode. 
100 mM sodium phosphate buffer pH 6.0 was added to the reaction 
chamber, to which 12.5 mM MV and 650 µM sodium dithionite was added. 
The reaction was initiated by the addition of 500 µg of cell lysate. B. Benzyl 
viologen (BV) reduction (H2 oxidation) was monitored at 578 nm in a UV-vis 
spectrometer. 1 ml quartz cuvettes were filled with H2-saturated buffer (50 
mM Tricine pH 8.0) and 13 mM BV. This was titrated with sodium dithionite 
to an absorbance of 0.4 - 0.7 and the reaction started by the addition of 1 mg 
of cell lysate. N2-saturation buffer and whole cells were used as controls. 
Error bars represent the standard error of three independent experiments. 
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 Characterisation of FTD147h3 expressing HydEFG: organic-acid production 3.3.6
The organic acids content of the spent culture media from FTD147h3 transformed with pSUtat-
Sh-GX-EF (Acc) was measured using HPLC. These samples were compared to samples from 
MG1655 cultures transformed with pSUtat-Sh-GX-EF (Acc) and pUNI-Tte-Hyd (Tte) or empty 
control vectors. A standard curve of organic acid standards was prepared (R2: 99.90%) and 
used to identify and quantify concentrations of pyruvate, succinate, lactate, formate, fumarate 
and acetate. Sample concentrations were normalised by cell weight, and the concentration of 
metabolites in starting media (LB + 0.4% (w/v) glucose) was subtracted to reveal changes in 
each metabolite (Figure 3.7). It is worth noting that the concentration of succinate in the 
starting L.B. media used in this experiment was almost twice as much as in the media used in 
the previous organic acid analysis (Section 3.3.3). 
The concentrations of succinate, lactate and acetate in the FTD14h3 + pSUtat-Sh-GX-EF 
samples was higher than either control sample. The MG1655 samples producing the H-cluster 
maturation proteins and the synthetic hydrogenase showed increased amounts of acetate 
relative to the control samples, but no other differences could be observed (Figure 3.7). 
Figure 3.7 Organic-acid analysis of FTD147h3 + pSUtat-Sh-GXEF fermentation broths relative to wild type 
samples. Test tubes filled with 16 ml  L.B. + 0.4% (w/v) glucose were inoculated 1:1000 with: MG1655 + pUNIPROM 
+ pSU23; MG1655 + pSUtat-Sh-GX-EF + pUNI-Tte-Hyd; and FTD147h3 + pSUtat-Sh-GX-EF, and cultures grown 
anaerobically. Cells were pelleted by centrifugation at 4000 rpm, the supernatant was passed through a 0.2 µm 
syringe filter and analysed by HPLC. For HPLC analysis, 5 µl of fermentation broth was separated at 0.7 ml min-1 and 
55 °C using a Dionex UltiMate 3000 HPLC system, fitted with an Aminex HPX-87H organic acid column and 
absorbance monitored at 210 nm. Organic acid standards were used all with R2 values greater than 99.90%. Bars 
represent difference in metabolite concentration between media before and after fermentation. Error bars 
represent standard error of three biological replicates. Inset graph represents concentration of each metabolite in 
media before inoculation.  
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 Metabolomic analysis of MC4100, FTD147 and FTD147h3 strains using LC-MS 3.3.7
In an attempt to better understand the fermentation characteristics of FTD147h3, and to 
better understand changes in E. coli metabolism lacking all hydrogenase activity (FTD147), 
non-targeted liquid chromatography-mass spectroscopy (LC-MS) was performed in 
collaboration with the Glasgow Polyomics Wolfson Wohl Cancer Research Centre at the 
University of Glasgow. 
FTD147h3, MC4100 and FTD147 were transformed with pSUtat-Sh-GX-EF or pSU23 and 
transformants used to inoculate 5 ml aerobic overnight cultures. The aerobic overnight 
cultures were used to inoculate (1:1000) 16 ml test tubes filled with LB + 0.5% (w/v) glucose. 
These were sealed to induce anaerobiosis and incubated at 37 °C without shaking for 72 h to 
ensure sufficient FTD147h3 + Acc cell weight. Cells were pelleted by centrifugation at 4000 
rpm and the culture supernatant was passed through a 0.2 µm filter to remove any remaining 
cells. Samples were then extracted using a chloroform:methanol:water (1:3:1) protocol and 
analysed on an Exactive Orbitrap mass spectrometer (Thermo Fisher) in both positive and 
negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-HILIC 
column (Sequant) as described previously (Vincent, et al., 2012). Growth media (LB + 0.5% 
(w/v) glucose) before fermentation was extracted as above and used as a negative control. 
Concentrations of individual metabolites relative to the concentrations in the control samples 
are given. In total, 1023 discrete compounds were detected using this method (Figure 3.8). 
Only compounds scored with an identification confidence value greater than 7/10 are 
discussed here. Metabolites linked to NADH biochemistry were studied in greater detail. 
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First, metabolites linked to carbon metabolism were analysed (Figure 3.15). Some of the 
metabolites that were found in higher concentrations in the FTD147h3 (+ Acc) culture 
supernatant were sorbitol 6-phosphate, propanoyl phosphate, 3-butynoate and myo-inositol 
(Figure 3.15). On the other hand, 3-ethylmalate, 3-oxopropanoate and 2-Deoxy-D-ribose 5-
phosphate were all found at lower concentrations in FTD147h3 (+ Acc) relative to the 
MC4100/FTD147 samples (Figure 3.9). Indeed, sorbitol 6-phosphate was not detected in any 
FTD147 or MC4100 culture supernatant samples. 
 
 
  
Figure 3.8  Grouping of compounds identified through non-targeted LC-MS analysis of fermentation broth 
according to metabolic pathways. 
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Figure 3.9 Metabolomic analysis of the spent culture supernatant (1). Metabolites 
involved in carbon metabolism were identified through non-targeted LC-MS analysis of 
spent fermentation supernatants after growth of either FTD147h3 + Acc, FTD147 + pSU23 
or MC4100 + pSU23. Samples were extracted using a chloroform:methanol:water (1:3:1) 
protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo Fisher) in both 
positive and negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) 
with a ZIC-HILIC column (Sequant). Y-axis represents relative concentration of metabolite 
in each sample compared to virgin culture media (LB + 0.4% (w/v) glucose). 
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Next, changes in amino-acid metabolism were also monitored in the FTD147h3 (+ Acc) samples 
relative to MC4100 or FTD147 (Figure 3.16). An increase in indole-3-acetaldehyde, 2-
formylaminobenzaldehyde, urocanate and S-ribosyl-L-homocysteine was observed in these 
samples (Figure 3.16). A drop in the concentration of 3-methylthio propionic acid, L-3-amino-
isobutanoate, indole-3-acetate, N-formyl-L-methionine and 5-hydroxyindolacetate was 
observed in FTD147h3 strains relative to MC4100 (Figure 3.10). Although only small 
concentrations of 2-formylaminobenzaldehyde in particular were found, this metabolite was 
completely absent from FTD147 and MC4100 samples. Small amounts of methylglyoxal were 
found in all three sample types.  
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Figure 3.10 Metabolomic analysis of the spent culture supernatant (2). Metabolites involved in amino-acid 
metabolism were identified through non-targeted LC-MS analysis of spent fermentation supernatants after growth 
of either FTD147h3 + Acc, FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a 
chloroform:methanol:water (1:3:1) protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo 
Fisher) in both positive and negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-
HILIC column (Sequant). Y-axis represents relative concentration of metabolite in each sample compared to virgin 
culture media (LB + 0.4% (w/v) glucose). 
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Next, attention turned to energy metabolism (Figure 3.17). Surprisingly, only a small number 
of metabolites known to play a role in energy metabolism could be identified in the culture 
supernatant in this experiment. The two metabolites that met the confidence threshold of 
7/10 were N-methyl-L-glutamate, which is completely absent from FTD147h3 samples and 
orthophosphate which was found at a consistent level in all three samples (Figure 3.11). 
 
  
Figure 3.11 Metabolomic analysis of the spent culture supernatant (3). Metabolites involved in energy 
metabolism were identified through non-targeted LC-MS analysis of spent fermentation supernatants after 
growth of either FTD147h3 + Acc, FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a 
chloroform:methanol:water (1:3:1) protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo 
Fisher) in both positive and negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a 
ZIC-HILIC column (Sequant). Y-axis represents relative concentration of metabolite in each sample compared to 
virgin culture media (LB + 0.4% (w/v) glucose). 
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Next, the pathways responsible for cofactor biosynthesis were considered (Figure 3.18). As the 
[NiFe]-hydrogenases of the E. coli strain MC4100 require complex cofactors such as iron, nickel 
and haem, and as the synthetic strain FTD147h3 +pSUtat-Sh-GX-EF expresses an active [FeFe]-
hydrogenase with its own cofactor requirement, changes in extracellular metabolites involved 
in cofactor metabolism were anticipated. However, the only minor change of note between all 
three samples was the observation of increase pantothenol in the FTD147h3 samples (Figure 
3.12). 
  
Figure 3.12 Metabolomic analysis of the spent culture supernatant (4). Metabolites involved in cofactor 
metabolism were identified through non-targeted LC-MS analysis of spent fermentation supernatants after growth 
of either FTD147h3 + Acc, FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a 
chloroform:methanol:water (1:3:1) protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo 
Fisher) in both positive and negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-
HILIC column (Sequant). Y-axis represents relative concentration of metabolite in each sample compared to virgin 
culture media (LB + 0.4% (w/v) glucose). 
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Next, compounds involved in fatty acid and lipid metabolism were analysed (Figure 3.19). The 
important glycolysis metabolites glycerone and glyceraldehyde were found in lower 
concentrations in the FTD147h3 and FTD147 culture supernatant samples compared to the 
MC4100 samples (Figure 3.13). The 2-butenoate compound was also found in lower 
concentrations in FTD147h3 samples (Figure 3.13). A number of metabolites were found in 
higher concentrations in samples of this mutant, including (R)-3-hydroxybutanoate, traumatic 
acid, 9-oxononanic acid and FA oxo(5:0)] 3-oxo-4-pentenoic acid (Figure 3.13). 
Figure 3.13 Metabolomic analysis of the spent culture supernatant (5). Metabolites involved in fatty-acid and lipid 
metabolism were identified through non-targeted LC-MS analysis of spent fermentation supernatants after growth 
of either FTD147h3 + Acc, FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a 
chloroform:methanol:water (1:3:1) protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo 
Fisher) in both positive and negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-
HILIC column (Sequant). Y-axis represents relative concentration of metabolite in each sample compared to virgin 
culture media (LB + 0.4% (w/v) glucose). 
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As Luria-Bertani media consists of a complex and undefined mixture of yeast-derived peptides, 
these metabolites were given close attention here (Figure 3.20).  A variety of peptides were 
found in higher concentrations in the FTD147h3 samples, including Leu-Val-Pro; Val-Gly-Pro; 
Asp-Leu-Pro-Pro and Leu-Gln-Pro (Figure 3.14). No Trp-Asp or Asn-Lys-Cys-Pro peptides were 
found in the FTD147h3 compared to the other two sample types (Figure 3.14).  
Figure 3.14 Metabolomic analysis of the spent culture supernatant (6). Certain short peptides were identified 
through non-targeted LC-MS analysis of spent fermentation supernatants after growth of either FTD147h3 + Acc, 
FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a chloroform:methanol:water (1:3:1) protocol 
and analysed on an Exactive Orbitrap mass spectrometer (Thermo Fisher) in both positive and negative modes 
(rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-HILIC column (Sequant). Y-axis represents 
relative concentration of metabolite in each sample compared to virgin culture media (LB + 0.4% (w/v) glucose). 
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Another major group of metabolites studied in this metabolomics experiment were those 
involved in nucleotide metabolism (Figure 3.21). Methyladenine was found in higher 
concentrations in the FTD147h3 extracellular environment than the other two culture 
supernatants, and a fragment of orotate was found at a concentration 7 times higher than 
either of the other two samples (Figure 3.15). Adenylyl sulphate and 2’3’-cyclic AMP were all 
found a lower concentrations in the FTD147h3 samples than the MC4100 samples, whereas 
the concentration of 5,6-dihydrouracil was reduced in both the FTD147h3 and FTD147 samples 
(Figure 3.15). 
 
Other interesting metabolites that showed a stark difference between the different culture 
supernatants included gentianamine, which was completely absent from FTD147h3 and 
FTD147 samples, and allylcysteine, which was completely absent in FTD147h3 samples (Figure 
3.16). Other compounds that were reduced in the FTD147h3 samples included myristic 
amide/tetradecanamide (reduced in both FTD147 and FTD147h3 samples); fagaronine; 
ethylpyruvate; hoyrine B; 2-keto-4-hydroxybutyrate (reduced in both FTD147 and FTD147h3 
samples); and butylene (Figure 3.16). A number of interesting metabolites were found in 
higher concentrations in the FTD147h3 supernatant including diethyl adipate; 2-
hydroxyadenine; and large amounts of 1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide 
(Figure 3.16). 
Figure 3.15 Metabolomic analysis of the spent culture supernatant (7). Metabolites involved in nucleotide 
metabolism were identified through non-targeted LC-MS analysis of spent fermentation supernatants after growth 
of either FTD147h3 + Acc, FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a 
chloroform:methanol:water (1:3:1) protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo 
Fisher) in both positive and negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-
HILIC column (Sequant). Y-axis represents relative concentration of metabolite in each sample compared to virgin 
culture media (LB + 0.4% (w/v) glucose). 
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Figure 3.16 Metabolomic analysis of the spent culture supernatant (8). Other potentially interesting metabolites  
were identified through non-targeted LC-MS analysis of spent fermentation supernatants after growth of either 
FTD147h3 + Acc, FTD147 + pSU23 or MC4100 + pSU23. Samples were extracted using a chloroform:methanol:water 
(1:3:1) protocol and analysed on an Exactive Orbitrap mass spectrometer (Thermo Fisher) in both positive and 
negative modes (rapid switching), coupled to a U3000 RSLC HPLC (Dionex) with a ZIC-HILIC column (Sequant). Y-axis 
represents relative concentration of metabolite in each sample compared to virgin culture media (LB + 0.4% (w/v) 
glucose). 
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 Development of a screen for fully integrated NADH-dependent hydrogenase activity. 3.3.8
The chromosomally-encoded synthetic Ca. tengcongensis [FeFe]-hydrogenase was active with 
redox dyes, but did not demonstrate NADH-dependent H2 production or support growth in the 
place of alcohol dehydrogenase. It was considered, therefore, that the [FeFe] hydrogenase 
module was not correctly communicating with the diaphorase module of the enzyme in this 
synthetic system. In order to tackle this it was decided to prepare a robust strain that could be 
used to screen for NADH recycling, and to prepare a random mutant library of hydA. 
As the ∆adhE::TtehydC-A mutant strain, FTD147h3, retains the ability to produce lactate 
production, catalysed by the ldhA gene product, which is a secondary method of NAD+ 
regeneration, the ldhA gene was specifically deleted from FTD147h (a strain similar to 
FTD147h3 but lacking an active Ca. tengcongensis hydA gene). The resultant strain was named 
RaisynA1 (Table 3.2). Next, a derivative of RaisynA1 lacking iscR (the transcriptional repressor 
of an iron sulfur cluster biosynthesis operon) was constructed by P1 transduction and termed 
IronBrew (Table 3.2). A hydrogenase- and alcohol dehydrogenase-positive strain lacking ldhA, 
Maggie1 (Table 3.2), was also constructed to use as a control. 
 
 
 
 
 
 
 
  
Strain Name Genotype 
FTD147h FTD147 ∆adhE::TtehydC-B, hydA- 
Maggie1 MG059e1 (MG1655 hycEHis) ∆ldhA 
RaisynA1 FTD147h ∆ldhA 
IronBrew RaisynA1 ∆iscR 
Table 3.2 Strains used in the screening of mutant NADH-dependent 
[FeFe]-hydrogenase genes 
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 Characterisation of RaisynA1 and IronBrew: growth in liquid media 3.3.9
The ability of RaisynA1 and IronBrew to grow fermentatively in both rich and minimal media 
was tested and compared with MG1655, FTD147h (the parent strain of RaisynA1), TeaTotal1 
(as FTD147 ∆adhE) and Maggie1 (∆ldhA). Cells were plated freshly from frozen stocks stored at 
-80 °C and single colonies used to inoculate 5 ml aerobic overnight cultures. These aerobic 
overnight cultures were used to inoculate (1:1000) 16 ml test tubes filled with LB + 0.4% w/v 
glucose (Figure 3.17A, B & C) or M9 + 0.4% w/v glucose (Figure 3.17D). These were sealed to 
induce anaerobiosis and incubated at 37 °C without shaking. Samples were taken 3, 6, 9, 11, 
13, 17, 21 and 38 hours after inoculation and optical density at 600 nm measured. 
In minimal M9 media supplemented with glucose, RaisynA1 (essentially ∆adhE, ∆ldhA) did not 
grow anaerobically (Figure 3.17D). Indeed, in rich LB medium + glucose RaisynA1 struggled to 
grow (reaching an OD600 of 0.2 after 38 h, with a lag phase of almost 20 h), whereas FTD147h 
and Teatotal (FTD147 ∆adhE) grew to an OD600 of approximately 0.7 and 0.6 respectively 
before entering stationary phase (Figure 3.17B). The MG1655 derivative lacking ldhA, Maggie1, 
grew well in LB + glucose until 11 h (OD600 of 0.9) before the cells appeared to lyse since 
turbidity dropped dramatically (OD600 of 0.4 at 17 h) and then stabilised (Figure 3.17C). The 
∆iscR derivative of RaisynA1, IronBrew grew slightly better than RaisynA1 in rich media (Figure 
3.17C). 
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Figure 3.17 RaisynA1 does not grown in minimal liquid media under fermentative conditions and grows poorly in 
rich media. Test tubes filled with 16 ml (A, B & C) L.B. + 0.4% w/v glucose or (D) M9 + 0.4% w/v glucose were 
inoculated 1:1000 with MG1655, RaisynA1, FTD147h, Teatotal, Maggie and IronBrew and cultures grown 
anaerobically. The optical density (OD600) of these cultures was recorded at various time points over 38 h. It was 
decided not to convert OD600 to log10 values, to better highlight differences in final cell concentrations. 
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 Characterisation of RaisynA1: organic acid analysis 3.3.10
In order to characterise the consumption of glucose by the RaisynA1 strain (∆adhE, ∆ldhA), and 
assess the production of other organic acids, HPLC was used. For the detection of glucose and 
ethanol a refractive index detector was connected downstream of the Aminex HPX-87H 
column in place of the UV detector. Standard curves of ethanol and glucose were prepared 
with R2 values of 0.9999% and 0.9997%, respectively. The RaisynA1 culture medium samples 
containing empty control vectors showed no ethanol production (Figure 3.18B), whereas the 
MG1655 spent culture supernatants (with or without synthetic hydrogenase and maturation 
proteins) contained approximately 0.4% (v/v) ethanol (Figure 3.18B). Surprisingly, the amount 
of glucose in the RaisynA1 samples apparently did not change between initiation and 
completion of anaerobic growths (Figure 3.18A), suggesting this plentiful carbon source was 
not used at all by this mutant for anaerobic growth in rich media. By contrast, all added 
glucose (initially 0.4% (w/v) or 22 mM) was completely consumed in the MG1655 samples 
(Figure 3.18A). 
The production of lactate, and the other main organic acids, was monitored by UV detection at 
210 nm. RaisynA1 does not produce lactate when grown on LB + glucose (Figure 3.19). 
However, the concentrations of succinate, acetate and pyruvate were reduced when the 
synthetic Ca. tengcongensis hydrogenase and the Sh. oneidensis maturation proteins were 
produced in RaiysnA1 (Figure 3.19). The reduction in the secreted concentrations of succinate, 
acetate and pyruvate was also observed in samples of IronBrew containing the activated 
hydrogenase (Figure 3.20), perhaps indicating the reduction in these organic acids was related 
to production of an active version of this enzyme. Note, however, that by comparison the 
relative concentrations of these organic acids in the growth medium was overall much higher 
in the IronBrew background than in the corresponding RaisynA1 samples. 
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Figure 3.18 RaisynA1 does not (A) consume glucose or (B) produce ethanol. Test tubes 
filled with 16 ml  L.B. + 0.4% (w/v) glucose were inoculated 1:1000 with:MG1655 + 
pUNIPROM + pSU23; MG1655 + pSUtat-Sh-GX-EF + pUNI-Tte-Hyd; or RaisynA1 + 
pUNIPROM + pSU23, and cultures grown anaerobically. Cells were pelleted by 
centrifugation at 4000 rpm, the supernatant was passed through a 0.2 µm syringe filter 
and analysed by HPLC. For HPLC analysis, 5 µl of fermentation broth was separated at 0.7 
ml min-1 and 55 °C using a Dionex UltiMate 3000 HPLC system, fitted with an Aminex HPX-
87H organic acid column and monitored using a refractive index detector. Standards of D-
glucose and ethanol were used all with R2 values greater than 99.999%. Bars represent 
difference in metabolite concentration between media before and after fermentation. 
Error bars represent standard error of three biological replicates. 
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Figure 3.20 Organic-acid analysis of fermentation broths of RaisynA1/IronBrew +/- pSUtat-Sh-GXEF and 
pUNI-Tte-Hyd. Test tubes filled with 16 ml  L.B. + 0.4% (w/v) glucose were inoculated 1:1000 with: RaisynA1 + 
pUNIPROM + pSU23; or RaisynA1 + pSUtat-Sh-GX-EF + pUNI-Tte-Hyd; IronBrew + pUNIPROM + pSU23; or 
IronBrew + pSUtat-Sh-GX-EF + pUNI-Tte-Hyd, and cultures grown anaerobically. Cells were pelleted by 
centrifugation at 4000 rpm, the supernatant was passed through a 0.2 µm syringe filter and analysed by HPLC. 
For HPLC analysis, 5 µl of fermentation broth was separated at 0.7 ml min-1 and 55 °C using a Dionex UltiMate 
3000 HPLC system, fitted with an Aminex HPX-87H organic acid column and absorbance monitored at 210 nm. 
Organic acid standards were used all with R2 values greater than 99.90%. Bars represent difference in 
metabolite concentration between media before and after fermentation. Error bars represent standard error 
of three biological replicates. Inset graph represents concentration of each metabolite in media before 
inoculation. 
Figure 3.19 Organic-acid analysis of fermentation broths of RaisynA1 +/- pSUtat-Sh-GXEF and pUNI-Tte-Hyd. 
Test tubes filled with 16 ml  L.B. + 0.4% (w/v) glucose were inoculated 1:1000 with: RaisynA1 + pUNIPROM + 
pSU23; or RaisynA1 + pSUtat-Sh-GX-EF + pUNI-Tte-Hyd, and cultures grown anaerobically. Cells were pelleted 
by centrifugation at 4000 rpm, the supernatant was passed through a 0.2 µm syringe filter and analysed by 
HPLC. For HPLC analysis, 5 µl of fermentation broth was separated at 0.7 ml min-1 and 55 °C using a Dionex 
UltiMate 3000 HPLC system, fitted with an Aminex HPX-87H organic acid column and absorbance monitored 
at 210 nm. Organic acid standards were used all with R2 values greater than 99.90%. Bars represent difference 
in metabolite concentration between media before and after fermentation. Error bars represent standard 
error of three biological replicates. Inset graph represents concentration of each metabolite in media before 
inoculation 
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 Construction and screening of a hydA mutant library 3.3.11
Random mutant libraries of hydA, which encodes the H-cluster-containing subunit of the 
synthetic Ca. tengcongensis [FeFe]-hydrogenase, were constructed using hypermutagenic PCR 
with biased dNTPs (Vartanian, et al., 1996a). This protocol is designed to introduce both 
transitions and transversions. Two libraries of the 1758 bp hydA gene were constructed, one 
with an error rate of 2.8% (considered a ‘low’ error rate library) and the other with an error 
rate of 4.5% (considered a ‘high’ error rate library). Each library consisted of 1.2 x 106 and 1.5 x 
106 independent clones, respectively, which represented a 682 and 853 times coverage of the 
hydA gene. 
Using RaisynA1, which does not grow anaerobically on minimal solid M9 agar plates 
supplemented with 0.4% (w/v) glucose, both low and high mutant libraries were screened for 
their ability to recover growth, the hypothesis being that a fully active NADH-linked 
hydrogenase could complement for the loss of the NADH-linked AdhE and LdhA. RaisynA1 was 
transformed with pSUtat-Sh-GX-EF and a single colony used to prepare electrocompetent cells 
(Sambrook, et al., 1989). The resultant RaisynA1 + pSUtat-Sh-GX-EF electrocompetent cells 
were transformed with 100 or 200 ng of each mutant library and plated on to selection plates, 
which were incubated at 37 °C for at least one week in anaerobic jars. RaisynA1 transformed 
with empty plasmids was used as a negative control. Aerobic controls on M9 + glucose plates 
were used to estimate transformation efficiency and the number of colonies screened. 
Transformation efficiencies of 200 - 400 transformants per ng plasmid DNA were observed and 
a total of approximately 270,000 colonies of the ‘low’ and 280,000 colonies of the ‘high’ hydA 
libraries were screened. No recovery of anaerobic growth was observed. Other incubation 
methods were also tested including the use of argon and the maintenance of a mild vacuum (-
1 bar), but no recovery of growth was observed. 
These negative results indicate that the Ca. tengcongensis [FeFe]-hydrogenase cannot 
complement the RaisynA1 fermentative phenotype and that that lack of complementation is 
probably not due to a problem with the HydA subunit. 
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 Discussion 3.4
In this Chapter, a genetically modified E. coli strain (FTD147h3) was constructed that expresses 
a novel [FeFe]-hydrogenase activity based on the NADH-dependent [FeFe]-hydrogenase from 
the thermophilic bacterium Ca. tengcongensis. This synthetic hydrogenase operon was 
integrated into the E. coli chromosome in place of adhE, which encodes alcohol 
dehydrogenase, the major NAD+ regenerator in E. coli during mixed-acid fermentation. In 
addition to assaying hydrogenase activity, this strain was characterised for growth on a variety 
of liquid and solid media under fermentative conditions. Organic-acid production by this strain 
with and without the H-cluster accessory proteins was also characterised. Finally a 
metabolomics study using LC-MS was used to study changes in other less well characterised 
metabolites. 
 FTD147h3 displays H2 oxidation and H2 production capabilities 3.4.1
When the essential H-cluster maturation proteins are expressed in the FTD147h3 strain both 
H2 oxidation and production activities can be detected with redox dyes. The successful 
integration of genes for a functional [FeFe]-hydrogenase onto the E. coli chromosome has not 
been reported to date. It is possible that the activity of this synthetic hydrogenase could be 
further improved by also integrating the optimised Sh. oneidensis hydGX-EF operon onto the 
chromosome, as others have recently performed (Yu, et al., 2011). This may help reduce any 
possible toxic effects resulting from the high level expression of the H-cluster maturation 
proteins. During the course of this work, it was reported that the deletion of iscR, which 
encodes the transcriptional repressor of the iron-sulphur cluster machinery operon, with the 
addition of extra cysteine and ferric ammonium citrate, resulted in an increase in [FeFe]-
hydrogenase activity in a heterologous system (Kuchenreuther, et al., 2010). A ∆iscR version of 
FTD147h3 was therefore constructed here, however it was not thoroughly tested due to time 
constraints. 
As no in vivo H2 production was observed in the FTD147h3 strain expressing the H-cluster 
maturation proteins, it was hypothesised that directed protein evolution might be required to 
activate this non-native thermophilic enzyme when expressed in E. coli at 37 °C. Indeed, no in 
vivo H2 production was observed in previous studies where the closely-related Thermotoga 
maritima [FeFe]-hydrogenase was heterologously expressed in E. coli (Agapakis, et al., 2010), 
although this was attributed to expression problems by those authors. The hypothesis was that 
variants of the synthetic enzyme that have increased, or modified, NADH-dependent 
hydrogenase activity could regenerate NAD+ during fermentation and therefore recover 
growth of ∆adhE, ldhA E. coli strains under these conditions. A variety of mutagenesis 
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approaches were used in this study. Mutant libraries of hydA were constructed using hyper-
mutagenic PCR and tested in the RaisynA1 strain, which encodes all of the synthetic Ca. 
tengcongensis [FeFe]-hydrogenase except HydA. No recovery of growth was observed when 
selected on minimal M9 + glucose agar plates incubated anaerobically. 
A number of other mutagenesis approaches were also undertaken. Mutant libraries of both 
the whole synthetic [FeFe]-hydrogenase plasmid, pUNI-Tte-Hyd, and the accessory plasmid, 
pSUtat-Sh-GX-EF, were constructed using XL1-Red competent cells, an E. coli strain deficient in 
three of the main E. coli DNA repair pathways (Greener, et al., 1996). In addition, chemical 
mutagenesis using methyl methane sulfonate (MMS) or Captan (Ohta, et al., 2000) was carried 
out directly on the two plasmids, as well as on the RaisynA1 strain pre-transformed with pUNI-
Tte-Hyd and pSUtat-Sh-GX-EF. Finally, mutagenesis using exposure to ultraviolet light was also 
carried out on this strain. No recovery of growth was observed using any of these mutagenesis 
approaches. 
One possible reason for the lack of recovery of growth could be that the Ca. tengcongensis 
[FeFe]-hydrogenase  follows a fundamentally different mechanism of H2 production than 
postulated in the original work (Soboh, et al., 2004). As now proposed for a number of other 
multimeric [FeFe]-hydrogenases (Schut and Adams, 2009) (Huang, et al., 2012; Schuchmann 
and Muller, 2012), it is worth considering that the Ca. tengcongensis enzyme produces H2 
through a bifurcating mechanism involving two separate electron donors; reduced ferredoxin 
(Fdred) and NADH. Preliminary work to investigate this has been undertaken here and tools are 
now available for the Ca. tengcongensis [FeFe]-hydrogenase and its maturation proteins to be 
co-expressed with Th. maritima pyruvate:ferredoxin oxidoreductase and ferredoxin in the 
FTD147h3 strain.  
The other consideration could be that the major problem lies with the activity of the HydB 
diaphorase subunit. It should therefore still be possible to perform directed protein evolution 
on all the other components of this complex system. Indeed, as an alternative to the live/dead 
selection method, it may be useful to devise a screening mechanism to detect improved 
hydrogenase activity resulting from any of these mutagenesis approaches such as the high-
throughput plate-based assay using redox dyes (Stapleton and Swartz, 2010b; Stapleton and 
Swartz, 2010a). 
Finally, it should be considered that swapping ethanol production for H2 production would not 
provide the correct redox balance for growth. However, in the course of this work, it was 
demonstrated that a bona fide NADH-dependent H2-producing enzyme (the soluble [NiFe]-
hydrogenase of the mesophilic organism Ralstonia eutropha H16) is introduced into an E. coli 
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strain lacking adhE, recovery of growth is reported as possible together with H2 yields of 
approximately 2 mol H2 per mol glucose (Ghosh, et al., 2013). During this project a synthetic 
operon encoding the R. eutropha SH was prepared but was shown to fail at the protein 
production stage. 
 Differences in growth of FTD147h3 and RaisynA1 in different types of media 3.4.2
It has been shown that adhE is essential for E. coli survival during the fermentation of glucose 
and hexoses more reduced than glucose, such as sorbitol (Lorowitz and Clark, 1982; 
Cunningham and Clark, 1986; Gupta and Clark, 1989). These experiments were all performed 
in minimal M9 media supplemented with the carbon source of choice. In this work, it was 
confirmed that FTD147h3 (FTD147 ∆adhE::TtehydC-A) did not grow anaerobically in minimal 
media with glucose as the sole carbon source. However, slow growth occurred in rich liquid 
media, supplemented with glucose, under anaerobic conditions. The growth of FTD147h3 was 
almost identical to that of Teatotal1 (FTD147 ∆adhE) in both rich liquid and minimal solid 
media. This implies that in rich liquid media, strains lacking alcohol dehydrogenase are capable 
or metabolising other carbon sources (e.g. amino acids) in the media and/or have the capacity 
to direct their metabolism towards alternative NAD+ regeneration pathways. 
RaisynA1 (FTD147h ∆ldhA) did not grow in either liquid or solid minimal media supplemented 
with glucose. Lactate production was abolished in this ∆ldhA strain. Interestingly, even in rich 
media RaisynA1 grew poorly, displaying a long lag phase of 17 h, but after 72 h growth 
sufficient biomass had accumulated to allow characterisation of the organic acid content of the 
extracellular media. No ethanol was produced by RaisynA1 (it carries a deletion in adhE). Very 
surprisingly, it was shown that RaisynA1 does not consume any of the glucose supplied in the 
starting culture media. It is likely that the yeast extract in LB broth is being used as the primary 
C source for growth under these conditions, and leading to ultimate secretion of acetate. 
Further evidence in support of this hypothesis can be found in the LC-MS metabolomics study 
comparing samples of growth media after “fermentation”, where the usage of peptides varied 
greatly between FTD147h3 and the other samples. 
 Identification of putative NAD+-regeneration pathways upregulated in FTD147h3 3.4.3
Although focused solely on secreted metabolites, the results of the metabolomics study give 
some indications as to possible mechanisms of NAD+ regeneration in FTD147h3 when grown 
anaerobically in rich media. Sorbitol-6-phosphate is only found in the FTD147h3 + pSUtat-Sh-
GX-EF samples and not in FTD147 or MC4100 samples and is likely produced from D-fructose 
6-phosphate in a reaction catalysed by sorbitol-6-phosphate dehydrogenase (SrlD; also known 
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as glucitol-6-phosphate dehydrogenase), which oxidises NADH to NAD+ (Lengeler, 1975). No 
sorbitol-6-phosphate was present in the culture media at the start of the experiment, 
suggesting that the build-up of this metabolite was not a result of product (D-fructose-6-
phosphate) inhibition, but rather the build-up of D-fructose-6-phosphate (Km: 568 µM) 
initiated this reaction in the direction of sorbitol 6-phosphate production (Km for sorbitol-6-
phosphate: 3.3 mM) (Novotny, et al., 1984; Roux, et al., 2006). 
1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide (reduced nicotinamide riboside) is a similar 
pyrimidine cofactor to NAD+ and was found outside the cell at a concentration > 8 times higher 
in FTD147h3 samples. This compound can be used by ‘NAD+ salvage pathway III’ of E. coli to 
regenerate NAD+. One multi-domain enzyme, NadR, catalyses both the ribosylnicotinamide 
kinase (1-(β-D ribofuranosyl)nicotinamide + ATP ↔ β-nicotinamide D-ribonucleotide + ADP + 
H+; Km for 1-(β-D ribofuranosyl)nicotinamide: 80 µM) and the NMN adenylyltransferase (β-
nicotinamide D-ribonucleotide + ATP + H+ ↔ NAD+ + diphosphate; Km for β-nicotinamide D-
ribonucleotide: 700 µM) reactions (Raffaelli, et al., 1999; Kurnasov, et al., 2002; Grose, et al., 
2005). 
Reactions involving the NAD+/NADH redox couple in the tryptophan-metabolism pathway also 
showed statistically-significant changes between the FTD147h3 samples and the other two 
sample types (P = 0.0001 in both cases). Indole-3-acetaldehyde was found at much higher 
concentrations than the other two sample types, whereas indole-3-acetate was found at much 
lower levels. Neither of these metabolites have been well studied in E. coli, however in a 
reaction independent of oxygen in plants and other organisms, indole-3-acetalydehyde is 
oxidised to indol-3-acetate, with the concurrent reduction of NAD+. This reaction is catalysed 
by an indole-3-acetalydehyde:NAD+ oxidoreductase. In this mutant and in these growth 
conditions, it’s possible that a similar NAD+-dependent reaction is inhibited by the lack of NAD+ 
and therefore indole-3-acetalydehyde accumulates. No other significant differences in 
metabolites of the tryptophan metabolic pathway were observed. 
The concentrations of glycerone (dihydroxyacetone) and glyceraldehyde recorded outside the 
cells were reduced in FTD147h3 samples. Each of these metabolites can be produced through 
reactions that involve the reduction of NAD+/NADP+ (e.g. glycerone can be produced 
anaerobically by glycerol:NAD+ 2-oxidoreductase, GldA), and therefore this reaction ceases or 
reverses in NAD+-limited conditions. It is interesting, however, that the amounts of glycerone 
and glyceraldehyde are also reduced in FTD147 samples compared to MC4100 samples, 
suggesting that other factors are involved in the lower amount of these metabolites (perhaps 
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as a result of a build-up of pyruvate, which in turn results from the inability to dispose of 
formate in strains defective in formate hydrogenlyase activity). 
Another interesting metabolite that showed significant changes between the samples was 2-
butenoate (crotonic acid). The amount of this metabolite was reduced in the FTD147 and 
FTD147h3 samples compared to the MC4100 samples and this difference was statistically 
significant in both cases (P = 0.0003). The metabolism of 2-butenoate in E. coli is not well 
characterised, but it has been studied in various Clostridia species (Bader, et al., 1980). In 
these organisms, the reduction of 2-butenoate is catalysed by a 2-enoate reductase, which 
oxidises NADH to NAD+. Crotonic acid is associated with both L-carnitine production (Elssner, 
et al., 2001) and glutamate fermentation (Buckel, 2001), as it is the precursor to crotonyl-CoA, 
which plays a key role in both pathways. Interestingly, the concentrations of (R)-3-
hydroxybutanoate, itself a precursor to crotonyl-CoA in the glutamate fermentation pathway 
of various Clostridia species (Buckel, 2001), was higher in FTD147h3 samples than both FTD147 
and MC4100 samples, indicating differential flux through these pathways. In a separate 
provisional metabolomics experiment, an increase in the amount of an unidentified metabolite 
was noticed in all ∆adhE mutant samples (Figure 3.21). This was tentatively identified as an 
analogue of carnitine (C19H40N3O3 or C17H36N3O3) through follow-up LC-MS analysis, adding 
weight to the hypothesis that carnitine metabolism is altered in these mutants. 
108 
 
 
 Redirection of metabolic flux towards increased acetate production 3.4.4
A large increase in acetate production was noticed in FTD147 and FTD147h3 samples (+/- 
pSUtat-Sh-GX-EF). One possible reason for this is implied by the lower amounts of 2-deoxy-D-
ribose 5-phosphate, an intermediate in the pentose phosphate pathway, in the extracellular 
environment of both of these samples. In the cytoplasm, 2-deoxy-D-ribose 5-phosphate is 
cleaved into acetaldehyde and D-glyceraldehyde 3-phosphate by deoxyribose-phosphate 
aldolase, DeoC (Racker, 1952). The D-glyceraldehyde 3-phosphate produced can enter 
glycolysis or other metabolic pathways, while the acetaldehyde can be further oxidised to 
either acetate by an NADP-dependent acetaldehyde dehydrogenase, AldB (Ho and Weiner, 
2005), or via a second acetaldehyde dehydrogenase, MhpF to acetyl-CoA (Ferrandez, et al., 
1997). Note that the latter reaction requires the oxidation of NAD+ and is therefore unlikely in 
NAD+-limited conditions. Presumably this excess acetate production is necessary for ATP 
production in these conditions. It is interesting, however, that a reduction in the concentration 
of 2-deoxy-D-ribose 5-phosphate and an increase in acetate is observed in FTD147 samples, 
which have functional AdhE. Perhaps the loss of H2 production, or build-up of intracellular 
Figure 3.21 An unknown metabolite found at a much higher level in ∆adhE mutant samples. Test tubes filled with 
16 ml L.B. + 0.4% (w/v) glucose were inoculated 1:1000 with MG1655 and FTD147h3 and cultures grown 
anaerobically. Cells were harvested by centrifugation at 4000 rpm before the culture supernatant was passed 
through a 0.2 µm filter and analysed by HPLC. For HPLC analysis, 5 µl of fermentation broth was separated at 0.7 ml 
min-1 and 55 °C using a Dionex UltiMate 3000 HPLC system, fitted with an Aminex HPX-87H organic acid column and 
absorbance monitored at 210 nm. The asterix (*) denotes the mystery peak noticed in the spent media all ∆adhE 
mutant samples. This was analysed by non-targeted LC-MS and putatively identified as a carnitine analogue. 
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formate, requires compensation in ATP production, again suggesting a link between formate 
efflux, influx or H2 production and energy conservation. 
 Other changes in metabolite concentrations  3.4.5
Small amounts of 2-formylaminobenzaldehyde were found in the FTD147h3 samples. This is 
likely to result from the oxidation of indole, which is a derivative of tryptophan breakdown. 
Interestingly, this reaction, catalysed by an indole:oxygen 2,3-oxidoreductase, requires O2 in 
other biological systems. The use of tryptophan as a nitrogen and/or carbon source by this 
mutant is likely. Another strange metabolite found in the FTD147h3 samples was pantothenol 
(dexpanthenol). This is usually used as a substrate in the pantothenate and CoA biosynthesis 
pathways, which is linked to the metabolism of various amino acids. The mechanism for its 
production in E. coli is unknown, however. Increasing the amount of pantothenol might 
therefore aid Coenzyme A production, which might be useful for the cell in these stressed 
conditions. 
Two other metabolites were increased in FTD147h3 samples. The concentration of 2-
hydroxyadenine (isoguanine) was approximately two and a half times that of the control 
sample. It is mutagenic to bacterial cells and therefore is normally quickly converted to 
xanthine by cytosine deaminase (Km for isoguanine: 72µM; Km for cytosine: 302 µM) 
(Hitchcock, et al., 2011). The second metabolite found at much higher levels in the FTD147h3 
samples was the aptly named traumatic acid. This metabolite is produced by many species of 
plants in response to wounding and has been shown to promote cell proliferation (Van 
Overbeek, 1940), but its production has not been characterised in E. coli previously. It was 
observed in cultures of Ralstonia sp., which produce it from the oxidation of a fatty acid α-
ketol (Schneider, et al., 1997). 
A number of metabolites were either completely absent or at lower concentrations in the 
FTD147h3 samples, yet found in large concentrations in the FTD147 and MC4100 controls. N-
methyl-L-glutamate and allylcysteine were completely absent from FTD147h3 samples and 
adenylyl sulphate was found at much lower concentrations then the other two sample types. 
The lack of N-methyl-L-glutamate could be explained by either the consumption of all of this 
metabolite in order to produce L-glutamate and methylamine which could be used as a carbon 
and nitrogen source, or alternatively its consumption could be linked to the production of L-
glutamate and formaldehyde. Both reactions are characterised in Pseudomonas sp. but not in 
E. coli (Shaw, et al., 1966; Hersh, et al., 1972). Allylcysteine is another poorly characterised 
metabolite, but is proposed to be produced from L-cysteine in combination with cyclopropene. 
It is found in high concentrations in the MC4100 samples and at half that concentration in the 
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FTD147 samples, but completely absent from the FTD147h3 + pSUtat-Sh-GX-EF samples. This is 
likely due to the consumption of L-cysteine to support the expression of the synthetic [FeFe]-
hydrogenase and HydEFG, which puts a strain on both the cellular iron-sulfur cluster 
machinery and the raw materials required (e.g. iron and cysteine). 
 Improvements in the design of future experiments 3.4.6
First, MC4100 should have been used as the wild-type control for all experiments as both 
FTD147h3 and RaisynA1 are derivatives of this strain. For all growth, organic acid and 
metabolomics analysis, the use of a fully defined rich media such as the EZ Rich Defined 
Medium from Teknova would be preferential. As the HPLC experiments demonstrate, the 
starting concentrations of various carbon and nitrogen sources vary dramatically from one 
batch of LB to another. This would allow the results from these experiments performed on 
different days to be compared directly. This is not possible with results from experiments in 
this chapter using LB as different starting concentrations of a carbon sources such as succinate, 
could potentially influence the direction of metabolic flux in E. coli strains. Finally, the use of an 
anaerobic chamber for some of the procedures in these experiments would be advantageous. 
No loss of hydrogenase activity from cell lysates of FTD147h3, containing the synthetic [FeFe]-
hydrogenase, would occur as a result of oxygen inactivation. O2-sensitive metabolites would 
also be protected in this environment.  
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 Introduction 4.1
 Glycerol metabolism in E. coli 4.1.1
Glycerol has long been regarded as a “non-fermentable carbon source” in Escherichia coli K12 
and was thought to require respiratory electron acceptors for its metabolism (Miki and Lin, 
1973; Lin, 1976). A glycerol transporter GlpF (a member of the aquaporin [AQP] channel 
family) is known to transport glycerol into the cytoplasm (Stroud, et al., 2003) where GlpK, a 
glycerol kinase encoded by an operon that includes glpF, phosphorylates glycerol in an ATP-
dependent manner resulting in glycerol-3-phosphate (Glyc-3-P). Alternatively, Glyc-3-P itself 
can be used directly as a carbon source and transported into the cell by the UgpBAEC uptake 
system (Schweizer, et al., 1982). Under aerobic or anaerobic respiratory conditions, Glyc-3-P is 
oxidised by one of two membrane-bound respiratory glycerol dehydrogenases: GlpD, the 
aerobic Glyc3PDH enzyme; or GlpABC, the anaerobic glycerol dehydrogenase, which is loosely 
attached to the cytoplasmic membrane). In both scenarios, dihydroxyacetone phosphate 
(DHAP; an intermediate compound in the Emden-Meyerhof glycolytic pathway) and quinol are 
the products of Glyc-3-P oxidation. DHAP can then be converted to D-glyceraldehyde 3-
phosphate (G-3-P) by the enzyme triose-phosphate isomerase (TIM, encoded by tpiA). 
 Glycerol would be an ideal substrate for biohydrogen production 4.1.2
Glycerol is a potentially excellent carbon source for the production of biochemicals. Glycerol is 
the major waste product of biodiesel production (4.5 kg of glycerol per 45 kg of biodiesel) and 
bioethanol production  (Yazdani and Gonzalez, 2007). Glycerol is now produced in such large 
quantities worldwide that its price has plummeted. If a sustainable carbon source could be 
used for the initial production of the fatty acids required for biodiesel production, glycerol 
would represent an even more attractive, affordable and sustainable substrate for commercial 
biochemical production. In addition, the higher degree of reduction (K) of glycerol (4.7) 
compared to glucose (4) or other carbohydrate sources means that it has the potential to 
produce higher yields of highly reduced fermentation products such as ethanol and H2, than 
other carbon sources.  
 A synthetic glycerol H2-producing enzyme 4.1.3
It would be extremely advantageous to construct a synthetic, insulated pathway for hydrogen 
production from glycerol in E. coli. Such a pathway would ideally only produce hydrogen and 
be unable to reoxidise this hydrogen, and so should also avoid the possible inhibitory effects 
resulting from a high p(H2) atmosphere. One design strategy for such a synthetic pathway 
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might involve the construction of a non-natural hydrogen-producing enzyme, capable of 
accepting electrons from the oxidation of glycerol and subsequently reducing protons directly. 
Such an enzyme could be constructed from the fusion of two unrelated polypeptides, each of 
which catalyses the desired half reaction, i.e. quinol oxidation and H2 production. 
 Properties of parts for construction of a synthetic glycerol-dependent H2-producing 4.1.4
enzyme 
In order to construct a synthetic hydrogen-evolving enzyme that is capable of accepting 
electrons released during glycerol oxidation, individual components or parts with important 
properties are required. Firstly, such a synthetic enzyme must display the ability to accept 
electrons directly from the cytoplasmic membrane quinol pool and transfer these electrons to 
its target substrate efficiently. Thiosulfate reductase, a well-studied and characterised redox 
enzyme found in Salmonella enterica serovar Typhimerium (Salmonella hereafter), is an 
interesting candidate for use in the desired synthetic hydrogen-producing system as it fulfils a 
number of the requirements. The thiosulfate reductase enzyme complex is encoded by the phs 
operon (Figure 4.1A) and is a heterotrimer consisting of PhsA, PhsB and PhsC (Heinzinger, et 
al., 1995). PhsA (83 kDa) is the molybdenum cofactor-containing catalytic subunit; PhsB (21 
kDa) is an Fe-S cluster-containing electron transfer subunit; and the hydrophobic PhsC (28.5 
kDa) subunit is a haem-containing integral membrane quinol dehydrogenase (Heinzinger, et 
al., 1995). The PhsAB proteins are positioned at the periplasmic face of the cytoplasmic 
enzyme by the Tat translocase where they form the final complex with PhsC (Figure 4.1B). The 
enzyme is therefore tightly membrane-bound and capable of oxidising menaquinol, which is 
the preferred electron carrier from the anaerobic oxidation of either glycerol or formate 
(Stoffels, et al., 2012), and transferring electrons to the terminal electron acceptor thiosulfate, 
thus producing sulphide (HS-) and sulphite. The phs operon can be expressed and the enzyme 
complex overproduced in E. coli with no loss in thiosulfate reductase activity (Bang, et al., 
2000). 
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Figure 4.1 A. The phsABC operon of Salmonella encodes thiosulfate reductase. B. PhsABC forms a 
heterotrimeric complex, which is capable of oxidising menaquinol and passing these electrons up an 
electrochemical potential gradient to reduce thiosulfate (S2O3
2-) to hydrogen sulphite (HS-) and 
sulphide (HSO3
-). 
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It has been shown that thiosulfate reductase is capable of reducing thiosulfate when glycerol is 
the sole carbon source and is therefore unusually capable of catalysing a highly endergonic 
reaction (Stoffels, et al., 2012). This ability to pass electrons up a thermodynamic gradient 
(difference in standard potential, ∆E0’, of menaquinol to thiosulfate under standard conditions 
= -328 mV) is made possible by the fact that thiosulfate reductase uses the transmembrane 
electrochemical gradient (or proton motive force [PMF]) to make up this energetic shortfall 
(Stoffels, et al., 2012). It has been suggested previously that during thiosulfate respiration this 
PMF is primarily generated by the reverse reaction of the F1Fo ATP Synthase (Sasahara, et al., 
1997). The ability of PhsC to use PMF to drive electrons ‘uphill’ towards the active site in PhsA 
would be extremely desirable to have in a glycerol-dependent hydrogen-producing enzyme. 
The H2/2H+ couple has a standard potential (E0’) of -421 mV (compared with an E0’ of -402 mV 
for the S2O32-/HS- + SO32- couple), therefore if it were possible to combine the menaquinol 
oxidation properties of thiosulfate reductase and the hydrogen-production activity of a 
hydrogenase active site in one fusion protein, it should in theory be able to pass electrons 
from the oxidation of glycerol to the reduction of protons. The final required property of an 
enzyme to catalyse the production of H2 from glycerol is that it be capable of transferring 
electrons through FeS clusters to a hydrogen-producing active site at a fast rate. One of the 
three E. coli hydrogenases, Hyd-2, which normally oxidises H2 has previously been shown to be 
capable of bidirectionality in vitro, high catalytic activity in highly reduced conditions, as well 
displaying low level of inhibition of O2 when producing H2 (Lukey, et al., 2010). It was therefore 
hypothesised that a novel chimeric metalloenzyme constructed from Salmonella thiosulfate 
reductase and E. coli Hyd-2 could be capable of hydrogen production with glycerol as the sole 
electron donor and carbon source.  
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 Aims 4.2
This Chapter aims to rationally design and construct a synthetic fusion metalloenzyme capable 
of accepting electrons from menaquinol generated through the oxidation of glycerol-3-
phosphate. Ideally, this chimeric metalloenzyme must also be capable of passing electrons up 
an electrochemical potential gradient and ultimately reduce protons to produce H2. The parts 
chosen to form this fusion enzyme are the thiosulfate reductase enzyme from Salmonella and 
hydrogenase-2 (Hyd-2) from E. coli. Construction of the fusion enzyme will be guided by 
structural and functional information available on both enzymes. Expression, stability, 
localisation and activity of the synthetic enzyme in the E. coli chassis will be fully characterised. 
Attempts to insulate, improve and optimise the synthetic glycerol-dependent hydrogen 
production pathway will also be performed. 
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 Results 4.3
 Examining Salmonella thiosulfate reductase as a suitable quinol dehydrogenase for 4.3.1
H2 production. 
In collaboration with Dr. Jennifer S. McDowall, the genetic requirements for in vivo thiosulfate 
reduction were investigated. Various strains of E. coli were transformed with plasmid pAH2 
(Stoffels, et al., 2012), which encodes the phsABC operon from Salmonella, and assessed for 
thiosulfate reductase activity by their ability to produce iron sulphide (black precipitate), when 
grown anaerobically for two days in 5 ml PI media (peptone, iron and thiosulfate) cultures 
containing either formate (final concentration: 0.4% w/v) or glycerol (final concentration: 0.5% 
v/v) as additional carbon source. E. coli strains B1LK0 (as MC4100 ∆tatC) and FTD128 (as 
MC4100 ∆fdhE; demonstrated good iron sulphide production in preliminary PI plate 
experiments) were chosen as negative and positive controls respectively (Figure 4.2A). The 
addition of tungstate (WO4) to the ∆fdhE strain was used to confirm the iron sulphide was the 
result of the activity of a molybdoenzyme, as excess tungstate can incorrectly inserted in place 
of molybdenum normally resulting in an inactive enzyme (Figure 4.2A). 
It was previously shown that menaquinol was the electron donor for thiosulfate reductase and 
that the enzyme required PMF to function (Stoffels, et al., 2012) and that the F1FO ATP 
synthase was required (Sasahara, et al., 1997). In agreement with these findings, iron sulphide 
production is abolished in ∆menA/D/E mutants (Figure 4.2B), which are required for the 
biosynthesis of the napthoquinones (Young, 1975; Kwon, et al., 1996; Jiang, et al., 2007) and in 
atpC/D/G/H mutants (Figure 4.2C), which form subunits of the F1 complex of the F1F0 ATP 
synthase (Engelbrecht and Junge, 1990; Senior, 1990; Tang and Capaldi, 1996). 
It was also shown recently that glycerol-dependent thiosulfate reductase activity was 
independent of H2 metabolism (Stoffels, et al., 2012). It was suggested, however, that the 
formate-dependent reduction of thiosulfate required H2 as an intermediate in the electron 
chain between formate and thiosulfate and this claim was assessed using this experimental set 
up. The E. coli strain FTD147, lacking all the large catalytic subunits of each of the three E. coli 
hydrogenases (Hyd-1, 2 & 3) and a ∆hypF mutant, a maturation protein required for the 
activity of all three hydrogenases, both showed iron sulphide production, indicating thiosulfate 
reductase activity (although less iron sulphide was observed in the FTD147 sample). 
 
 
118 
 
  
Figure 4.2 Menaquinone and ATP synthase are essential for formate-dependent thiosulfate reduction, but H2 
metabolism is not. Various strains of E. coli were transformed with plasmid pAH2, which encodes phsABC from 
Salmonella, and assessed for thiosulfate-reductase activity by their ability to produce iron sulphide (black 
precipitate), when grown anaerobically for two days in 5 ml PI media (peptone, iron and thiosulfate) cultures 
containing either formate (final concentration: 0.4% w/v) or glycerol (final concentration: 0.5% v/v) as the sole 
carbon source.  A. E. coli strains BILKO (as MC4100 ∆tatC) and FTD128 (as MC4100 ∆fdhE; demonstrated good 
iron sulphide production in preliminary PI plate experiments) were chosen as negative and positive controls 
respectively. Tungstate was added to ∆fdhE strain to confirm iron sulphide production was specific to 
molybdenum-containing thiosulfate reductase. B. Genes involved in the menaquinone-biosynthesis pathway 
were shown to be essential for thiosulfate reductase activity. C. Genes encoding subunits of the F1F0 ATP 
synthase were shown to be essential for thiosulfate reductase activity. D. H2 metabolism was shown to be non-
essential for formate-dependent thiosulfate reductase activity. 
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 The design and construction of a synthetic fusion metalloenzyme operon 4.3.2
Initially, the genes encoding the quinol dehydrogenase subunit of Salmonella thiosulfate 
reductase (PhsC) and the electron-transferring subunit PhsB were cloned into a medium-copy 
E. coli expression vector based on pUNI-PROM (Jack, et al., 2004). The pUNI-CFM plasmid in 
question encodes an unusual fusion protein between the TorA signal peptide, chloramphenicol 
acetyl transferase, the FdnH transmembrane domain, and maltose binding protein. More 
importantly, this plasmid contains all the restriction sites necessary to build a Hyd-
2/thiosulfate reductase fusion. The natural transcriptional/translational coupling between the 
phsB and phsC genes was maintained but the Salmonella phsB gene was amplified with a 
primer containing the DNA sequence that encodes a haemaglutinin (HA) epitope tag. The HA-
phsBC PCR product was digested with NcoI and HindIII and replaced the fdnH-malE fragment in 
pUNI-CFM. This plasmid was termed pUNI-CPhs and encodes a fusion between TorA-CAT and 
PhsB via an HA linker. Next, the hybO gene encoding the E. coli Hyd-2 small subunit was 
amplified and used to replace the torA-cat allele as a BamHI-BspLU11I fragment. The HybO 
protein contains a twin-arginine signal peptide at its N-terminus and a transmembrane domain 
at its C-terminus. In order to attempt to tightly fuse HybO closely to the modified HA-PhsB 
polypeptide, HybO must be truncated sufficiently to remove this transmembrane helix but to 
retain its distal 4Fe-4S cluster. In this case two shortened versions of hybO, each with different 
lengths of 3’-end deletions, were cloned into pUNI-CPhs to produce the two final expression 
plasmids: pUNI-OSPhs (shortest version of HybO; Figure 4.3A); and pUNI-OLPhs (longer version 
of HybO; Figure 4.3B). The pUNI-PROM plasmid has two promoters upstream of its MCS, the 
well characterised PT7lac and the constitutive E. coli promoter Ptat, as well as a Shine Dalgano 
sequence from the E. coli tatA gene. The final plasmids would therefore encode a Tat-
dependent fusion protein between HybO and PhsB. The final required catalytic subunit of the 
synthetic fusion Hyd-2/thiosulfate reductase complex is HybC, the catalytic subunit of Hyd-2. 
Rather than clone this gene as well, a host strain was designed that the pUNI-OSPhs and pUNI-
OLPhs plasmids could be expressed in. An E. coli strain was constructed called IC011, which is 
based on MC4100 but carries ∆hyaB, ∆hycE and ∆hybOA alleles.  The IC011 strain is therefore 
devoid of all endogenous hydrogenase activity but, because the ∆hybOA allele has been 
carefully designed in-frame, should still express the remaining hybBCDEFG genes of the operon 
encoding Hyd-2. 
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Figure 4.3 The design and construction of synthetic chimeric metalloenzyme for H2 production from glycerol in E. 
coli. Two plasmids were constructed that encode a synthetic fusion protein consisting of E. coli hybO (the small 
subunit of Hyd-2) and Salmonella phsB (the small subunit of thiosulfate reductase). The two genes were cloned into 
pUNIPROM (constitutive promoter, Ptat; optimised RBS) with the sequence that encodes HA tag inserted between 
the penultimate codon of hybO and the second codon of phsB. The gene encoding the quinol dehydrogenase 
subunit of thiosulfate reductase, phsC, was cloned in after this fusion gene. A. pUNI-OSPhs encodes a shorter fusion 
protein with most of the C-terminal transmembrane helix removed. B. pUNI-OLPhs encodes a longer fusion protein 
with more of the C-terminal transmembrane helix remaining. 
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 The synthetic chimeric metalloenzyme is expressed in E. coli  4.3.3
In order to validate that the newly constructed metalloenzyme chimeras were expressed in E. 
coli, radiolabelling experiments were performed. Expression of both the synthetic fusion gene 
(hybO-HA-phsB) and phsC was investigated using 35S-Methionine radiolabelling experiments. E. 
coli strain K38 (containing plasmid pGP1-2, a temperature-sensitive plasmid that encodes T7 
polymerase) was transformed with either pUNI-OSPhs or pUNI-OLPhs and minimal M9 cultures 
lacking cysteine and methionine were labelled in vivo for 15 min by the addition of 35S-
methionine. Samples were then analysed by SDS-PAGE (12% w/v polyacrylamide), fixed, and 
visualised by autoradiography (Figure 4.4A). Distinct prominent bands corresponding to the 
expected molecular weight of both the shorter fusion protein and the longer fusion protein 
were observed indicating that both fusion proteins are expressed in E. coli.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.4 Short and long HybO-PhsB fusion 
polypeptides are expressed. 35S-methionine 
radiolabelling confirms expression and 
translation of the synthetic fusion hybO-HA-
phsB gene. E. coli strain K38/pGP1-2 was 
transformed with plasmids: pUNI-OSPhs; or 
pUNI-OLPhs, and minimal M9 cultures lacking 
cysteine and methionine were labelled for 15 
min by the addition of 35S-methionine. Samples 
were then separated on a 12% SDS-PAGE gel 
and visualised by autoradiography. 
122 
 
 The synthetic chimeric metalloenzyme displays in vitro hydrogenase activity 4.3.4
Once expression of the synthetic gene encoding the chimeric metalloenzyme in E. coli was 
confirmed, it was now important to answer two essential questions. First, does the plasmid-
encoded HybO interact with HybC to form an active enzyme? And second, is the complex 
transported to the periplasm? The BV-reduction assay can answer both of these questions. As 
the cytoplasmic membrane is only partially permeable to BV, H2-dependent (equivalent to H2 
oxidation) BV reduction would indicate that some of the synthetic fusion enzyme complex has 
been successfully transported across the inner membrane to the periplasm.  
The IC011 (∆hyaB, ∆hycE, ∆hybOA) reporter strain was transformed separately with either 
pUNI-PROM, pUNI-OSPhs or pUNI-OLPhs and was assayed for hydrogenase activity using the 
artificial electron acceptor benzyl viologen (BV). Unbroken, whole-cell samples of IC011 [pUNI-
OSPhs] catalysed the H2-dependent reduction of BV with a specific activity of 10.8 ± 0.4 µmol 
min-1 mg-1 cells. In comparison, IC011 [pUNI-OLPhs] had a slightly lower activity of 8.7 ± 0.4 
µmol min-1 mg-1 cells. IC011 cells transformed with the empty vector pUNI-PROM displayed 
only trace activity (Figure 4.5). 
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Figure 4.5 Synthetic chimeric metalloenzyme displays in vitro hydrogenase activity. 
Benzyl viologen (BV) reduction (H2 oxidation) was monitored at 578 nm in a UV-vis 
spectrometer. 1 ml quartz cuvettes were filled with H2-saturated buffer (50 mM Tricine pH 
8.0) and 13 mM BV. This was titrated with sodium dithionite to an absorbance of 0.4 - 0.7 
and the reaction started by the addition of 500 µg of IC011 whole cells expressing either 
pUNIPROM; pUNI-OSPhs; or pUNI-OLPhs. Error bars represent the standard error of 
biological replicates 
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 The synthetic chimeric metalloenzyme can produce H2 in a glycerol-dependent 4.3.5
manner 
Next, the synthetic chimeric metalloenzyme was tested for its ability to generate hydrogen 
when coupled to glycerol-3-phosphate respiration. The IC011 strain harbouring either pUNI-
OSPhs or pUNI-OLPhs was grown anaerobically in rich media supplemented with glycerol and 
fumarate before being harvested and washed under anaerobic conditions. Intact cell samples 
were introduced into a Clark-type electrode (modified for H2 measurement) and following a 
period of equilibration, excess glycerol (170 mM final concentration) was added (Figure 4.6). 
No external electron acceptors were added to the reaction chamber. Under these conditions 
the IC011 [pUNI-OSPhs] whole cell sample slowly produced hydrogen (22 nmol over ~100 
minutes). H2 production notably ceased after approximately 90 minutes, and the rates and 
durations of H2 production were less in the strain harbouring the pUNI-OSPhs plasmid. IC011 
whole cells transformed with pUNI-PROM were assayed as a control and produced no H2 from 
glycerol, confirming that all of the H2 observed was indeed from the synthetic chimeric 
metalloenzyme. 
When the amount of IC011 + pUNI-OSPhs cells added to the reaction chamber was doubled, 
the rate and total amount of H2 produced increased and H2 production was sustained for 
longer. This result demonstrated that the availability of glycerol was not the limiting factor but 
instead cessation of H2 production must be linked to an internal cellular factor such as 
depletion of ATP reserves or an inability to generate a proton motive force (PMF). Finally, the 
synthetic chimeric metalloenzyme was shown to be unable to reoxidise the H2 produced from 
glycerol, as the addition of a terminal electron acceptor did not reduced the amount of H2 in 
the reaction chamber (data not shown).  
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Figure 4.6. Either version of the synthetic chimeric metalloenzyme is capable of producing H2 directly from 
glycerol. Cells were grown for 16 h overnight at 37° C in sealed, stationary 500 ml Duran bottles, containing 500 ml 
Luria Broth supplemented with 0.5% (v/v) glycerol and 0.4% (w/v) fumarate. Cells were harvested by 
centrifugation, washed twice in anaerobic buffer (100 mM sodium phosphate, pH 6.8) to remove any trace of 
growth media, glycerol and fumarate, and resuspended in 2 ml of the same anaerobic buffer per 1 g of cells (wet 
weight). Assays were carried out using a modified Clark-type electrode (Hansatech Oxygraph). 2 ml of the same 
anaerobic buffer was added to the reaction chamber and 50 mg of either IC011 + pUNI-PROM (full circle), IC011 + 
pUNI-OSPhs (open triangle) or IC011 + pUNI-OLPhs (open diamond) whole cells were added. After equilibration, 
glycerol at a final concentration of 170 mM was added to the reaction chamber (point A; t = 0 s). H2 production was 
measured by following the current generated following calibration with known amounts of H2. These results show 
that both the short and long fusion enzyme versions are capable of producing H2 directly from glycerol. The 
experiment was also performed with the addition of 100 mg of IC011 + pUNI-OSPhs (full square). Representative 
traces of each sample type are shown. 
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 The design and construction of new fusion proteins with alternative peptide linkers 4.3.6
The original plasmids were constructed with a HA-tag linker between PhsB and the truncated 
HybO. It has been shown recently that varying the length and amino acid composition of the 
linker can radically alter the properties of fusion proteins (Agapakis, et al., 2010; Chen, et al., 
2012). The original HA-tag linker (YPYDVPDYA) of pUNI-OSPhs was therefore replaced with a 
variety of different peptide linkers to try and improve the stability and activity of the fusion 
enzyme (Figure 4.7). 
It has previously been shown that the optimum distance for spontaneous electron transfer 
between redox-active centres is 10 - 15 Å (Page, et al., 1999; Page, et al., 2003; Fritsch, et al., 
2011). Thus one of the keys to efficient operation of this fusion protein is finding the optimum 
distance between the PhsB and HybO Fe-S clusters. In order to reduce the distance between 
the hypothetical N-terminal 4Fe-4S cluster of PhsB (the structure of this protein is not known) 
and the distal 4Fe-4S cluster of HybO, the sequence encoding the HA-tag linker was replaced 
with a Sal I restriction enzyme site, which encodes the amino acid sequence EL (Figure 4.7B). 
The resulting plasmid pUNI-OSSalIPhs should encode a fusion protein where the two subunits 
are held in a tight rigid conformation with the N- and C-termini of the proteins in the closest 
possible proximity to each other. Two fusion proteins were next constructed which had well 
characterised flexible linkers instead of the HA-tag linker. The first of these plasmids, pUNI-
OSFlexAPhs, encodes the fusion protein with the flexible linker, GGGGS (Figure 4.7C). The small 
non-polar glycine residue allows flexibility, therefore allowing these Fe-S cluster-containing 
subunits to move around, which might be important for efficient electron transfer. The 
addition of a small polar serine residue is thought to increase solubility of fusion proteins and 
help stabilise the linker in aqueous solutions (Chen, et al., 2012). The second of these plasmids, 
pUNI-OSFlexDPhs, encodes the fusion protein with the flexible linker, GGGGGGGG (Figure 
4.7D). The next plasmid constructed was pUNI-OS-6aaFLexAPhs and it encodes the same 
GGGGS flexible linker as used in the FlexA version, but encodes a further truncated version of 
HybO. Six codons at the 3’-end of the already-shortened hybO gene were deleted, which 
should result in a fusion with PhsB that is very close to the final cysteines predicted to ligate 
the distal 4Fe-4S cluster of HybO (Figure 4.7E). Finally, in the course of plasmid construction, a 
derivative of pUNI-OSPhs was isolated with the full hybOS-HA-phsB sequence but with 
mutations in a number of locations in the vector backbone (pUNI-OSmutPhs).  
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Figure 4.7 The design of new linker peptides between HybO and PhsB. A. The original linker peptide used to fuse 
HybO and PhsB was a H. influenza haemaglutinin (HA) tag. A variety of different peptide linkers were selected to 
replace the HA tag: B. a short linker consisting of just two amino acids (EL); C. a flexible linker consisting of glycines 
and a serine residue (GGGS); D. a longer flexible linker consisting of just glycines (GGGGGGGG); and E. the flexible 
linker GGGGS was used in the construction of a new fusion protein with a further truncation of the C terminus of 
HybO. 
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 Expression and stability of the synthetic chimeric metalloenzyme with alternative 4.3.7
peptide linkers 
The expression of the newly constructed metalloenzyme chimeras with alternative peptide 
linkers was tested in E. coli using 35S-Methionine radiolabelling. The E. coli strain K38 
(containing plasmid pGP1-2, a temperature-sensitive plasmid that encodes T7 polymerase) was 
transformed separately with pUNI-OSmutPhs, pUNI-OSSalIPhs, pUNI-OSFLexAPhs, pUNI-
OSFlexDPhs or pUNI-OS-6aaFlexAPhs. Cultures of M9 minimal medium lacking cysteine and 
methionine were labelled in vivo for 15 min by the addition of 35S-methionine. Samples were 
then analysed by SDS-PAGE (12% w/v polyacrylamide), fixed, and visualised by 
autoradiography (Figure 4.8). Distinct prominent bands corresponding to the expected 
molecular weight of OSFlexAPhs and OS-6aaFlexPhs (identical to OSPhs) were observed 
indicating that both fusion proteins are expressed in E. coli. No band corresponding to the 
expected molecular weight of OSSalIPhs was observed, however a prominent band at 
approximately 34 kDa and a much fainter band at approx. 100 kDa could be seen. pUNI-
OSFlexDPhs did not appear to be expressed correctly in E. coli as no bands could be detected. 
Finally, the pUNI-OSmutPhs plasmid expressed the main HybO-Phs fusion protein as in pUNI-
OSPhs, however another prominent band at approximately 36 kDa and numerous bands of 
lower molecular weight were also detected. Indeed numerous shorter proteins were 
expressed in all samples except pUNI-OSFlexDPhs. 
Figure 4.8 Expression and stability of the new linker fusion 
enzyme genes in E. coli. A. 35S-methionine radiolabelling 
confirms expression and translation of three of the new linker 
hybO-phsB genes in E. coli. E. coli strain K38/pGP1-2 was 
transformed with plasmids: pUNI-OSPhs; pUNI-OLPhs; pUNI-
OSmutPhs; pUNI-OSSalIPhs; pUNI-OSFlexAPhs; pUNI-
OSFlexDPhs; or pUNI-OS-6aaFlexPhs, and minimal M9 cultures 
lacking cysteine and methionine were labelled for 15 min by the 
addition of 35S-methionine. Samples were then run on a 12% 
SDS-PAGE gel and visualised by autoradiography. 
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Next, whole cell BV-linked hydrogenase activity was determined (Figure 4.9). IC011 cells 
transformed with the FlexA, OSmut or SalI plasmid variants displayed slight increases in H2-
dependent BV reduction activity compared to the OS plasmid. The FlexD variant as expected 
showed trace activity, however the -6aaFlex variant only showed trace activity. 
  
Figure 4.9 Three of the new linker-peptide versions of the synthetic chimeric metalloenzyme operons show in 
vitro hydrogenase activity. Benzyl viologen (BV) reduction (H2 oxidation) was monitored at 578 nm in a UV-vis 
spectrometer. 1 ml quartz cuvettes were filled with H2-saturated buffer (50 mM Tricine pH 8.0) and 13 mM BV. 
This was titrated with sodium dithionite to an absorbance of 0.4 - 0.7 and the reaction started by the addition of 
500 µg of IC011 whole cells expressing either pUNIPROM; pUNI-OSPhs; pUNI-OLPhs; pUNI-OSmutPhs; pUNI-
OSSalIPhs; pUNI-OSFlexAPhs; pUNI-OSFlexDPhs; or pUNI-OS-6aaFlexPhs. Error bars represent the standard error 
of three biological replicates. 
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 Localisation of the synthetic chimeric metalloenzymes with alternative peptide 4.3.8
linkers 
The subcellular localisation of the synthetic chimeric enzymes was analysed using rocket 
immunoelectrophoresis. The E. coli strain IC011 was transformed separately with pUNIPROM 
(Uni; negative control), pUNI-OSPhs (OS), pUNI-OSSalIPhs (SalI), pUNI-OSFlexAPhs (FlexA), 
pUNI-OSFlexDPhs (FlexD), pUNI-OSmutPhs (OSmut) or pUNI-OS-6aaFlexAPhs (-6aaXFlex) and 
transformants used to inoculate 500 ml anaerobic LB cultures supplemented with glycerol, 
fumarate and appropriate antibiotics, which were incubated at 37 °C for ~16 h. Cultures were 
centrifuged and cell pellets used for subcellular fractionation. Cytoplasmic and membrane 
fractions were isolated and the membranes solubilised using Triton X-100. Cytoplasmic and 
solubilised membrane samples were then analysed for the presence of active enzyme by 
rocket immunoelectrophoresis. Samples were separated on a non-denaturing agarose gel 
containing HybOC antisera, which binds to the corresponding protein as it migrates and 
eventually stalls its progress. These gels can then be stained for H2-dependent BV-reduction 
activity in the presence of triphenyl tetrazolium chloride (tetrazolium red; an irreversible redox 
dye). These experiments give qualitative information on the presence and amount of active 
enzyme in the specific cellular fractions. 
Membrane samples prepared from the OS, FlexA, SalI and OSmut cultures displayed a small 
amount Hyd-2, indicating that these metalloenzyme chimeras were successfully assembled in 
the membrane (Figure 4.10A). The corresponding cytoplasmic fractions, however, also 
contained very large amounts of active enzyme (Figure 4.10B). The membrane and cytoplasmic 
fractions of FlexD, -6aaXFlex and Uni samples were negative.  
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Figure 4.10 OS, FlexA, SalI and OSmut chimeric metalloenzymes were successfully transported across and 
inserted into the cytoplasmic membrane. A. Membrane and B. cytoplasmic fractions of overnight 500 ml 
anaerobic cultures of IC011 transformed with either pUNI-OSPhs, pUNI-OSFlexAPhs, pUNI-OSSalIPhs, pUNI-
OSFlexDPhs, pUNIPROM, pUNI-OS-6aaXFlexPhs or pUNI-OSmutPhs plasmids, were analysed by rocket 
immunoelectrophoresis. Samples were separated for ~8 h on non-denaturing agarose gels containing α-HybOC 
antibody (A: antibody was diluted 1 in 2 with running buffer before adding to agarose gel; B: antibody was 
undiluted before adding to agarose gel). Upon completion, each gel was incubated in 25 ml of H2-saturated buffer 
containing 600 mg BV and 700 mg tetrazolium red and stained for 24 h before photographing. 
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 Increasing or maintaining the PMF through heterologous expression of a 4.3.9
proteorhodopsin increases H2 production 
The data presented in Figure 4.6 show a slow rate of H2 production that tails off and stops. This 
is similar to what has been observed for the activity of the native thiosulfate reductase as it 
reaches, what is thought to be, a thermodynamic equilibrium (Stoffels et al. 2012). The 
hypothesis that the production of H2 by the synthetic chimeric metalloenzyme was close to 
thermodynamic equilibrium was tested by attempting to increase or maintain the proton 
motive force (PMF) at the cytoplasmic membrane and then monitoring any changes in H2 
production activity. A metagene encoding a proteorhodopsin from an uncultured marine γ-
proteobacterium was recently discovered and when expressed heterologously in E. coli was 
shown to pump protons, thus increasing PMF in E. coli (Tipping, et al., 2013). The gene 
encoding this proteorhodopsin (PR) was amplified by PCR and cloned into the medium copy E. 
coli expression vector, pSUPROM, which gives constitutive transcription of the PR gene from 
the tat promoter. The resulting plasmid was named pSU-PR. 
IC011 cells were co-transformed with pUNI-OSPhs and pSU-PR plasmids and transformants 
used to inoculate two 500 ml anaerobic LB cultures supplemented with glycerol and fumarate. 
All-trans retinal, the cofactor necessary for an active proteorhodopsin, is not normally 
produced by E. coli, however it can be supplied exogenously to the culture media and taken up 
by the cell. All-trans retinal was therefore supplied to one of these cultures and omitted from 
the other (as a negative control) and both were incubated without shaking at 37 °C for ~ 16 
hours in complete darkness (to protect the light-sensitive cofactor). All subsequent steps were 
performed in complete darkness unless otherwise stated and black light-proof Falcon™ tubes 
used. Cells were harvested, washed twice in anaerobic buffer and resuspended in anaerobic 
buffer (100 mM sodium phosphate buffer, pH6.8). The cells that received all-trans retinal were 
pink in colour indicating the successful expression of the proteorhodopsin and incorporation of 
the cofactor. 
Intact cell samples were introduced into a Clark-type electrode chamber, modified for H2 
measurement. Following a period of equilibration, the chamber was illuminated for 10 minutes 
before an excess of glycerol (170 mM final concentration) was added and the reaction allowed 
to continue in light until completion. As shown in Figure 4.11, the sample containing no all-
trans retinal (‘no ret’) produced 25 nmol H2 over ~ 40 minutes, whereas the sample containing 
all-trans retinal (‘plus ret’) produced more than twice the total amount of H2 and sustained H2 
production for longer (60 minutes) (Figure 4.11).  
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Figure 4.11 Increasing or maintaining the PMF improves H2 production from synthetic chimeric metalloenzyme. 
Cells were grown for 16 h overnight at 37° C in sealed, stationary 500 ml Duran bottles, containing 500 ml Luria 
Broth supplemented with 0.5% (v/v) glycerol and 0.4% (w/v) fumarate and with/without exogenous all-trans 
retinal. Cells were harvested by centrifugation, washed twice in anaerobic buffer (100 mM sodium phosphate, pH 
6.8) to remove any trace of growth media, glycerol and fumarate, and resuspended in 2 ml of the same anaerobic 
buffer per 1 g of cells (wet weight). Assays were carried out using a modified Clark-type electrode (Hansatech 
Oxygraph). 2 ml of the same anaerobic buffer was added to the reaction chamber and 50 mg of IC011 + pUNI-
OSPhs + pSU-PR plus/minus all-trans retinal added. After equilibration, the reaction chamber was illuminated for 
10 m (point A) before glycerol (at a final concentration of 170 mM) was added to the reaction chamber (point B). 
H2 production was measured by following the current generated following calibration with known amounts of H2. 
These results show that increasing the PMF through the heterologous expression of a PR (with required cofactor) 
is sufficient to increase the amount of H2 produced. Representative traces of each sample type are shown. 
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 Discussion 4.4
 Rational design of polypeptides – in silico 4.4.1
The rational design of protein domains, long polypeptide chains and ultimately useful 
functional proteins and enzymes has been a long standing aim of many research groups 
around the globe. Many groups over the last 15 years have attempted to computationally 
design artificial enzymes with novel functions. This difficult and highly controversial research 
area has seen a mixture of successes and failures. The most fundamental requirement for 
successful in silico rational protein design is the development of sophisticated software 
programs to create accurate models of these artificial proteins based on information in 
structural databases. This should then be followed by construction of a number of protein 
models, rigorous characterisation of these artificial proteins and finally the improvement of 
the original software by feeding back the characterisation data. 
In a series of important papers at the start of this century, the lab of Homme Hellinga at Duke 
University claimed the successful design and construction of artificial enzymes using the 
computer software DEZYMER. In one of these studies, they used DEZYMER to design the 
introduction of iron and oxygen binding sites into a thioredoxin scaffold (Benson, et al., 2000). 
The data showed tight binding of O2 and high specific activity. However in recent years a 
number of papers from the Hellinga lab, using the same DEZYMER software have been 
challenged by other research groups who saw no specific binding of these rationally-designed 
proteins to their supposed ligands/substrates (Schreier, et al., 2009). These papers used more 
accurate methods to test binding and specific activity, including isothermal titration 
calorimetry (ITC) and nuclear magnetic resonance (NMR) spectroscopy, which showed no 
direct/specific binding to any of the protein constructs tested. This has led to the retraction of 
a number of high profile papers based on this software (Dwyer, et al., 2004). 
In a more successful example of rationally designed artificial metalloenzymes, a “designed 
evolution” approach was adopted, which combines rational design with combinatorial 
screening (Creus and Ward, 2007). In this study, proteins such as biotin-streptavidin or biotin-
avidin were used as scaffolds to hold a diverse range of metal catalysts including non-biological 
metals such as rhodium. This introduces the possibility of novel catalytic reactions that are not 
currently found in nature. Libraries of the protein scaffold, protein linker and ligand scaffold 
can all be screened to optimise activity, selectivity, or stability etc. and thus was described as a 
“chemogenetic approach”. 
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However the success in silico design of proteins with novel functions is still an unsolved 
challenge. In a recently published study, the computer program ROSETTA was used to attempt 
to introduce a D-ala-D-ala binding pocket in an existing protein scaffold (Morin, et al., 2011). 
Twelve resulting proteins were constructed and characterised and although structurally the 
designed proteins were as predicted by the software, none of the 12 proteins showed high 
affinity binding to the target ligand. It is clear, therefore, that the software used in the de novo 
design of proteins requires further development and validation until it reaches the level of 
reliability necessary to form the backbone of rational protein design projects. Perhaps a better 
approach for the construction of synthetic enzymes with novel functions is to take existing and 
well characterised enzymes and construct chimeras of these enzymes using a variety of 
different protein engineering techniques. 
 Rational design of enzymes - fusion 4.4.2
One of the most famous and earliest examples of a successful construction and application of a 
fusion protein came from the group of Greg Winter in Cambridge (Riechmann, et al., 1988). 
They took a human IgGI antibody and replaced the hypervariable regions with those from a rat 
antibody raised directly against human lymphocytes and the resulting “humanised” antibody 
(named Campath-1H) showed great efficacy as a clinical therapeutic against lymphoma. 
Another early example of a fusion protein involved the fusion of the lacZ and galK genes of E. 
coli. The resulting soluble bifunctional enzyme catalysed both lactose hydrolysis and the 
phosphorylation of galactose as normal (Bulow, 1987). 
More recently a number of more sophisticated approaches to the construction of fusion 
enzymes have been described. The exponential growth of available protein sequence and 
structural data allows for greater cognizant design of fusion proteins. Traditionally fusion 
hydrogenases were constructed in an end-to-end fashion, i.e. the C-terminus of one 
polypeptide is fused to the N-terminus of the other polypeptide (or vice versa). However if 
structural knowledge is available, the catalytic domain of one enzyme can be introduced into a 
non-essential or disordered region of another enzyme, hopefully resulting in a bifunctional 
enzyme. This approach was used to generate a chimeric bifunctional laccase/gluconase 
enzyme with improved activity than the wild type enzymes (Furtado, et al., 2013). In a similar 
recent study, a single-chain protein was constructed from the well characterised and tight-
binding rapamycin-binding domain (resulting polypeptide named uniRapR). This synthetic 
polypeptide was then inserted into a known site of a well characterised kinase (Dagliyan, et al., 
2013). The phosphorylation activity of resulting fusion kinase can then be regulated by the 
binding of rapamycin to the uniRapR domain and this was demonstrated with molecular 
135 
 
dynamics experiments as well as enzymatic activity assays. These examples highlight the 
successful fusion of two unrelated polypeptides, which linked up both catalytic activities. 
Some examples of fusion hydrogenases exist in the literature. In a nice study by the Silver 
group at Harvard, the [FeFe]-hydrogenase of Clostridium acetobutylicum was fused to the 
ferredoxin from Spinacea olearcea and hydrogen production compared to strains expressing 
both proteins in their non-fused form (Agapakis, et al., 2010). In this study they also 
systematically altered the length of amino acid linker between the two proteins to increase 
hydrogenase activity in vivo. In an earlier study by another research group, the membrane-
bound [NiFe]-hydrogenase of Ralstonia eutropha H16 was fused to Photosystem I of the 
cyanobacteria Thermosynechococcus elongatus (Ihara, et al., 2006). This introduced a novel 
and direct light-to-hydrogen conversion system. 
 A functional synthetic chimeric metalloenzyme for hydrogen production in E. coli 4.4.3
In this work a synthetic chimeric metalloenzyme was designed and constructed that was 
capable of producing hydrogen in an engineered E. coli when glycerol was the sole carbon 
source. The quinol-dehydrogenase and electron-transfer subunits of thiosulfate reductase 
from Salmonella were identified as attractive candidate parts for the synthetic enzyme. 
Thiosulfate reductase from Salmonella is unusually capable of passing electrons up a 
thermodynamic gradient (Stoffels, et al., 2012) of approximately the same magnitude as would 
be required to produce hydrogen from menaquinols. It achieves this through its utilisation of 
the PMF. 
In this chapter, it has been shown that H2 oxidation is not essential for electron transfer 
between formate dehydrogenase (Fdh-O) and the native thiosulfate reductase, as neither a 
strain devoid of all hydrogenase large subunits (HyaB, HybC and HycE), nor a strain devoid of 
an essential hydrogenase maturase, HypF, was negative for iron sulphide production in PI 
indicator media. This is contrary to a previous suggestion (Stoffels, et al., 2012). 
Hydrogenase-2 from E. coli was an attractive enzyme to mine for the parts required to firstly 
accept and transfer electrons from the thiosulfate reductase subunits, and finally to reduce 
protons to molecular hydrogen, as it displays bidirectionality when immobilised to a graphite 
electrode (Lukey, et al., 2010). These parts from two different organisms were successfully 
combined to produce a novel, rationally-designed synthetic metalloenzyme. The genes 
encoding this synthetic enzyme are expressed in E. coli, the HybO-PhsB fusion polypeptide is at 
least partly successfully transported across the cytoplasmic membrane via the twin-arginine 
translocation (Tat) machinery and the subunits form an active complex in the cytoplasmic 
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membrane. This synthetic enzyme shows unidirectional H2-producing activity, demonstrating 
that the catalytic bias is radically different to the original E. coli Hyd-2 enzyme. 
It would be interesting to characterise this synthetic fusion hydrogenase further. Purification of 
the fusion enzyme would give valuable information on the size, stability and oligomeric state 
of the entire PhsC-HybOPhsB-HybC complex. If the fusion could be additionally affinity-tagged, 
IMAC, size-exclusion chromatography and SEC-MALLS could be employed to this end. If 
successful, the purified enzyme could be entered into crystallisation studies to obtain 
structural information on the complex. An alternative approach would be to clone and express 
only the HybO-PhsB fusion gene in an E. coli strain lacking the Tat machinery (e.g. DADE). This 
fusion protein could then be purified and entered into crystallisation studies. This should result 
in a stable, soluble protein of reduced hydrophobicity, which is desirable in crystallisation 
studies, as well as removing the requirement for detergents during purification. The 
information garnered could then be used to design improved versions of the synthetic 
chimeric metalloenzyme. 
 A novel insulated synthetic glycerol-dependent H2 production pathway in E. coli 4.4.4
The introduction of this synthetic chimeric enzyme into a previously engineered E. coli strain 
with no hydrogenases at all (IC011), allowed H2 production to occur when glycerol was the sole 
carbon source. This is very exciting as glycerol is a cheap and attractive substrate for 
commercial H2 production. The conversion of glycerol to H2 in this system is however 
extremely inefficient, as 8.6 mmoles of glycerol added produced only 22 nmoles of H2. It 
should be noted that anaerobic glycerol metabolism might also produce some formate, which 
itself could be used as a respiratory electron donor by FdoGHI in this system. 
 Energy depletion as a limiting factor 4.4.5
The collapse of the cytoplasmic membrane PMF, which allows the transfer of electrons from 
PhsC to the [NiFe] active site of HybC, is the most likely reason for H2 production to cease in 
this system. The boosting of PMF through the heterologous expression of a proteorhodopsin 
(PR) and supply of light to the resulting E. coli strain was hypothesised to partially overcome 
this problem (Figure 4.12). In support of this hypothesis, the successful expression of PR (with 
its essential cofactor, all-trans retinal) increased both the rate and duration of H2 production 
from this synthetic H2-producing system. A total of 62 nmol of H2 was produced from 8.6 mmol 
of glycerol using this system. Interestingly, the rate and amount of H2 production in the IC011 + 
pUNI-OSPhs and pSU-PR sample with no added all-trans retinal (Figure 4.11) was slightly higher 
than in the earlier experiments without PR (Figure 4.6). Thus may simply be due to increase in 
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temperature (from 25 °C to 35 °C), as a result of illumination of the reaction chamber with a 
halogen bulb. Further optimisation of this system is necessary (e.g. by trying light sources with 
different wavelengths and intensities). Product inhibition, due to a build-up of H2 in the closed 
environment of the chamber of the H2 electrode, is another possible contributing factor to the 
premature cessation of H2 production observed in this experimental set up. 
 
 Enzyme assembly and stability as a limiting factor 4.4.6
Degradation or instability of the HybO-PhsB fusion protein in E. coli was proposed as a possible 
reason for the low level of activity. However, exchange of the HA-tag linker with other well 
characterised rigid and flexible linker peptides did not drastically improve stability or 
hydrogenase activity. The -6aaFlex chimera, which has a further C-terminal truncation of HybO 
(compared to the OS variant), was successfully expressed in E. coli, however no active enzyme 
could be detected in either the cytoplasmic or membrane fractions, indicating that HybO was 
no longer able to form a stable complex with HybC and is probably degraded. The truncation 
to the C terminus likely destabilised the protein environment surrounding the distal FeS 
cluster, causing either protein misfolding and/or the loss of the FeS cluster. 
Three of the four genes that encode the subunits of synthetic chimeric enzyme are currently 
under the control of the constitutive promoter, Ptat, and expressed from the medium-copy 
expression vector, pUNI-PROM. The last gene, hybC is encoded on the E. coli chromosome. It is 
Figure 4.12 The expression of a proton-pumping proteorhodopsin could increase or maintain PMF and therefore 
drive sustained H2 production from the synthetic chimeric metalloenzyme. 
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probable that this differential level of gene expression results in problems related to the 
stoichiometry of individual subunits (e.g. HybC may be at too low a level in the cell to match 
the higher levels of PhsC and HybO-PhsB proteins, therefore resulting in non-functional 
PhsCHybO-PhsB complexes lacking a catalytic subunit). In addition, high levels of expression of 
FeS cluster-containing proteins would create a strain on the cellular FeS cluster machinery, as 
well as deplete cellular iron and sulfur levels. This could lead to incomplete maturation of all 
FeS clusters in the subunits of the synthetic chimeric metalloenzyme (Pinske and Sawers, 
2012a).  
Both of these complications might also contribute to the incomplete transport/insertion of the 
synthetic enzyme complex across/into the cytoplasmic membrane, as shown by the results of 
the rocket immunoelectrophoresis experiments. These results showed that the majority of 
enzyme remains in the cytoplasm and is therefore not transported across the cytoplasmic 
membrane. HybO has been shown to accumulate in the cytoplasm when HybC is missing, as 
HybC requires the Tat signal sequence of HybO in order to be successfully transported across 
the inner membrane (Rodrigue, et al., 1999). The Tat proofreading machinery is known to 
prevent premature transport of proteins lacking their full complement of cofactors (Palmer 
and Berks, 2012). Even when successfully transported, it can be seen in the membrane-free 
periplasmic fractions (data not shown), indicating it is either not inserted into the membrane 
correctly or some subunits dissociate from the membrane-bound subunits. 
To attempt to solve these challenges, a number of approaches could be employed. Firstly the 
synthetic chimeric metalloenzyme operon could be inserted on the chromosome under the 
control of the native hybO promoter, thus ensuring the level of gene expression is similar to 
that of hybC. Secondly an optimised RBS and linker could be inserted upstream of hybC on the 
chromosome to ensure that translation levels are also similar. Finally, it has been shown that E. 
coli strains where the gene encoding the repressor of the iron sulfur cluster machinery operon, 
iscR, has been deleted are able to support over expression of FeS cluster-containing proteins 
when extra iron and cysteine are supplied (Kuchenreuther, et al., 2010). The construction of a 
synthetic E. coli strain where the iron sulfur cluster machinery is upregulated and the synthetic 
chimeric metalloenzyme operon is expressed from the chromosome should result in increased 
rates of H2 production as well as total yields from this synthetic system. 
 Directed protein evolution of the synthetic chimeric metalloenzyme 4.4.7
It is likely that these rational approaches to improve the stability and activity of the synthetic 
fusion enzyme must be combined with other protein engineering techniques that do not rely 
on such rational design. Although currently fused C terminus to N terminus, HybO and PhsB 
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are excellent candidate parts to use in domain shuffling experiment. Similarly, random 
mutagenesis of phsC, and the hybO-phsB fusion gene would result in interesting libraries to be 
screened for improved stability, transport and ultimately hydrogenase activity. However, these 
ideas would require the development of a high throughput screen or preferably a method of 
selection, where H2 production was linked to cell survival. One such hypothetical screen could 
involve the construction of a formate-dependent kill switch, where excess formate induces cell 
death at a specific threshold concentration and therefore only mutant variants that are 
capable of increased H2 production from formate survive (either indirectly as in the case of 
artificial respiration-linked H2 production, or directly as with FHL) (Figure 4.13). This synthetic 
formate-dependent kill switch would be regulated by FhlA, the well characterised formate-
associated transcriptional activator of the formate hydrogenlyase encoding genes 
(Leonhartsberger, et al., 2000; Sawers, 2005). Formate binds to one domain of FhlA, thus 
increasing the affinity of its DNA-binding domain, which aids the recruitment of σ54 polymerase 
activating the transcription of genes with σ54-dependent promoters (Leonhartsberger, et al., 
2000). The synthetic kill switch construct, would therefore consist of σ54-dependent promoter 
inserted upstream of a gene that encode a toxic protein such as RelF (Knudsen and Karlstrom, 
1991), Hok (Bej, et al., 1988) or Gef (Bej, et al., 1992). Where no, or poor, H2 production from 
formate occurs, formate would accumulate in the cell late in growth and bind to FhlA. This 
would induce relF transcription and once a threshold level of RelF is reached, cell death would 
occur (Figure 4.13A). However, if sufficient formate oxidation occurs, presumably linked to H2 
production, expression of relF is reduced/inhibited as the majority/all of the formate is 
oxidised, which directly or indirectly leads to H2 production (Figure 4.13B). Such a synthetic 
system to select for formate-dependent H2 production would of course require significant 
tuning of a number of its components. First, consideration would have to be given to the level 
of fhlA expression in the cell as well as the post-transcriptional regulator of FhlA, the sRNA 
OxyS and may therefore require synthetic regulation. Second, a library of σ54-dependent 
promoters and partner RBSs may have to be constructed and screened to allow a range of 
formate-oxidation/H2-production levels to be selected for. And finally, a variety of genes 
encoding toxic proteins may have to be screened in order to find one that only exhibits toxicity 
above a specific concentration. 
 
 
 
 
140 
 
 
  
Figure 4.13 A hypothetical formate-dependent kill switch to allow for selection of formate-dependent H2 
producing mutants. An fhlA-dependent promoter could be inserted upstream of a toxic gene such as relF or hok 
protein. Where no/poor H2 production from formate occurs, formate would accumulate in the cell and bind to 
FhlA. This would induce relF transcription and once a threshold level of RelF is reached, cell death would occur. 
However if sufficient H2 production occurs, expression of relF is reduced/inhibited as the majority/all of the 
formate is oxidised, which directly or indirectly leads to H2 production. E. coli cells expressing this synthetic kill 
switch could be transformed with mutant libraries of hydrogenases and those that produce H2 from the oxidation 
of formate could be selected for. 
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5. In vivo bidirectionality of 
E. coli Hyd-2 and its role in 
glycerol fermentation 
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 Introduction 5.1
 Glycerol respiration by E. coli 5.1.1
The glycerol metabolism pathways of Escherichia coli K12 were long thought to require 
quinone-linked respiratory dehydrogenases and therefore the involvement of exogenous 
electron acceptors (Miki and Lin, 1973; Lin, 1976). Initially, a glycerol transporter GlpF (a 
member of the aquaporin [AQP] channel family, impermeable to all ions including protons) 
transports glycerol into the cytoplasm (Stroud, et al., 2003). GlpK, a glycerol kinase (glpK found 
in operon with glpF), phosphorylates glycerol in an ATP-dependent manner resulting in 
glycerol-3-phosphate (Glyc-3-P). Under aerobic conditions, Glyc-3-P is oxidised by the 
membrane-bound aerobic Glyc-3-P dehydrogenase (aeGlyc3PDH) complex, GlpD, which 
couples the reaction to quinone reduction and ultimately the reduction of O2 to water. When 
oxygen is absent, an alternative electron acceptor such as fumarate, TMAO, nitrate or nitrite is 
required. Under these conditions, an anaerobic Glyc-3-P dehydrogenase (anGlyc3PDH) 
complex consisting of GlpA, GlpB and GlpC ,and loosely attached to the cytoplasmic 
membrane, oxidises Glyc-3-P, with the resulting electrons passing to the quinone pool and 
ultimately to a terminal electron acceptor. In both cases, dihydroxyacetone phosphate (DHAP) 
is the product of Glyc-3-P oxidation (Figure 5.1). This can then be converted to D-
glyceraldehyde 3-phosphate (G-3-P) by the enzyme triose-phosphate isomerase (TIM, encoded 
by tpiA), which can be further oxidised through glycolysis. It was thought that the absence of 
Glyc-3-P dehydrogenase activity in fermentative growth conditions (i.e. no exogenous electron 
acceptors present), would lead to a build-up of a dead-end product Glyc-3-P in the cytoplasm 
that would inhibit cell growth. 
  
Figure 5.1 Glycerol respiration by E. coli in aerobic or anaerobic conditions. During respiratory glycerol 
metabolism, glycerol is phosphorylated to glycerol-3-phosphate (Glyc-3-P) by a glycerol kinase (GlpK). Glyc-3-P is 
then oxidised by one of two glycerol dehydrogenases depending on the external electron acceptor present. In 
aerobic conditions this enzyme is GlpD and in anaerobic conditions with an electron acceptor other than O2, 
GlpABC is the dehydrogenase. The resulting dihydroxyacetone phosphate (DHAP) can then be converted to D-
glyceraldehyde 3-phosphate (G-3-P) by a triose isomerase (TIM) which enters glycolysis. 
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 H2 respiration by E. coli 5.1.2
The E. coli chromosome contains genes for four [NiFe]-hydrogenases, three of which have 
been biochemically characterised: Hyd-1; Hyd-2; and Hyd-3. Hyd-3 forms part of the formate 
hydrogenlyase (FHL) complex, a large membrane-attached complex of at least seven-proteins, 
responsible for H2 production during mixed-acid fermentation by E. coli. Hyd-1 and Hyd-2 on 
the other hand are involved in H2 oxidation (H2 uptake). The physiological role of Hyd-1 in E. 
coli is still not fully known, although it is oxygen-tolerant and capable of H2 oxidation coupled 
to the reduction of nitrate, O2 or DMSO (Laurinavichene and Tsygankov, 2001; Laurinavichene 
and Tsygankov, 2003). 
Hyd-2 appears to oxidise H2 under anaerobic respiratory conditions and this H2 oxidation is 
coupled to the reduction of fumarate, DMSO and nitrate (Laurinavichene and Tsygankov, 
2001). Hyd-2 is a periplasm-facing and membrane-attached enzyme (Ballantine and Boxer, 
1986). In its native form, HybOC forms a large respiratory complex with HybA and HybB and 
this association is essential for H2-dependent fumarate reduction and growth on hydrogen and 
fumarate alone (Dubini, et al., 2002) 
Bidirectionality of Hyd-2 activity has previously been demonstrated in vitro through a series of 
electrochemical and spectrophotometric experiments on the isolated HybOC proteins (Lukey, 
et al., 2010). Hyd-2 shows higher overall hydrogenase activities than Hyd-1 (Sawers and Boxer, 
1986; Menon, et al., 1991) and is optimised for H2 oxidation under more reducing conditions. 
Hyd-2 is also capable of H2 production in vitro and as a result it was postulated that this 
enzyme may operate as an “electron release valve” operating in reverse to maintain redox 
balance when the quinone/quinol pool becomes over reduced (Lukey, et al., 2010).  
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 Aims 5.2
This Chapter aims to investigate whether Hyd-2 is capable of both producing and oxidising H2 
in vivo. This will be done by testing if whole cells expressing Hyd-2 are capable of producing H2 
directly from respiratory electron donors such as glycerol, as well as by studying the effect of 
the addition of exogenous electron acceptors on cellular hydrogenase activity. The other E. coli 
hydrogenases will also be studied for glycerol-dependent H2 production and H2 oxidation 
activity in situ. 
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 Results 5.3
 Whole cells producing only Hyd-2 can reduce protons to H2 in a glycerol-dependant 5.3.1
manner 
E. coli Hyd-2 is a well-characterised uptake hydrogenase with homologues in other bacteria. 
Interestingly, the isolated enzyme is fully reversible when attached to a graphite electrode or 
platelet (Lazarus, et al., 2009; Lukey, et al., 2010), which led to hypothesis that Hyd-2 may also 
be reversible in vivo. In order to test the reversibility of Hyd-2 in the living cell an experiment 
was devised using exogenously-added glycerol, which is traditionally regarded as a non-
fermentable carbon source, and respiratory electron donor, for E. coli. 
In vivo hydrogen-production assays were performed using a modified Clark-type electrode. E. 
coli strains producing Hyd-2 only (IC010: ∆hyaB; ∆hycE), Hyd-1 only (IC009: ∆hybC; ∆hycE), or 
no hydrogenases at all (IC011: ∆hyaB; ∆hycE; and ∆hybOA), were cultured anaerobically in the 
presence of glycerol and fumarate before being harvested and washed under anaerobic 
conditions. Whole cells were added to anaerobic buffer (100 mM sodium phosphate buffer, pH 
6.8) within the electrode chamber and H2 production assayed upon addition of 170 mM 
glycerol. Note that no external electron acceptors (e.g. fumarate, nitrate, etc.) were added to 
the reaction chamber. Cells producing Hyd-2 only (IC010) produced H2 at a rate of 0.2 nmol H2 
min-1 mg-1 whole cells added (Figure 5.2), while cells producing Hyd-1 only, or none of the well-
characterised [NiFe] hydrogenases of E. coli, produced no detectable H2 over the time course 
of this experiment (Figure 5.2). This provides initial direct and genetic evidence that Hyd-2 is 
indeed capable of accepting electrons, probably via the quinol pool, and reducing protons to 
produce H2 in vivo at pH 6.8. 
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Figure 5.2. Hyd-2 is capable of producing H2 directly from glycerol. Cells were grown for 16 h overnight at 
37° C in sealed, stationary 500 ml Duran bottles, containing 500 ml Luria Broth supplemented with 0.5% (v/v) 
glycerol and 0.4% (w/v) fumarate. Cells were harvested by centrifugation, washed twice in anaerobic buffer 
(100 mM sodium phosphate, pH 6.8) to remove any trace of growth media, glycerol and fumarate, and 
resuspended in 2 ml of the same anaerobic buffer per 1 g of cells (wet weight). Assays were carried out using 
a modified Clark-type electrode (Hansatech Oxygraph). 2 ml of the same anaerobic buffer was added to the 
reaction chamber and 25 mg of either IC010 (full circle), IC009 (open triangle) or IC011 (full square) whole 
cells were added (point A). After approximately 30 m, glycerol at a final concentration of 170 mM was added 
to the reaction chamber (point B). H2 production was measured by following the current generated following 
calibration with known amounts of H2. Hyd-2 only cells (IC010: ∆hyaB; ∆hycE) are capable of producing H2 
directly from glycerol in vivo. Hyd-1 only cells (IC009: ∆hybC; ∆hycE) and cells with no active hydrogenases 
(IC011: ∆hyaB; ∆hycE; and ∆hybOA) produced no H2 from glycerol. These results show that Hyd-2 is capable of 
producing H2 from menaquinol, which results from glycerol oxidation, but Hyd-1 cannot. 
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 Evidence that Hyd-2 activity  is rapidly reversible in vivo. 5.3.2
The ability of Hyd-2 to switch from H2 production to H2 oxidation was assessed using the 
electrode-based whole cell hydrogenase assay. The IC010 (Hyd-2 only) strain was grown 
anaerobically in the presence of glycerol and fumarate before being harvested and washed 
under anaerobic conditions. The cells were introduced to the electrode and Hyd-2-dependent 
H2 production induced by the addition of excess glycerol (Figure 5.3). After a short time an 
external electron acceptor (nitrate, fumarate or TMAO) was added to the reaction chamber. 
The H2 production was immediately observed to cease and the H2 previously produced in the 
chamber was quickly oxidised (Figure 5.3). Hyd-2 therefore is a true in vivo bidirectional 
enzyme depending on the presence of an external electron acceptor. 
 
 
 
 
 
  
Figure 5.3. Hyd-2 is a bona fide bidirectional enzyme in vivo. Cells were grown for 16 h overnight at 37° C in 
sealed, stationary 500 ml Duran bottles, containing 500 ml Luria Broth supplemented with 0.5% (v/v) glycerol 
and 0.4% (w/v) fumarate. Cells were harvested by centrifugation, washed twice in anaerobic buffer (100 mM 
sodium phosphate, pH 6.8) to remove any trace of growth media, glycerol and fumarate, and resuspended in 2 
ml of the same anaerobic buffer per 1 g of cells (wet weight). Assays were carried out using a modified Clark-
type electrode (Hansatech Oxygraph), calibrated with known amounts of H2. 2 ml of the same anaerobic buffer 
was added to the reaction chamber and 25 mg of Hyd-2 only whole cells (IC010) were added (point A). After 
equilibration, glycerol at a final concentration of 170 mM was added to the reaction chamber (point B). H2 
production was measured as previously observed. After approximately 20 m, TMAO (full square, 67.5 mM final), 
fumarate (open triangle, 25 mM final), or nitrate (full circle, 60 mM final) was added (point C, D and E 
respectively). Hyd-2 only cells are therefore capable of producing H2 from glycerol, and subsequently reoxidising 
this H2, passing electrons via membrane quinone pool to a terminal electron acceptor. 
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 Hyd-3 is the main H2 producer when glycerol is the sole carbon source  5.3.3
The ability to produce H2 from glycerol, and subsequently reoxidise this H2, was assayed in 
MC4100 (containing all [NiFe]-hydrogenases) and FTD89 (Hyd-3 only) whole cells. H2 
production from glycerol was observed for both MC4100 and FTD89, with more H2 (approx. 
300 nmol more) produced by the FTD89 strain lacking the uptake hydrogenases (Figure 5.4). 
The parent strain MC4100 was capable of oxidising this endogenously-produced H2 
immediately upon addition of fumarate, nitrate or TMAO, however the FTD89 uptake mutant 
was unable to do this (Figure 5.4). 
  
Figure 5.4. Hyd-3 is the predominant H2 producer with glycerol as the sole substrate. Cells were grown for 16 h 
overnight at 37° C in sealed, stationary 500 ml Duran bottles, containing 500 ml Luria Broth supplemented with 
0.5% (v/v) glycerol and 0.4% (w/v) fumarate. Cells were harvested by centrifugation, washed twice in anaerobic 
buffer (100 mM sodium phosphate, pH 6.8) to remove any trace of growth media, glycerol and fumarate, and 
resuspended in 2 ml of the same anaerobic buffer per 1 g of cells (wet weight). Assays were carried out using a 
modified Clark-type electrode (Hansatech Oxygraph), calibrated with known amounts of H2. 2 ml of the same 
anaerobic buffer was added to the reaction chamber and 50 mg of MC4100 (full circle) or FTD89 (∆hycB, ∆hyaB, 
open triangle) whole cells were added (point A). After equilibration, glycerol at a final concentration of 170 mM 
was added to the reaction chamber (point B) and H2 production was measured. After approximately 120 m, 
TMAO (67.5 mM final), fumarate (25 mM final), or nitrate (60 mM final) was added (point C, D and E 
respectively). These results show that Hyd-3 produces H2 from glycerol at a higher rate (need numbers) than 
Hyd-2. Hyd-3 is not a reversible enzyme as the addition of TMAO, fumarate, or nitrate does not induce H2 
oxidation (as was observed with Hyd-2). MC4100 cells however produce less total H2 than FTD89 cells and as 
they have Hyd-1 and Hyd-2 activity, they are capable of H2 oxidation upon addition of exogenous electron 
acceptor. 
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 Hyd-2 is essential for H2-dependent fumarate or TMAO reduction, but not nitrate 5.3.4
reduction. 
HybA, a membrane-anchored periplasmic ferredoxin-like protein, and HybB, a large integral 
membrane protein with a predicted ten transmembrane helices, are peripheral and poorly-
characterised components of the membrane-bound Hyd-2 complex. Two E. coli strains, FTD671 
(∆hybA) and FTD672 (∆hybB), were assessed for their ability to both produce H2 from glycerol 
and reoxidise this endogenous H2 (Figure 5.5). Both mutant strains retained Hyd-3 activity, 
thus H2 production from glycerol was observed to proceed at a similar rate to that recorded for 
the parent strain, MC4100 (Figure 5.4). Interestingly, however FTD672 produced less H2 in total 
(approx. 200 nmol less) than either MC4100 or FTD671. In the midst of endogenous H2 
production, respiratory electron acceptors were added to the reaction chamber (Figure 5.5). 
Somewhat surprisingly, the addition of fumarate to the reaction chamber did not initiate H2 
oxidation, but resulted in a spike in the rate of H2 production (Figure 5.5). However, the 
addition of nitrate immediately started H2 oxidation and all of the available H2 was reoxidised 
(Figure 5.5). The addition of TMAO to the reaction chamber was not sufficient to start H2 
oxidation, however it did immediately cease H2 production, presumably as electrons from the 
remaining electron donors in the chamber (glycerol and glycerol-derived formate) were 
preferentially passed to TMAO along respiratory chains (Figure 5.6). 
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Figure 5.5. Hyd-2 is essential for H2-dependent fumarate reduction. Cells were grown for 16 h overnight at 
37° C in sealed, stationary 500 ml Duran bottles, containing 500 ml Luria Broth supplemented with 0.5% 
(v/v) glycerol and 0.4% (w/v) fumarate. Cells were harvested by centrifugation, washed twice in anaerobic 
buffer (100 mM sodium phosphate, pH 6.8) to remove any trace of growth media, glycerol and fumarate, 
and resuspended in 2 ml of the same anaerobic buffer per 1 g of cells (wet weight). Assays were carried out 
using a modified Clark-type electrode (Hansatech Oxygraph), calibrated with known amounts of H2. 2 ml of 
the same anaerobic buffer was added to the reaction chamber and 50 mg of either FTD671 (∆hybA, full 
circle) or FTD672 (∆hybB, open triangle) whole cells were added (point A). After equilibration, glycerol at a 
final concentration of 170 mM was added to the reaction chamber (point B) and H2 production was 
measured. After approximately 15 m, fumarate (25 mM final) or nitrate (60 mM final) was added (point D 
and E respectively). HybA, a membrane–anchored periplasmic ferredoxin-like protein and HybB a large 
integral membrane protein, are therefore not required for H2 production from glycerol. They are however 
required for reoxidation of this H2 when fumarate is the terminal electron acceptor but not with nitrate. 
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Figure 5.6. Hyd-2 is involved in H2-dependent fumarate or TMAO reduction. Cells were grown for 16 h 
overnight at 37° C in sealed, stationary 500 ml Duran bottles, containing 500 ml Luria Broth supplemented 
with 0.5% (v/v) glycerol and 0.4% (w/v) fumarate. Cells were harvested by centrifugation, washed twice in 
anaerobic buffer (100 mM sodium phosphate, pH 6.8) to remove any trace of growth media, glycerol and 
fumarate, and resuspended in 2 ml of the same anaerobic buffer per 1 g of cells (wet weight). Assays were 
carried out using a modified Clark-type electrode (Hansatech Oxygraph), calibrated with known amounts of 
H2. 2 ml of the same anaerobic buffer was added to the reaction chamber and 50 mg of FTD672 (∆hybB, full 
triangle) whole cells were added (point A). After equilibration, glycerol at a final concentration of 170 mM 
was added to the reaction chamber (point B) and H2 production was measured. After approximately 7 m, 
fumarate (25 mM final), TMAO (67.5 mM final), or nitrate (60 mM final) was added (point D, C and E 
respectively). As previously observed, HybB is not required for H2 production from glycerol but is essential 
to allow reoxidation of this H2 when fumarate is the terminal electron acceptor but not with nitrate. 
Interestingly the addition of TMAO as the terminal electron acceptor immediately stops H2 production from 
glycerol (accepting electrons from oxidised glycerol) but is still unable to initiate H2 oxidation 
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 Discussion 5.4
In this study, H2 production from glycerol was monitored directly and in real time. This 
provides an advantage over previous studies where headspace gases of growing cultures were 
studied after glycerol fermentation, or where hydrogenase activity was measured using 
artificial electron donors and acceptors, e.g. benzyl viologen. The combination of this real-time 
H2 production assay with mutant strains defective in different hydrogenases allowed the 
contribution of each isoenzyme to glycerol-dependent H2 production to be more accurately 
determined. 
 Hyd-2 is a true bidirectional enzyme, capable of both H2 production and oxidation 5.4.1
It was previously suggested that Hyd-2 may be capable of H2 production in certain conditions 
(Lukey, et al., 2010), however this study is the first time this has been demonstrated directly. 
Hyd-2 is therefore a true bidirectional enzyme under physiological conditions. Hyd-2 can 
switch almost immediately from H2 production to H2 oxidation, upon the addition of an 
external electron acceptor, e.g. fumarate, nitrate or TMAO. This adds weight to the suggestion 
in the above electrochemical study that Hyd-2 might act as an “electron-release valve”, 
reducing protons to H2 to blow off excess reducing equivalents when none of the more 
traditional electron acceptors are present. One peculiarity of the Hyd-2 H2 production assays 
was that a small spike of H2 production was often observed upon addition of the cells to 
anaerobic buffer. This could represent the oxidation of trace amounts of an internal electron 
donor, remaining after harvesting the cells. 
 Hyd-1 is not capable of H2 production from glycerol 5.4.2
These results demonstrate that, at pH 6.8, Hyd-2 and Hyd-3 are the only hydrogenases of E. 
coli K-12 capable of H2 production from glycerol as original substrate. Hyd-1 is not capable of 
H2 production from glycerol, since IC009 (Hyd-1 only) produced no H2. This contradicts some 
earlier findings, which suggested both Hyd-1 and Hyd-4 contributed to H2 production from 
glycerol (Trchounian and Trchounian, 2009; Trchounian, et al., 2013). This conclusion is, 
however, in perfect agreement with the results in a more recent study (Sanchez-Torres, et al., 
2013). 
 FHL/Hyd-3 is the main H2 producer from glycerol (at pH 6.8) 5.4.3
It has been shown that Hyd-3  is the predominant H2 producer at pH 6.8 when glycerol is the 
sole carbon source, since FTD89 (no Hyd-1 or Hyd-2 activity) whole cells produced > 10 times 
more H2 from the same amount of exogenous glycerol than IC010 (no Hyd-1 or Hyd-3 activity) 
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cells. What is the link between glycerol and Hyd-3? The FHL complex disproportionates 
formate into CO2 and H2 (Sawers, 2005). These data suggest E. coli is capable of metabolising 
glycerol, and so producing some formate, in the absence of an external electron acceptor. 
Indeed, it has been previously suggested that E. coli could ferment glycerol (Gonzalez, et al., 
2008) and others have suggested that the CO2 product of FHL actually feeds back into the new 
glycerol fermentation pathway (Dharmadi, et al., 2006). As the Hyd-3 only strain (FTD89) was 
unable to reoxidise the H2 produced, upon addition of fumarate, nitrate or TMAO, it is unlikely 
that Hyd-3 is a physiologically reversible enzyme capable of H2 uptake as surprisingly claimed 
in another study, which used the artificial electron acceptor, MV (Maeda, et al., 2007b). 
Indeed, it has been known for some years that Hyd-3 can reduce redox dyes in crude cell 
extracts (Sawers, et al., 1985). 
 Glycerol fermentation in E. coli and other bacteria 5.4.4
A few microorganisms are capable of true fermentative glycerol metabolism coupled to cell 
growth and proliferation. These include certain species of the genera Klebsiella, Enterobacter 
and Citrobacter (Bouvet, et al., 1995). In these organisms, fermentative dissimilation of 
glycerol occurs through a reductive and parallel oxidative branch. In the oxidative branch, 
glycerol is oxidised directly to dihydroxyacetone (DHA) by a type I NAD+-dependent glycerol 
dehydrogenase (glyDH-1). DHA is then phosphorylated resulting in dihydroxyacetone 
phosphate (DHAP) and this reaction is catalysed by an ATP/PEP-dependent DHA kinase (DHAK). 
In the reductive branch, glycerol can be converted into 3-hydroxypropionaldehyde (3-HPA), 
through its dehydration catalysed by a coenzyme B12-dependent glycerol dehydratase 
(encoded by glyD). 3-HPA can then act as a sink for the reducing equivalents generated by the 
parallel branch, regenerating NAD+ as it is reduced to the major fermentation product 1,3-
propanediol (1,3-PDO) by the NADH-dependent 1,3-PDO dehydrogenase (1,3-PDODH). The 
presence and activity of both glyDH-1 and 1,3-PDODH is therefore essential for the 
fermentative metabolism of glycerol in these organisms. 
Fermentation of glycerol (C3H8O2) by E. coli, instead of glucose (C6H12O6) or other sugars is 
extremely desirable, as the more highly reduced state (degree of reduction) of its carbons 
would allow the production of larger yields of reduced fermentation products such as ethanol 
and hydrogen. Recent studies demonstrated that E. coli is in fact capable of metabolising 
glycerol when either exogenous electron acceptors are absent, or when respiratory glycerol 
metabolism pathways are disrupted (i.e. in ∆glpA, ∆glpD, ∆frdA strains) (Dharmadi, et al., 
2006; Gonzalez, et al., 2008; Murarka, et al., 2008). In contrast to the 1,3-PDO/DHA pathway in 
other bacteria, glycerol fermentation in E. coli involves a type II glycerol dehydrogenase and 
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requires the production of 1,2-PDO (as the sink for reducing equivalents). Note, however, that 
there is a difference here in that E. coli remains incapable of anaerobic growth with glycerol as 
the sole carbon source: E. coli K-12 will not grow under fermentative conditions in true 
minimal media with glycerol as the sole carbon source.  Instead, it has been shown that E. coli 
K-12 cells can metabolise glycerol by a previously unsuspected route.  
In this newly described glycerol fermentation pathway of E. coli, a type II NAD+-dependent 
glycerol dehydrogenase (glyDH-II), GldA, is one of two main enzymes required. This enzyme 
has been studied for many years, yet its true physiological role in E. coli remained a mystery. 
An NAD+-dependent glyDH-II (now identified as GldA) was originally purified from ∆glpK E. coli 
mutants (Asnis and Brodie, 1953; St Martin, et al., 1977; Tang, et al., 1979). It was shown to 
have specific dehydrogenation activity with glycerol and 1,2-propanediol as substrates, as well 
as the ability to reduce DHA and hydroxyacetone (HA) (St Martin, et al., 1977; Kelley and 
Dekker, 1985). More recently in an attempt to elucidate the in vivo role of GldA in E. coli, it was 
demonstrated that at neutral pH, the enzyme’s affinity towards DHA, methylglyoxal (MG) and 
glycolaldehyde was much higher than glycerol (Km values of 0.30, 0.50, 0.85 and 56 mM 
respectively) (Subedi, et al., 2008). Based on these findings it was concluded that the primary 
role of GldA is to remove the toxic intermediates DHA and MG, and not to oxidise glycerol. 
Indeed, in all of the older studies where GldA was identified and its properties investigated, no 
anaerobic growth on glycerol in the absence of external electron acceptors was observed (St 
Martin, et al., 1977; Tang, et al., 1982). Finally, in a series of papers from the Gonzalez group in 
Rice University, Texas (Dharmadi, et al., 2006; Murarka, et al., 2008), anaerobic fermentative 
growth of E. coli on glycerol was demonstrated, although it should be noted that the growth 
medium was supplemented with tryptone. A new model of glycerol fermentation, based on 
genetic, biophysical and environmental studies, was proposed (Gonzalez, et al., 2008). There is 
no doubt that E. coli can metabolise glycerol by this alternative pathway. This new model of 
fermentative glycerol metabolism in E. coli is summarised (Figure 5.7). In this model, glycerol is 
directly oxidised by GldA to DHA, which in turn is phosphorylated by a phosphoenolpyruvate-
dependent DHA kinase (DHAK, encoded by dhaKLM), resulting in DHAP. The essential role of 
these enzymes in glycerol fermentation was demonstrated convincingly. ∆gldA strains and 
∆dhaKLM strains were both unable to grow fermentatively on glycerol. The ∆gldA mutant also 
demonstrated no glycerol dehydrogenase activity compared to the WT strain (MG1655). 
Fermentative growth in ∆gldA strain was partially complemented by reintroducing this gene 
into the strain on a plasmid. Full complementation of the ∆dhaKLM strain was achieved by 
transforming with plasmids encoding these genes. Finally full complementation was achieved 
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in the ∆gldA mutant when transformed with both of these plasmids (gldA and dhaKLM 
containing plasmids). 
In addition to being able to enter into glycolysis as discussed previously, it was demonstrated 
that DHAP must be converted to 1,2-PDO. This reaction involves the synthesis of two 
intermediates: MG (catalysed by methylglyoxal synthase (MGS); encoded by mgs); and HA 
(catalysed by aldo-keto reductase (AKR), encoded by yeaE, yghZ and yafB, regenerates NAD+). 
The final conversion of HA to 1,2-PDO is catalysed by GldA (regenerates NAD+), which neatly 
resolves historical observations of its ability to carry out both glycerol oxidation and HA 
reduction in vitro. In addition to 1,2-PDO synthesis, ethanol production (and therefore the 
regeneration of NAD+, as well as the generation of 1 ATP per glycerol metabolised) is essential 
for glycerol fermentation (∆adhE strain is unable to ferment glycerol) (Murarka, et al., 2008). 
This is reflected by the observation that the major fermentation product (97% of products 
found in fermentation broth) is ethanol. 
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Figure 5.7. New model of glycerol metabolism by E. coli under different physiological 
conditions. Glycerol metabolism in the presence or absence of an external electron acceptor is 
shown above. During respiratory glycerol metabolism, glycerol is phosphorylated to glycerol-3-
phosphate (Glyc-3-P) by a glycerol kinase (GlpK). Glyc-3-P is then oxidised by one of two glycerol 
dehydrogenases depending on the external electron acceptor present. In aerobic conditions this 
enzyme is GlpD and in anaerobic conditions with an electron acceptor other than O2, GlpABC is 
the dehydrogenase. The resulting dihydroxyacetone phosphate (DHAP) can then be converted to 
D-glyceraldehyde 3-phosphate (G-3-P) by a triose isomerase (TIM) which enters glycolysis. In the 
recently described fermentative pathway of glycerol metabolism (in grey oval), glycerol is 
oxidised directly by a class II type of glycerol dehydrogenase, GldA. The resulting DHA is 
subsequently phosphorylated in a phosphoenolpyruvate (PEP)-dependent manner to DHAP. And 
through a number of intermediates, methylglyoxal (MG) and hydroxyacetone (HA), DHAP is then 
converted to 1,2-propanediol (1,2-PDO), a reaction also catalysed by GldA. 
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 Glycerol fermentation and H2 production 5.4.5
The roles of the individual E. coli hydrogenases: Hyd-1; Hyd-2; and Hyd-3, in H2 metabolism 
during glycerol fermentation has been studied recently. Some of these studies suffered from 
sub-optimal experimental design (e.g. whole cell hydrogenase-activity assays using the 
artificial electron acceptor BV) and jumped to premature conclusions, some of which 
contradicted the published data detailed in the aforementioned glycerol fermentation studies 
(e.g. no influence of FHL on H2 production from glycerol). In later papers, they further 
contradict the results documented in their own earlier papers (Trchounian and Trchounian, 
2009; Trchounian, et al., 2011; Trchounian, et al., 2013). 
Formate produced by glycerol fermentation, in the absence of both an active FHL complex and 
external electron acceptors, could be oxidised by FdnO, which results in an overly reduced 
quinone pool. This excess of reduced quinones is subsequently oxidised by Hyd-2 and the 
reducing equivalents used for proton reduction (Figure 5.8B). This theory could be tested using 
∆fdhO strains. Alternatively if either the respiratory anaerobic GlpABC enzyme, or even more 
unlikely, the aerobic GlpD enzyme are oxidising Glyc-3-P in the absence of a terminal electron 
acceptor, and Hyd-2 is reducing protons as a last resort (Figure 5.8A), this could be tested by 
using ∆glpABC or ∆glpD strains. Another approach could be to test H2 production in ∆tpiA 
strains with/without FHL (lacking triose-phosphate isomerase, which converts DHAP to D-
glyceraldehyde 3-phosphate) which would halt glycolysis. It is unclear however, if Hyd-2 
produces H2 when an active FHL complex is present, however it has been shown that Hyd-2 
and Hyd-3 are required for optimum glycerol fermentation (∆hycE & ∆hybC strains showed 
decreased cell fitness, glycerol consumption and increased the production of oxidised 
fermentation products e.g. acetate) (Sanchez-Torres, et al., 2013). 
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If Hyd-2 does produce H2 in WT E. coli cells during glycerol fermentation, one possible reason 
for this might be to maintain redox balance and ensure the cell does not become over reduced 
which would halt glycerol fermentation. The level of 1,2-PDO production is thought to be low 
in WT E. coli cells and therefore the transfer of excess reductant through proton reduction by 
Hyd-2 might be a previously uncharacterised facilitative pathway in glycerol fermentation. This 
could be tested by repeating these real-time H2 production assays in E. coli strains lacking two 
essential genes for 1,2-PDO synthesis: mgs; and gldA. Perhaps this would compensate for the 
absolute requirement for tryptone supplementation for glycerol fermentation shown 
previously (Gonzalez, et al., 2008). It has been suggested that tryptone does not act as an 
electron acceptor and only as a supplement to provide materials for cell biomass (Gonzalez, et 
al., 2008). However this could be tested by adding tryptone (of HA, shown to compensate for 
tryptone deficiency) to the H2 production and oxidation assays used in this chapter and noting 
any significant differences. 
Figure 5.8. Possible reductant sources for Hyd-2 catalysed H2 production during glycerol metabolism. A. 
Glycerol-3-phosphate is oxidised using respiratory glycerol dehydrogenase (GlpABC) and the resulting quinol is 
oxidised by Hyd-2 to produce H2. B. During glycerol fermentation excess formate produced during glycolysis is 
oxidised by FdO, with the resulting quinol being oxidised by Hyd-2 to produce H2. 
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Alternatively the transport or oxidation of various amino acids could be coupled to glycerol 
metabolism. To test whether this plays any role in glycerol fermentation the assays could be 
repeated in ∆dadA strains. Differences in pH have been shown to be important in both glycerol 
fermentation and H2 production from glycerol. All of these assays were carried out using a mild 
acidic buffer (pH 6.8). These assays should be repeated over a range of pH, from pH 4.0 to pH 
9.0 to see what differences are observed. Indeed if FHL activity is impaired at more alkaline pH, 
it might be expected to see an increase in H2 production from Hyd-2. On a related note, one 
suggestion as to why glycerol fermentation was thought impossible in E. coli for so long was 
that the minimal media contained high levels of potassium and phosphate ions, which 
inhibited key enzymes in the glycerol fermentation pathways (including GldA), which resulted 
in toxicity (Truniger and Boos, 1994). In this study, 100 mM sodium phosphate buffer was used 
in all experiments. It would be interesting to test a number of different buffers to see if they 
impact H2 production from glycerol. 
H2 itself has been suggested as an inhibitory factor to allow glycerol fermentation to continue 
(Dharmadi, et al., 2006). The historical use of sealed Hungate tubes, filled almost completely 
with media, in previous studies of E. coli glycerol metabolism (i.e. a closed system where H2 
accumulates in the minimal headspace) has been suggested as a key factor in why glycerol 
fermentation was not previously thought possible in E. coli. The addition of known amounts of 
H2 to the reaction chamber before the addition of cells and/or glycerol might give interesting 
information on whether a high H2 atmosphere can inhibit H2 production by Hyd-2. 
Electrochemical studies have shown that H2 had a low inhibitory effect on Hyd-2 H2 production 
activity (Lukey, et al., 2010). In this study, a large difference was observed in the amount of H2 
produced by MC4100 and FTD89 whole cells (FTD89 produced 50% more H2 than MC4100). 
The reasons for this are unclear at this stage. It’s possible that small amounts of fumarate are 
being produced internally and subsequently used as an electron acceptor from the oxidation of 
H2 as catalysed by either Hyd-1 or Hyd-2. This could explain the lower amount of total H2 
produced by MC4100. Alternatively the reoxidation of H2 and reduction of fumarate by the 
fumarate reductase (FRD) could result in redox imbalance as suggested previously (Murarka, et 
al., 2008), which stops glycerol fermentation and therefore H2 production. Both of these could 
be tested by assessing the glycerol-dependent H2 production of a ∆frdA mutant (unable to 
reduce fumarate). Measuring changes in the amount of fermentation by-products (e.g. 
ethanol, succinate, acetate, lactate, formate etc.) might also give some indication of changes in 
redox balance etc. 
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 Specialised respiratory supercomplexes in E. coli 5.4.6
It is unclear from this study, whether HybA or HybB, the two other membrane-associated 
subunits that form the larger respiratory complex of Hyd-2 (HybO and HybC being the main 
structural catalytic subunits), are involved in H2 production from Hyd-2, as the total amount of 
H2 produced (and the rate of H2 production) was much higher in strains containing an active 
FHL complex (FTD89 or MC4100). This could be investigated by deleting hybA and/or hybB 
from the chromosome of IC010 and repeating these experiments. It was however shown that 
HybA and HybB were essential for H2 oxidation when fumarate or TMAO are the terminal 
electron acceptors indicating that Hyd-2 is unable to reduce quinones from H2 without these 
subunits. This is in perfect agreement with the an earlier study (Dubini, et al., 2002), which 
showed that these strains were unable to grow anaerobically on fumarate and glycerol and 
that FTD671 had no H2 oxidation activity with fumarate as sole electron acceptor (similar levels 
to ∆hybC mutant). Furthermore whereas the addition of TMAO at least stopped H2 production 
from glycerol (i.e. accepting electrons generated from glycerol/glycerol-3-phosphate oxidation 
via the quinone/quinol pool), the addition of fumarate did not halt H2 production. 
One interpretation of this could be that perhaps fumarate reductase (FRD) and Hyd-2, 
although not forming protein-protein interactions between subunits, are functionally 
organised in the bacterial membrane (i.e. are spatially colocalised to the same parts of the 
cytoplasmic membrane to form a modular respiratory microdomain). And as both FTD671 and 
FTD672 were capable of H2 oxidation when nitrate was the terminal electron acceptor, 
presumably catalysed by Hyd-1 and not Hyd-2, perhaps Hyd-1 is therefore similarly associated 
with nitrate reductase A (NRA). 
The idea of supramolecular organisation of the bacterial membrane has gained momentum in 
recent years, and has now been accepted in mitochondria. In contrast to the random diffusion 
model of bacterial membranes (Singer and Nicolson, 1972), where respiratory complexes are 
randomly distributed throughout the membrane and only linked by the diffusion of electron 
carriers such as quinones etc., this new model is based on the idea of lipid rafts/microdomains, 
such as those spingolipid–cholesterol rafts found in eukaryotic cells (Simons and Ikonen, 1997). 
These are areas of highly organised lipid-protein complexes that function to compartmentalise 
related functional proteins, in effect forming supercomplexes. Indeed all mitochondrial 
respiratory complexes except Complex II have been shown to be capable of associating in 
three supercomplexes: the respirasome (Complexes I, III and IV); Complex I and III; and 
Complexes III and IV (Lapuente-Brun, et al., 2013). It has also been shown that supercomplex 
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formation is advantageous in preventing the formation of reactive oxygen species (ROS) from 
the respiratory chain, implicated in aging and major chronic diseases (Maranzana, et al., 2013) 
Cardiolipin (CL), an anionic phospholipid that makes up 5–10% of total lipid content in E. coli, 
has been suggested to play a role in the organisation of the cytoplasmic membrane into 
microdomains (Arias-Cartin, et al., 2011), as was demonstrated in the mitochondria of yeast 
(Bazan, et al., 2013). CL has been shown to bind tightly to a number of respiratory complexes, 
e.g. formate dehydrogenase (FdnGHI) (Arias-Cartin, et al., 2012), nitrate dehydrogenase 
(NarGHI) (Arias-Cartin, et al., 2011) and succinate dehydrogenase (SdhABCD) (Arias-Cartin, et 
al., 2012). CL is required for activity of some respiratory enzyme complexes and it has also 
been suggested that CL localises in discreet foci of the bacterial cell. It is proposed that CL 
found in these foci, hold related functional enzyme complexes closely together in the same 
area of the cytoplasmic membrane (Arias-Cartin, et al., 2011). The advantage of such an 
arrangement is obvious as quinol and quinone binding sites within physiologically-related 
enzymes would be in close proximity to each other, resulting in short and very efficient 
electron transfer and allowing higher activities than in the random diffusion model (Singer and 
Nicolson, 1972). Furthermore, specific proteins may be required to segregate the lipid content 
of the cytoplasmic membrane. One such protein has been described, flotillin-like proteins with 
a flotillin domain as well as prohibitin (PHB) or stomatin/prohibitin/flotillin/HflKC (SPFH) 
domains. In Bacillus subtilis 168, YuaG has been shown to be essential for lateral segregation 
of membrane domains (Bach and Bramkamp, 2013). Through pull-down experiments it was 
shown to interact with a number of distinct classes of proteins, including those involved in cell-
wall machinery, protein transport and secretion (Sec), signalling and finally energy metabolism 
(e.g. Nag, SdhA etc.). A final related observation on possible mechanisms for spatial 
organisation of related functional respiratory complexes in bacteria, is that in yeast, almost all 
membrane proteins segregate into distinct domains based on their membrane anchors (Spira, 
et al., 2012). 
Through a bioinformatics search, only two homologs of B. subtilis 168 YuaG are found in the E. 
coli genome: YqiK, a PHB family protein with periplasmic, transmembrane and cytoplasmic 
domains (28% identity and 47% similarity); and YbbK, a multicopy suppressor of ftsH 
hypX/membrane-anchored predicted protease (22% identity and 44% similarity). Both 
homologs contain band 7 flotillin-like domains and therefore might be involved in the 
organisation of the E. coli membrane into functional microdomains. In a recent study YqiK has 
been shown to cluster in discreet foci along the cytoplasmic membrane (Lopez and Kolter, 
2010), which is consistent with the hypothesis that the organisation of membrane 
microdomains is coordinated by flotillin-like proteins. 
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This formation of a supercomplex or respiratory module consisting of Hyd-2 and FRD (with 
their menaquinone/menaquinol binding sites in very close proximity) could therefore explain 
why the loss of HybA or HybB leads to an inability to transfer electrons from H2 to fumarate 
reductase. This hypothesis is outlined below (Figure 5.9). The idea that Hyd-1 and NRA (both 
specific for menaquinone/menaquinol) could colocalise to the same membrane microdomain 
is complicated by two factors. Firstly previous gene expression studies have shown that nitrate 
represses hydrogenase operon expression (Richard, et al., 1999), however it has also been 
shown that both Hyd-1 and NRA are expressed in the absence of nitrate, suggesting they could 
form a functional supercomplex in physiological conditions. And secondly in this study, IC010 
(deletion of hyaB, encoding the [NiFe] active site containing large subunit of Hyd-1) cells are 
still capable of nitrate reduction from H2 oxidation. 
 
 
 
 
 
 
 
 
It would be very interesting therefore, to repeat the H2 production and oxidation assays in a 
∆yqiK mutant. Deletion of this gene has already been shown to be non-lethal (Hinderhofer, et 
al., 2009). If physiologically/functional respiratory complex microdomains are really formed in 
E. coli, and if YqiK is involved in the organisation of these microdomains, differences in these 
assays may be observed. For example, if Hyd-2 and FRD are found closely packed in the same 
microdomain, the rate of H2 oxidation in a ∆hyaB, ∆hycE, ∆yqiK strain (as IC010 but lacking 
yqiK) may be significantly lower than in IC010, as the two enzyme complexes may be randomly 
distributed along the membrane. Similarly in a ∆yqiK, ∆hybA or ∆yqiK, ∆hybB strain, Hyd-1 may 
now be able to oxidise H2 in the presence of fumarate, as FRD would be randomly distributed 
across the membrane and not tied up in microdomains. Similar experiments could be carried 
out with mutants lacking the cardiolipin synthase genes, clsA, clsB or clsC to investigate if 
cardiolipin played a role in organising these respiratory complexes and resulted in differences 
Figure 5.9. Possible organisation of cytoplasmic membrane into microdomains. It is proposed that bacterial 
membranes are organised into microdomains. Certain types of lipids as well as specific proteins containing band 7 
flotillin-like domains (YqiK in E. coli) are thought to play a key role in these microdomains. Functionally-related 
protein complexes (e.g. respiratory enzymes) might therefore concentrate in these microdomains, allowing 
increased enzymatic activities due to the close proximity of their quinone/quinol binding sites. Hydrogenase-2 
(Hyd-2) and fumarate reductase (FRD) are proposed to form a respiratory module, whereas hydrogenase-1 (Hyd-1) 
might reside in another microdomain where nitrate reductase A (NRA) is also localised. 
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in H2 production and oxidation. The hypothesis that electrons could be conducted along 
hydrogenase/reductase small subunits lacking the large catalytic subunit and back into the 
quinone/quinol pool could be tested through deletions of the genes encoding the small 
subunits, e.g. hyaA, hybO etc. It would be interesting for example to perform H2 oxidation 
assays in IC009 (Hyd-1 only) with fumarate as the sole electron acceptor, and compare these 
results to assays performed with IC009 lacking hybO. If H2-dependent fumarate reduction 
activity was abolished, this would infer both a tight association between Hyd-2 and FRD, as 
well as suggesting that HybOAB is possible of electron transfer along the membrane. 
And finally, the observation that the plasma membrane proteins of Saccharomyces cerevisiae 
with similar or identical transmembrane sequences colocalised to membrane microdomains 
and furthermore that protein relocation to another microdomain was possible by swapping 
their transmembrane sequence is very exciting (Spira, et al., 2012). If a similar phenomenon 
was found in bacteria and in particular with respiratory enzyme complexes, then it can be 
imagined that manipulation of the transmembrane anchor sequences might result in 
relocation of these enzymes to another microdomain. If proven, this ability to colocalise and 
compartmentalise related enzymes in the cytoplasmic membrane could increase reaction rates 
and higher yields of specific products. In addition this would be extremely useful as a basic tool 
in the biochemical study of many membrane proteins. 
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6. Future Perspectives 
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 Synthetic biology approaches to the synthesis of natural and synthetic bio-6.1
products 
Tools developed by synthetic biology have the potential to contribute to the solution of many 
global grand challenges, including the production of cheap, sustainable and environmentally-
friendly biofuels, as well as new and inexpensive drugs to fight disease and antibiotic 
resistance. One of the most famous and successful examples of a synthetic biology application 
in this area was in the production of artemisinic acid, an inexpensive precursor to the most 
effective anti-malarial drug Artemisinin (Paddon, et al., 2013). This I.P.-free project used a 
variety of synthetic biology tools to engineer E. coli to produce high yields (100 mg/l) of 
artemisinic acid, which could then be converted into Artemisinin in a cost-effective and reliable 
manner. 
Many research groups and pharmaceutical companies are currently engaged in the 
development of new antibiotic and antibacterial drugs in a frantic attempt to combat the 
global emergency of antibiotic resistance. Synthetic biology approaches are being used to 
expand upon the four main categories of broad spectrum antibiotics: cephalosporins; 
penicillins; quinolones; and macrolides, thus enabling libraries of completely novel antibiotics 
to be synthesised (Medema, et al., 2011; Thaker and Wright, 2012). Other groups are also 
engaged in engineering bacteriophage for use as anti-biofilm therapeutics which increases the 
susceptibility of certain bacteria to antibiotics (Lu and Collins, 2009). 
Important and high-value chemicals can also be produced using a variety of synthetic biology 
approaches such as heterologous enzyme expression, metabolic pathway engineering and the 
directed evolution of enzymes. Advanced biofuels are one such high-value commodity and 
indeed are the driving motivation of many synthetic biologist’s research (reviewed in 
Rabinovitch-Deere, et al., 2013). High yields of 2,3-butanediol (and mannitol) were produced 
using strains of Lactococcus lactis engineered to overexpress desired NAD+- regeneration 
enzymes (Gaspar, et al., 2011). In another example n-butanol was produced with high yields 
(28% w/w) from glucose through the introduction of synthetic heterologous enzymes, which 
drive the normally reversible reaction in a unidirectional manner (Bond-Watts, et al., 2011). 
This study also attempted to ensure that the redox balance of the host chassis was maintained 
during fermentation. A variety of higher alcohols (C4 and C5 alcohols such as isobutanol, 1-
butanol and 2-phenylethanol) were produced in high yields in another study, through the re-
engineering of the amino acid biosynthetic pathway of E. coli, into which two non-native 2-
keto-acid decarboxylases were introduced (Atsumi, et al., 2008). Engineered cyanobacteria are 
another promising chassis for the production of biofuels such as alkanes (Wang, et al., 2013) 
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and ethylene (Guerrero, et al., 2012). Other biofuels produced using synthetic biology 
approaches include isopropanol (Hanai, et al., 2007; Jojima, et al., 2008), fatty-acid based 
biofuels from plant biomass (Steen, et al., 2010) and bisabolene (a terpene-based biofuel) 
(Peralta-Yahya, et al., 2011). These examples and the many others in the literature show the 
great potential of synthetic biology to cheaper, sustainable and biologically-produced fuels. 
 Metabolic engineering approaches to increase fermentative biohydrogen 6.2
production in E. coli 
Many groups have performed metabolic engineering of E. coli strains in order to increase 
overall biohydrogen yields and/or biohydrogen production rates during mixed-acid 
fermentation. The Hallenbeck group studied the effect of deletions to the hyaB and hybC, 
which encode the two uptake hydrogenases of E. coli: Hyd-1 and Hyd-2. They also disrupted 
ldhA and expressed a mutant fhlA that encodes a truncated version of the transcriptional 
activator known to constitutively induce all genes in the formate regulon (Bisaillon, et al., 
2006). The strains lacking both Hyd-1 and Hyd-2 produced 37% more H2 (48.1 µmol H2; in 
batch fermentations) than the wild type strain (35 µmol H2). The ldhA and fhlA mutants 
showed 18% (41.4 µmol H2) and 11% (39.1 µmol H2) increases respectively in H2 yield relative 
to wild type, and when these mutations were combined in the same strain, a 47% increase in 
H2 (51.5 µmol H2) was observed. The group also studied the effect of limiting various nutrients 
and found that they could increase fermentative H2 production to close to 2 mol H2 mol-1 
glucose (in 0.03% glucose) in an engineered strain expressing neither Hyd-1, Hyd-2 nor LdhA 
and expressing the mutant (active) FhlA (Bisaillon, et al., 2006). This increase in H2 yields upon 
deletion of the genes encoding Hyd-1 and Hyd-2 was also observed in another study 
(Redwood, et al., 2008). 
The Chatterjee group engineered the E. coli strain W3110 by deleting the individual genes 
encoding FocA, NarL (the global nitrate-dependent transcriptional regulator), Ppc and HybC, 
but only modest increases in H2 yields were achieved (Fan, et al., 2009). The overexpression of 
fnr (the global anaerobic transcriptional regulator) in the ∆focA mutant however, led to a large 
increase in H2 yield  from 1 µmol H2 mg-1 dry cell mass in the W3110 strain and 6 µmol H2 mg-1 
dry cell mass in the W3110 strain overexpressing fnr, to over 10 µmol mg-1 dry cell mass (Fan, 
et al., 2009). Increases in H2 production rates do not always equate to increased yields of H2 
per mol of substrate. The Wood group have performed numerous metabolic engineering 
studies on E. coli in order to boost H2 production during fermentation (Maeda, et al., 2007a; 
Maeda, et al., 2008). And although 141 fold increases in the rate of H2 production from 
formate were observed, overall H2 yields from glucose only increased from 0.47 to 0.70 mol H2 
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per mol of glucose (Maeda, et al., 2008). A final example of metabolic engineering to increase 
H2 production was combined with metabolic flux analyses of mutants (Kim, et al., 2009). H2 
production rates and total H2 yields were increased in mutants no longer expressing lactate 
dehydrogenase or fumarate reductase (30.6 mmol H2 g-1 cell h-1 and 1.20 mol H2 mol-1 glucose 
for the wild type strain BW25113; 45.6 mmol H2 g-1 cell h-1 and 1.61 mol H2 mol-1 glucose for 
the ∆ldhA mutant; and 52.2 mmol H2 g-1 cell h-1 and 1.80 mol H2 mol-1 glucose for the ∆frd 
mutant) (Kim, et al., 2009). Metabolic flux analysis confirmed that most of the carbons from 
glucose were being directed through the FHL complex as predicted in silico (Kim, et al., 2009). 
It is clear from these examples that metabolic engineering of E. coli strains to delete or 
interrupt pathways competing for electrons with FHL alone, is not sufficient to reach the yields 
of H2 required for commercial biohydrogen production (Section 1.6.3) (Benemann, 1996). For 
this reason, many commentators have suggested the integration of dark/heterotrophic 
fermentative biohydrogen production from substrates such as glucose, and photo-
fermentation by purple-photosynthetic bacteria such as Rhodobacter sphaeroides, which can 
convert organic acids produced during fermentation into further H2 (Vardar-Schara, et al., 
2008; Kim, et al., 2009). 
 Heterologous hydrogenase expression and other synthetic biology approaches to 6.3
increase biohydrogen production 
Another approach to boosting H2 yields during heterotrophic fermentation is the construction 
of synthetic hydrogen-production pathways in a suitable chassis. This can then be combined 
with directed enzyme evolution and pathway engineering in order to increase overall H2 
production rates and yields. These synthetic pathways can be designed so they are insulated 
from or fully integrated into the metabolism of the chassis. A number of interesting examples 
are described below. 
It had been shown that in vitro H2 production systems could be constructed from purified 
mesophilic enzymes of the oxidative pentose phosphate cycle in combination with a purified 
NADPH-dependent hydrogenase from the thermophilic bacterium Pyrococcus furiosus 
(Woodward, et al., 2000). Using this in vitro enzymatic system 11.6 mol H2 mol-1 from glucose 
6-phosphate were achieved (which is close to the theoretical maximum yield), however the 
rate of H2 production was very slow. In order to increase the reaction rates, thermally stable 
enzymes of the pentose phosphate pathway would be required (Woodward, et al., 2000). A 
completely cell-free system for the transcription, translation and maturation of hydrogenases 
was demonstrated using the [FeFe]-hydrogenase from Clostridium pasteurianum (Boyer, et al., 
2008). H-cluster maturation was accomplished using HydEFG-containing crude cell extracts 
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from Shewanella oneidensis. Active synthetic enzyme constituted 44% of the synthesised 
protein, and this could be increased through the addition of Fe and S to cell extracts prior to 
maturation. It is worth noting that the authors used oxidised MV as an artificial electron 
acceptor from H2, as no physiological electron donor/acceptor was synthesised (Boyer, et al., 
2008). Building upon this newly-developed technique, high-throughput screening of mutant 
[FeFe]-hydrogenase libraries for increased hydrogenase activity could be performed (Stapleton 
and Swartz, 2010b; Stapleton and Swartz, 2010a; Bingham, et al., 2012). Microfluidics 
techniques were utilised to develop an in vitro compartmentalisation method for the 
synthesis, maturation and screening of mutant hydrogenase libraries for properties such as O2 
tolerance in [FeFe]-hydrogenase (Stapleton and Swartz, 2010a; Stapleton and Swartz, 2010b). 
Another interesting protein evolution approach to increase H2 production during fermentation 
was performed on FhlA, the transcriptional regulator of the E. coli formate regulon (including 
FHL/Hyd-3) (Sanchez-Torres, et al., 2009). Random mutagenesis of fhlA followed by screening 
identified a number of FhlA variants that led to an increase of up to nine fold in total H2 yields. 
Before the identities of the essential [FeFe] active site maturation proteins, HydE, HydF and 
HydG were known, many groups expressed these hydrogenases in a chassis known to encode 
[FeFe]-hydrogenases. Clostridium acetobutylicum is one such organism and was used to 
overexpress its own [FeFe]-hydrogenase, as well as the heterologous expression of those from 
Chlamydomonas reinhardtii and Scenedesmus obliquus (Girbal, et al., 2005). Enzyme could be 
purified with high specific activities indicating this strategy was successful. The C. reinhardtii 
hydrogenase was also heterologously expressed in a Shewanella oneidensis chassis with active 
enzyme purified (Sybirna, et al., 2008). Metagenomics offers an exciting bioprospecting tool 
for synthetic biologists as DNA sequences from unculturable organisms can now be 
cloned/synthesised and novel enzymes hopefully identified. One of the first uses of this 
metagenomic approach in the hydrogenase field involved the cloning of environmental DNA 
from Sargasso Sea that was suspected to encode a [NiFe]-hydrogenase (Maroti, et al., 2009). 
The sequence shared 60% sequence identity with a [NiFe]-hydrogenase found in Thiocapsa 
roseopersicina and therefore this synthetic hydrogenase was expressed in this organism. Only 
two extra accessory genes: hyaD; and hupH from the putative operon identified in the 
metagenomic study were required for full maturation of the [NiFe] active site as the rest could 
be performed by host maturation machinery. H2 uptake and production were observed 
confirming the successful expression and maturation of this synthetic hydrogenase sequence 
in a new chassis (Maroti, et al., 2009). 
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Once the maturation proteins required for [FeFe] active site maturation were identified, 
synthetic biologists could immediately use this information to express [FeFe]-hydrogenases in 
E. coli, which does not contain any of these accessory genes. This could then lead to the 
construction of more complex synthetic devices incorporating the fast H2-producing [FeFe]-
hydrogenases in a wide variety of chasses. High-yields of heterologously-expressed [FeFe]-
hydrogenases from C. pasteurianum and C reinhardtii can now be expressed in E. coli along 
with hydEFG (Kuchenreuther, et al., 2010). These enzymes were purified and displayed high 
specific H2 production and oxidation activities with artificial and physiologically-relevant 
electron donors and acceptors (MV and ferredoxin respectively). More complex synthetic H2-
production pathways have also been constructed in E. coli, which are capable of expressing not 
only the [FeFe]-hydrogenase and accessory genes but also the genes encoding the 
physiological electron donor in their native organism, ferredoxin and the oxidoreductase 
responsible for reducing this electron donor from pyruvate. One such study expressed 
Clostridium acetobutylicum hydA, hydE, hydF and hydG in addition to the gene encoding the 
[4Fe–4S]-ferredoxin from Clostridium pasteurianum (Akhtar and Jones, 2009). The authors 
tested the ability of the putative E. coli pyruvate ferredoxin oxidoreductase (PFOR) homolog, 
YdbK, to oxidise pyruvate and concurrently reduce the C. pasteurianum ferredoxin. If 
successful this should pass electrons to the [FeFe]-hydrogenase and produce H2. Yields of up to 
1.46 mol H2 mol-1 glucose were obtained (measured using gas chromatography) and this was 
improved further through nutritional supplementation to the growth media (Akhtar and Jones, 
2009).The additional introduction of AmyE from Bacillus subtilis enabled starch-dependent H2 
synthesis in minimal media (Akhtar and Jones, 2009). 
In a study by the Silver lab at Harvard, an insulated synthetic H2-producing pathway was 
constructed in E. coli (Agapakis, et al., 2010). Various combinations of ferredoxins, PFORs, 
HydEFG-encoding synthetic operons and [FeFe]-hydrogenases were tested for high levels of H2 
production and the best combination selected. Synthetic codon-optimised genes encoding the 
ferredoxin and [FeFe]-hydrogenase from Clostridium acetobutylicum along with the PFOR from 
Desulfovibrio africans and HydEFG from C. reinhardtii were designed, constructed and 
successfully expressed in E. coli (Agapakis, et al., 2010). A number of insulation strategies were 
tested including: the deletion of competing native FeS proteins (∆ydbK = 1.4 fold increase in H2 
production); the physical linking of the [FeFe]-hydrogenase to the ferredoxin protein with 
flexible peptide linkers (14 aa = 5 fold increase in H2 yields relative to non-linked); the 
attachment of the hydrogenase and ferredoxin to a protein scaffold with different peptide 
linkers (3 fold increase in H2 when scaffolded; closer scaffolding = better; 2:1 ratio of linked 
hydrogenase molecules to ferredoxin = 1.5 fold increase over 1:1 ratio); and finally attempts to 
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improve the interaction between the ferredoxin and hydrogenase through the mutation of 
specific surface residues (Agapakis, et al., 2010). In another study by the Silver lab, rationally 
designed RNA aptamer scaffolds with distinct docking sites were used to spatially organise a 
[FeFe]-hydrogenase and a ferredoxin (Delebecque, et al., 2011). The three different RNA 
scaffold types increased total H2 yield by 4, 11 and 48 times respectively (Delebecque, et al., 
2011). 
 Concluding remarks 6.4
This project used a number of synthetic biology approaches to produce biohydrogen in E. coli. 
A synthetic [FeFe]-hydrogenase operon was successfully constructed, expressed and the 
enzyme complex characterised in E. coli. A synthetic E. coli strain was then constructed to host 
this synthetic hydrogenase and fully integrate the envisaged synthetic H2-production pathway 
into mixed-acid fermentation. This integration into central metabolism would allow for the 
directed evolution of the enzyme coupled with selection or screening for variants with 
increased catalytic activity and/or reaction specificity. An active, synthetic, chimeric 
metalloenzyme capable of producing H2 in E. coli was also constructed in this project. This 
fusion-protein approach, where the catalytic activities of two unrelated enzymes were 
combined, has not been widely explored in the hydrogenase field and could lead to new H2 
production pathways. New pathways for H2 production will be essential to achieve the 
biohydrogen yields required to make it commercially viable. 
Synthetic biology projects utilising hydrogenase enzymes require fundamental biochemical 
research for a number of reasons. Firstly identify new candidate biological parts and secondly 
the comprehensive characterisation of these enzymes (in a number of different environmental 
conditions) is essential to fully elucidate the mechanisms of biosynthesis and catalysis, which 
can be used in biotechnological projects. With this motivation, novel H2 production by E. coli 
Hyd-2 was also demonstrated and investigated in this project. 
In the future, it is likely that commercial biohydrogen production will require a combination of 
natural hydrogenase enzymes and new artificial biomimetic catalysts. These artificial chemical 
catalysts mimic the active site of hydrogenase enzymes and can perform H2 catalysis at high 
rates (Helm, et al., 2011; Berggren, et al., 2013). Electrons of course are still required and 
perhaps it would be advantageous in the future to use de novo protein scaffolds (such as those 
designed by the Baker lab at Washington State University; e.g. Tinberg, et al., 2013), which 
have been optimised for efficient and rapid electron transfer to such a synthetic catalyst. 
Furthermore it would be amazing if these catalysts and scaffolds could be genetically encoded 
using novel synthetic nucleic-acid code and then fully assembled in a chassis. Such a truly 
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“synthetic” organism could produce cheap and plentiful biohydrogen for use as the future fuel 
of the planet. 
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7. Materials and Methods 
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 Table of Bacterial Strains  7.1
Bacterial Strain Genotype Antibiotic 
Resistance 
Reference 
MG1655 wild-type E. coli strain 
F-, λ-, rph-1, ilvG, rfb-50 
None (Blattner, et al., 1997) 
MC4100 F- [araD139]B/r Δ(argF-lac)169 
&lambda- e14- flhD5301 Δ(fruK-
yeiR)725 (fruA25)‡ relA1 
rpsL150(strR) rbsR22 Δ(fimB-
fimE)632(::IS1) deoC1 
None (Casadaban, 1976) 
K38 (pGP1-2) HfrC phoA4 pit-10, tonA22 ompF 
627, relA1 spoT1 λ+ 
pGP1-2 encodes T7 RNA 
polymerase 
Kan (Tabor and 
Richardson, 1985) 
FTD147 As MC4100 but ∆hyaB, hybC, hycE None (Redwood, et al., 
2008) 
FTD89 As MC4100 but ∆hyaB, hybC None (Sargent, et al., 1999) 
DH5α F-, φ80dlacZΔM15, Δ(lacZYA-
argF)U169, deoR, recA1, endA1, 
hsdR17(rK-, mK+), phoA, supE44, λ-
, thi-1, gyrA96, relA1 
None (Grant, et al., 1990) 
FTD147h As FTD147 but ∆adhE::TtehydC-B None This work 
FTD147h3 As FTD147 but ∆adhE::TtehydC-A None This work 
RaisynA1 As FTD147h but ∆ldhA None This work 
Teatotal1 As FTD147 ∆adhE None This work 
MG059e1  MG1655 that encodes a version of 
HycE with an internal 6xHis 
epitope tag 
None (McDowall, Palmer 
and Sargent, 
unpublished) 
Maggie1 As MG059e1 but ∆ldhA None This work 
IronBrew As RaisynA1 but ∆iscR None This work 
FTD147h3∆iscR As FTD147h3 but ∆iscR None This work 
PK4854 As MG1655 but ∆iscR None (Schwartz, et al., 2001) 
PK4854∆hypF As PK4854 but ∆hypF None This work 
PK4854∆metJ As PK4854 but ∆metJ None This work 
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FTD147(DE3)∆metJ As FTD147(DE3) but ∆metJ None This work 
IC010 As MC4100 but ∆hyaB, hycE None (Deplanche, et al., 
2010) 
IC009 As MC4100 but ∆hybC, hycE None (Deplanche, et al., 
2010) 
IC011 As MC4100 but ∆hyaB, hycE, 
hybOA 
None This work 
FTD671 As MC4100 but ∆hybA None (Dubini, et al., 2002) 
FTD672 As MC4100 but ∆hybB None (Dubini, et al., 2002) 
XL1-Red endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac mutD5 
mutS mutT Tn10 
Tet Stratagene 
XL10-Gold (mcrA)183 Δ(mcrCB-hsdSMR-
mrr)173 endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac 
Hte [F´ proAB lacIqZΔM15 Tn10] 
Tet, Cml Stratagene 
Table 7.1 Table of bacterial strains used in this study 
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 Media and Additives 7.2
Medium Components Sterilised Quantity (L-1) 
Cohen-Rickenberg (CR) media K2HPO4 
KH2PO4 
Peptone 
(NH4)2SO4 
Trace elements * 
100 mM MoSes * 
1% Thiamine * 
1 M MgCl2 * 
10% casamino acids * 
 
 
 
 
autoclave 
filtered 
filtered 
filtered 
autoclave 
4.8 g 
9.8 g  
5 g 
2 g 
1 ml 
1 ml 
1 ml 
2 ml 
2 ml 
LB-agar NaCl 
Tryptone 
Yeast Extract 
Agar 
 10 g 
10 g 
5 g 
15 g 
LBMC soft agar NaCl 
Tryptone 
Yeast Extract 
Agar 
0.5 M CaCl2 * 
1 M MgSO4 * 
 
 
 
 
filtered 
filtered 
10 g 
10 g 
5 g 
6.5 g 
10 ml 
10 ml 
Luria Bertani medium (LB) NaCl 
Tryptone 
Yeast Extract 
 10 g 
10 g 
5 g 
M9 medium 100 mM CaCl2 * 
10x M9 salts * 
1 M MgSO4 * 
1% Thiamine * 
MoSe’s * 
filtered 
autoclave 
filtered 
filtered 
filtered 
 
1 ml 
100 ml 
2 ml 
2 ml 
1 ml 
M9 agar As M9 medium 
+ Agar 
  
16 g 
R-medium 
 
NaCl 
Tryptone 
Yeast Extract 
Agar 
20% Glucose * 
0.5 M CaCl2 * 
 
 
 
 
filtered 
filtered 
5 g 
10 g 
5 g 
15 g 
5 ml 
4 ml 
TYGES NaCl 
Tryptone 
Yeast Extract 
20% Glucose * 
 
 
 
filtered 
5 g 
10 g 
5 g 
20 ml 
SOB medium Tryptone 
Yeast extract 
NaCl 
 
 
 
20 g 
5 g 
5 g 
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Medium Components Sterilised Quantity (L-1) 
1 M MgCl2 
1 M MgSO4 
filtered 
filtered 
10 ml 
10 ml 
SOC medium As SOB medium + 
0.4% Glucose 
 
filtered 
 
20 ml 
Table 7.2 Growth media used in this study. 
Constituents were sterilised by autoclaving unless indicated by an asterisk in which case it was sterilised individually 
and then added to the media afterwards 
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Media Supplement Stock 
concentration 
Final concentration 
Glucose 20% 0.4% 
Glycerol 50% 0.5% 
IPTG 1 M 2 mM 
SDS 20% 2% 
Sodium formate 50% 0.5% 
Sodium fumarate 16% 0.4% 
Sodium nitrate 20% 0.4% 
Sodium pyrophosphate 250 mM 3.125 mM 
Ferric ammonium citrate 1 M 2 mM 
Cysteine 1 M 2 mM 
L-arabinose 1 M 2 mM 
Trace elements (g L-1) 
0.48 g FeCl3.6H2O 
0.33 g MnCl2.4H2O 
0.36 g CaCl2.2H20 
2 g ZnCl2 
0.2 g H3BO3 
0.1 g CoSO4 
1000x 1x 
M9 salts  (g L-1) 
10 g NH4Cl 
5 g NaCl 
30 g KH2PO4 
64 g NaH2PO4.7H2O 
10x 1x 
Table 7.3 Media supplements 
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Antibiotic Stock 
concentration 
Prepared in Final 
concentration 
Ampicillin 125 mg ml-1 Water 100 μg ml-1 
Chloramphenicol 25  mg ml-1 80% ethanol 25 μg ml-1 
Kanamycin 50 mg ml-1 Water 50 μg ml-1 
 Table 7.4 Antibiotics 
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 Culture conditions 7.3
Aerobic growth of E. coli strains was achieved by culturing the bacteria in Luria Bertani (LB) 
medium at 37 °C with shaking at 200 rpm.  A minimum liquid to air ratio of 1:4 was maintained 
in each case.  Anaerobic growth of E. coli was ensured by completely filling the growth vessel 
with LB medium and incubating, without agitation, at 37 °C. 500 ml volumes were typically 
used for H2 oxidation/production assays with whole cells/cell lysates. 
For growth on solid media, LB containing 1.5% agar was utilised and incubated at 37 °C. Two 
methods were tested to generate anaerobic conditions for solid agar plate experiments. Plates 
were incubated in Oxoid anaerobic jars with either Oxoid Anaerogen sachets or by 5 cycles of 
filling and evacuation of Argon gas. Merck Anaerotest strips were used to confirm 
anaerobiosis. 
Inoculated plates were stored at 4 °C for no more than 14 days.  Strains and plasmid stocks (in 
DH5α) were stored in cryogenic vials at -80°C long term.  Long term, strain and plasmid stocks 
(in DH5α) were flash frozen in liquid nitrogen and then stored at -80°C as 25% (v/v) glycerol 
stock cultures in cryogenic vials. 
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 Buffers and solutions 7.4
Buffer/Solution Component 
APS 10% ammonium persulphate 
Carbonate transfer buffer 10 mM NaCHO3 pH 9.9 
3 mM Na2CO3 
20% (v/v) methanol 
Sodium dithionite 1% (w/v) dithionite 
Dissolved in 1mM NaOH 
DNA loading buffer 0.25% (w/v) bromophenol blue 
0.25% (w/v) xylene cyanol blue 
40% (w/v) sucrose  
Laemmli sample buffer (2x) 62.5 mM Tris HCl pH 6.8 
2% (w/v) SDS 
5% (v/v) β-mercaptoethanol 
25% (v/v) glycerol  
0.01% (w/v) bromophenol blue 
Lysozyme  
(60 mg ml-1) 
6% lysozyme (from chicken egg white) 
Dissolved in 1 ml Tris (HCl) pH 7.5 
MC Buffer 100 mM MgSO4  
5 mM CaCl2  
Mg buffer (10x) 100 mM Tris HCl pH 7.5 
12 mM MgCl2 
Phosphate buffer pH 7.0 Na2HPO4 to desired molarity 
(pH in NaH2PO4) 
SDS-running buffer (5x) 25 mM Tris HCl pH 8.3 
192 mM glycine 
0.5% (w/v) SDS  
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Buffer/Solution Component 
TAE buffer 40 mM Tris HCl pH 8.0 
1.142% (v/v) acetic acid 
1 mM EDTA 
TBS-Tween (TBS-T) 1x TBS 
0.1% (v/v) Tween 20 
Transformation Buffer (TSB) 20 ml LB  
1 ml 1 M MgSO4  
1 ml DMSO 
2 g PEG 6000 
Tris buffered saline (TBS) 20 mM Tris HCl pH 7.6 
137 mM NaCl 
Rocket immunoelectrophoresis 
running buffer 
20 mM Sodium barbitone HCl pH 8.6 
0.1% (v/v) Triton X-100 
Tris-sucrose buffer 50 mM Tris HCl, pH 7.5 
40% (w/v) Sucrose 
Tris HCl 50 mM Tris HCl 
Adjusted to required pH by the addition of 
HCl 
Ni-purification resuspension buffer 50 mM Tris HCl pH7.5 
1 mM DTT 
2 mM flavin mononucleotide 
150 mM NaCl 
25 mM imidazole 
Ni-purification buffer A 50 mM Tris HCl pH7.5 
1 mM DTT 
150 mM NaCl 
25 mM imidazole 
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Buffer/Solution Component 
Ni-purification buffer B 50 mM Tris HCl pH7.5 
1 mM DTT 
150 mM NaCl 
1 M imidazole 
SEC buffer 50 mM Tris HCl pH7.5 
1 mM DTT 
150 mM NaCl 
Benzyl viologen (BV) 250 mM (stock) 
Methyl viologen (MV) 250 mM (stock) 
Table 7.5 Buffers and solutions used 
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 Molecular Biology Techniques 7.5
 Table of Plasmids 7.5.1
Plasmid Details Antibiotic 
resistance 
Reference 
pUNIPROM Medium copy expression vector 
with promoter and RBS from tat 
operon 
Amp (Jack, et al., 2004) 
pSUPROM Low copy expression vector with 
promoter and RBS from tat 
operon 
Kan  
pUNI-Tte-Hyd Synthetic Tte hydC-A cloned 
BamHI – HindIII into pUNIPROM 
Amp This work 
pUNI-Tte-HydhisC As pUNI-Tte-Hyd but encodes a 6 
x His tag on HydC 
Amp This work 
pUNI-Tte-HydhisC 
∆hydD 
As pUNI-Tte-HydhisC but ∆hydD Amp This work 
pUNI-Tte-HydhisC 
∆Tte0891 
As pUNI-Tte-HydhisC but ∆Tte0891 Amp This work 
pSU-Sh-EFG Sh. oneidensis hydGXEF operon 
cloned BamHI – HindIII into 
pSUPROM 
Kan This work 
pSU-Tte-EFG Synthetic operon encoding Ca. 
tengcongensis hydEFG homologs 
cloned BamHI – SalI into 
pSUPROM  
Kan This work 
pACYCDuet1 Medium copy expression vector 
with two separate MCS, T7lac 
promoters and T7 terminators 
Cml Novagen 
pAC-Tte-EFG Synthetic operon encoding Ca. 
tengcongensis hydEFG homologs 
cloned BamHI – SalI into 
pACYCDuet-1 
Cml This work 
pAC-Duet-Sh-GX-EF Sh. oneidensis hydGX (EcoRI - 
HindIII) and hydEF (BglII - AatII) 
cloned in two MCS of pACYCDuet-
1 
Cml This work 
pAC-Duet-Sh-GX Sh. oneidensis hydGX cloned EcoRI 
- HindIII into the first MCS of 
pACYCDuet-1 
Cml This work 
pSU23 Medium copy expression vector Cml (Bartolome, et al., 
1991) 
pUNI-Tte-EFG Synthetic operon encoding Ca. 
tengcongensis hydEFG homologs 
cloned BamHI – SalI into 
Amp This work 
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pUNIPROM 
pUNI-Sh-EFG Sh. oneidensis hydGXEF operon 
cloned BamHI – HindIII into 
pUNIPROM 
Amp This work 
pSU23-Sh-GX-EF Two MCS of pAC-Duet-Sh-GX-EF 
cloned EcoRI – KpnI into pSU23 
Cml This work 
pSUtat-Sh-GX-EF As pSU23-Sh-GX-EF but with tat 
promoter upstream of first MCS 
Cml  
pSU23-Sh-GXEF-TM As pSU23-Sh-GX-EF but with Th. 
maritima hydF homolog TM0445 
cloned in downstream of hydEF 
Cml This work 
pSUtat-Sh-GXEF-TM pSU23-Sh-GX-EF-TM but with tat 
promoter upstream of first MCS 
Cml This work 
pCP20 Temps vector containing FLP 
recombinase 
Amp / 
Cml 
(Datsenko and 
Wanner, 2000) 
pUNI-Tm-Fd6 Th. maritima TM0927 ferredoxin 
gene cloned BamHI – SalI into 
pUNIPROM so it encodes a N-
terminal His tag 
Amp This work 
pUNI-Tm-Fd8 Th. maritima TM0927 ferredoxin 
gene cloned BamHI – SalI into 
pUNIPROM so it encodes a C-
terminal His tag 
Amp This work 
pUNI-Tm-PORhis Th. maritima PFOR operon 
(TM0015-0018) cloned XbaI – 
HindIII into pUNIPROM 
Amp This work 
pUNI-Tm-Fd-PORhis Th. maritima Fd gene (TM0927; 
XbaI - HindIII) and PFOR operon 
(TM0015-0018; BamHI - XbaI) 
cloned into pUNIPROM 
Amp This work 
pKS II + pBluescript, high copy expression 
vector 
Amp Stratagene 
pMAK705 low copy temperature sensitive 
plasmid 
Cml (Hamilton, et al., 
1989) 
pKSmetJ 500 bp up and downstream 
sequence of metJ cloned KpnI – 
HindIII into pKS II+ 
Amp This work 
pMAKmetJ 500 bp up and downstream 
sequence of metJ cloned KpnI – 
HindIII into pMAK705 
Cml This work 
pKSiscR 500 bp up and downstream 
sequence of iscR cloned KpnI – 
HindIII into pKS II+ 
Amp This work 
pBAD33 medium copy expression vector 
with Para 
Kan <WHO MAKES 
THIS?> 
pBAD33-PR Proteorhodopsin gene cloned SalI Cml This work 
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- HindIII into pBAD33 expression 
vector 
pSU-PR Proteorhodopsin gene cloned SalI 
- HindIII into pSUPROM 
Kan This work 
pGP1-2 Temps plasmid that expresses T7 
polymerase when induced at 42 
°C 
Kan (Tabor and 
Richardson, 1985) 
pUNI-Tte-
Hyd(adhEprom) 
As pUNI-Tte-Hyd but with adhE 
promoter instead of tat promoter 
Amp This work 
pUNI-Tte-
Hyd(fadhprom) 
As pUNI-Tte-Hyd but with fadh 
promoter instead of tat promoter 
Amp This work 
pUNI-Tte-
Hyd(fadhprom)hisC 
As pUNI-Tte-HydhisC but with fadh 
promoter instead of tat promoter 
Amp This work 
pUNI-Tte-
Hyd(hyaAprom) 
As pUNI-Tte-Hyd but with hyaA 
promoter instead of tat promoter 
Amp This work 
pUNI-Tte-
Hyd(hyaAprom)hisC 
As pUNI-Tte-HydhisC but with hyaA 
promoter instead of tat promoter 
Amp This work 
pUNI-Tte-
Hyd(hybOprom) 
As pUNI-Tte-Hyd but with hybO 
promoter instead of tat promoter 
Amp This work 
pUNI-Tte-
Hyd(hybOprom)hisC 
As pUNI-Tte-HydhisC but with hybO 
promoter instead of tat promoter 
Amp This work 
pAH2 Plasmid encoding phsABC from 
Salmonella 
Amp (Stoffels, et al., 
2012) 
pUNI-OSPhs Fusion gene of highly-truncated 
hybO and phsB with HA-tag linker 
peptide and phsC cloned BamHI - 
HindIII into pUNIPROM 
Amp This work 
pUNI-OLPhs Fusion gene of a less-truncated 
hybO and phsB with HA-tag linker 
peptide and phsC cloned into 
pUNIPROM 
Amp This work 
pUNI-OSSalIPhs As pUNI-OSPhs but HA-tag linker 
replaced with two amino acid 
linker 
Amp This work 
pUNI-OSFLexAPhs As pUNI-OSPhs but HA-tag linker 
replaced with a flexible peptide 
linker 
Amp This work 
pUNI-OSFlexDPhs As pUNI-OSPhs but HA-tag linker 
replaced with flexible peptide 
linker 
Amp This work 
pUNI-OS-6aaFlexAPhs As pUNI-OSPhs but HA-tag linker 
replaced with flexible peptide 
linker and a further truncation to 
hybO 
Amp This work 
pUNI-OSmutPhs As pUNI-OSPhs but mutations to 
backbone of vector 
Amp This work 
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Table 7.6 Table of plasmids used in this study 
 
 Plasmid DNA preparation 7.5.2
Plasmids were extracted from cell pellets of 5 ml overnight aerobic cultures of E. coli strains 
transformed with the plasmid of interest using the QIAprep® Spin Miniprep Kit (Qiagen), which  
is based on the alkaline lysis method of extracting plasmid DNA developed by Birnboim and 
Doly (Birnboim and Doly, 1979). Plasmid DNA was then eluted in the elution buffer supplied.  
Plasmids used in this study are listed in Table 7.6. DNA was quantified spectrophotometrically 
using a NanoDrop ND-1000 system (Thermo Scientific) and by recording the absorbance peak 
of nucleic acid at 260 nm. 
 Polymerase Chain Reaction (PCR) 7.5.3
DNA fragments were amplified using the polymerase chain reaction (PCR). Standard reaction 
mixtures used are shown in Table 7.7. GoTaq DNA polymerase (BioRad) was typically used for 
diagnostic PCRs using genomic DNA from bacterial colonies as the template (one colony in 60 
μl Milli-Q water; 3 μl used). Herculase II (Agilent Technologies) was used for high fidelity PCR 
and to amplify DNA fragments used for cloning, and approximately 200 ng of plasmid or 
genomic DNA was used as the template. Standard reaction cycling conditions are detailed in 
Table 7.8. Annealing temperature varied depending on the melting temperature of the primers 
used (50 – 60 °C) and 30 cycles were typically performed. 
 
Component Volume 
10 x buffer (Herc)/5 x buffer (GoTaq) 5 µl (Herc)/10 µl (GoTaq) 
Forward primer (10 µM) 1.5 µl 
Reverse primer (10 µM) 1.5 µl 
dNTPs (20 µM) 1.0 µl 
Polymerase 1.0 µl (Herc)/0.5 µl (GoTaq) 
DNA template 1.0 µl 
ddH2O 39.0 µl (Herc)/34.5 µl (GoTaq) 
Total 50 µl 
Table 7.7 PCR reaction mixtures 
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Step Temperature Time 
Initial denaturation 95 °C 5 m 
Denaturation 95 °C 30 s 
Annealing 50 – 60 °C 30 s 
Elongation 72 °C 1 m/kb 
Final elongation 72 °C 5 m 
       Table 7.8 PCR reaction cycling conditions 
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 Table of Primers 7.5.4
Name Sequence 5’ to 3’ Details 
hyaAPROMfor GCGCGAATTCGATGCGGCGTGTAAACC Used to amplify promoter sequence of hyaA to 
clone in front of Tte Hyd operon 
hyaAPROMrev GCGCGGATCCCTCCTTGCGACACCGGCAGG Used to amplify promoter sequence of hyaA to 
clone in front of Tte Hyd operon 
hybOPROMfor GCGCGAATTCAATTCTGTGCCGATTATAAACG Used to amplify promoter sequence of hybO to 
clone in front of Tte Hyd operon 
hybOPROMrev GCGCGGATCCTTGCGAAGACCTGGCATATATTTTGC Used to amplify promoter sequence of hybO to 
clone in front of Tte Hyd operon 
adhEPROMfor GCGCGAATTCGGTTAGCTCCGAAGCAAAAG Used to amplify promoter sequence of adhE to 
clone in front of Tte Hyd operon 
adhEPROMrev GCGCGGATCCAATGTTAAACTTTTTTAGTAAATCATCTGC Used to amplify promoter sequence of adhE to 
clone in front of Tte Hyd operon 
fadhPROMfor GCGCGAATTCCAAGGCGCACCAAATTTCTCCTGG Used to amplify promoter sequence of fadh to 
clone in front of Tte Hyd operon 
fadhPROMrev GCGCGGATCCTGTAAAATAATTGTTATGTGGTCG Used to amplify promoter sequence of fadh to 
clone in front of Tte Hyd operon 
EcoRIT5PROMfor GCGCGAATTCAAATCATAAAAAATTTATTTGCTTTGTGAGC Used to amplify promoter sequence of T5 to clone 
in front of Tte Hyd operon 
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EcoRIT5promrev GCGCGAATTCTTTCTCCTCTTTAATGTATTCTGTGTGAAATTGTTATC Used to amplify promoter sequence of T5 to clone 
in front of Tte Hyd operon 
NdeIT5promfor GCGCCATATGAAATCATAAAAAATTTATTTGCTTTGTGAGC Used to amplify promoter sequence of T5 to clone 
in front of Tte Hyd operon 
NdeIT5promrev GCGCAGATCTTTTCTCCTCTTTAATGTATTCTGTGTGAAATTGTTATC Used to amplify promoter sequence of T5 to clone 
in front of Tte Hyd operon 
TtehydCNTermHisfor GCGCACTAGTAGGAGGAAAAAAAAATGCACCATCACCATCACCATCAAGGTATGAAAGAG
GCG 
Used to introduce a C-terminal 6xHis epitope tag 
onto HydC of synthetic Tte Hyd operon 
TtehydCNTermHisrev GCGCACTAGTTTATTCGAACTTTTTCAGGATTTCG Used to introduce a C-terminal 6xHis epitope tag 
onto HydC of synthetic Tte Hyd operon 
TtehydANTermHisfor GCGCCTCGAGTCAATGGTGATGGTGATGGTGTTTTACCAGCGGGTACAGTTCTTTACG Used to introduce a C-terminal 6xHis epitope tag 
onto HydA of synthetic Tte Hyd operon 
TtehydANTermHisrev GCGCCTCGAGAGGAGGAAAAAAAAATGGACAAAGTCCG Used to introduce a C-terminal 6xHis epitope tag 
onto HydA of synthetic Tte Hyd operon 
SSMAfor 
 
CTATAAGAAGTAAGCATACATCGAGAGGAGG Quikchange™ primers used to change the first two 
bases of four that was needed to be changed 
SSMArev CCTCCTCTCGATGTATGCTTACTTCTTATAG Quikchange™ primers used to change the first two 
bases of four that was needed to be changed 
SSMBfor CTATAAGAAGTAAGCATAGATCTAGAGGAGG Quikchange™ primers used to change the second 
two bases of four that was needed to be changed 
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SSMBrev CCTCCTCTAGATCTATGCTTACTTCTTATAG Quikchange™ primers used to change the second 
two bases of four that was needed to be changed 
pBAD33PRfor GCGCGTCGACAGGAGGAAAAAAAAATGGGTAAATTATTACTGATATTAGGTAGTG Used to amplify proteorhodopsin gene from an 
pBAD21-PR to clone into pBAD33 and pSUPROM 
pBAD33PRrev GCGCAAGCTTTCATCCGCCAAAACAGCCAAGCTGGAG Used to amplify proteorhodopsin gene from an 
pBAD21-PR to clone into pBAD33 and pSUPROM 
SalIonlylinkrev GTCGACGGCAAGCTGATGGATGCCTTTATGGAAGC Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with just two 
amino acids 
SalIonlylinkfor GTCGACAATCATTTAACGAATCAGTACGTCATGC Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with two amino 
acids 
FlexASacIfor GAGCTCGGTGGTGGTGGTTCTAATCATTTAACGAATCAGTACG Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with a flexible 
linker 
FlexASacIrev GAGCTCAATCATTTAACGAATCAGTACGTCATGC Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with a flexible 
linker 
FlexDSacIfor GAGCTCGGTGGTGGTGGTGGTGGTGGTGGTAATCATTTAACGAATCAGTACG Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with a different 
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flexible linker 
FlexDSacIrev GAGCTCAATCATTTAACGAATCAGTACGTCATGC Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with a different 
flexible linker 
6shortaaFlexfor TCTAGATACCCATACGATGTTCCAGATTACGCTAATCATTTAACG Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with a flexible 
linker and a C-terminal truncation of HybO 
6shortaaFlexrev TCTAGAGATACCTTCTTCGTTACAGCCATAGCAAGG Used to exchange the HA-tag linker between 
HybO and PhsB of fusion enzyme with a flexible 
linker and a C-terminal truncation of HybO 
DRGXfor GCGCGAATTCAGGAGGAAAAAAAAATGAGCACACACGAGC Used to amplify the Sh. oneidensis hydGX genes to 
clone into pACYC-Duet 
DuetShGtoXrev CGCGAAGCTTTCATCTGTTAAACCC Used to amplify the Sh. oneidensis hydGX genes to 
clone into pACYC-Duet 
DREFfor GCGCAGATCTAGGAGGAAAAAAAAATGATCACTCGCCCTAGC Used to amplify the Sh. oneidensis hydEF genes to 
clone into pACYC-Duet 
newDuetShEtoFrev CGCGGACGTCCTATTGCTGAGGATTGCGG Used to amplify the Sh. oneidensis hydEF genes to 
clone into pACYC-Duet 
rmhydB1 ATGAGAGCTCGCATGCAGG Used to amplify the Tte hydB gene for the 
construction of a random mutant library 
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rmhydB2 TTTTCCTCCTCTAGATCTATGC Used to amplify the Tte hydB gene for the 
construction of a random mutant library 
rmhydA1 GAAGTAAGCATAGATCTAGAGGAGG Used to amplify the Tte hydA gene for the 
construction of a random mutant library 
rmhydA2 GCTGCAGGTCGACCTCGAG Used to amplify the Tte hydA gene for the 
construction of a random mutant library 
iscRupfor GCGCGGTACCCCGTTACGCTGCGGTGCCAGGTAGG Used to amplify 500 bp sequence upstream of iscR 
to clone into pKS II + 
iscRuprev GCGCGTCGACTAAAAAGAATTCAGAATCAGGC Used to amplify 500 bp sequence upstream of iscR 
to clone into pKS II + 
iscRdownfor GCGCGTCGACGTCTTACTTCACCTCAAACTCGC Used to amplify 500 bp sequence downstream of 
iscR to clone into pKS II + 
iscRdownrev GCGCGCGCAAGCTTGGATTCTGGCTTCTATTGAGCAGC Used to amplify 500 bp sequence downstream of 
iscR to clone into pKS II + 
metJupfor GCGCGGTACCGTTTGCGCCAGTTTTTGC Used to amplify 500 bp sequence upstream of 
metJ to clone into pKS II + 
metJuprev GCGCGTCGACAGCAAAAAAGAGCGG Used to amplify 500 bp sequence upstream of 
metJ to clone into pKS II + 
metJdownfor GCGCGTCGACGAGATACTTAATCCTCTTCG Used to amplify 500 bp sequence downstream of 
metJ to clone into pKS II + 
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metJdownrev GCGCAAGCTTGTATTAGTAAGTACTGCACC Used to amplify 500 bp sequence downstream of 
metJ to clone into pKS II + 
Tma0927for1 GCGCGGATCCAGGAGGAAAAAAAAATGAAGGTAAGAGTTGACGC Used to amplify Th. maritima ferredoxin gene 
TM0927 to clone into pUNIPROM 
Tma0927rev1 GCGCGTCGACTCACTCTTCTACGCTGATAGC Used to amplify Th. maritima ferredoxin gene 
TM0927 to clone into pUNIPROM 
Tma0927Hisfor2 GCGCGGATCCAGGAGGAAAAAAAAATGCACCATCACCATCACCATAAGGTAAGAGTTGAC
GC 
Used to amplify Th. maritima ferredoxin gene 
TM0927 to clone into pUNIPROM so it will encode 
an N-terminal 6xHis tag 
Tma0927Hisrev2 GCGCGTCGACTCAATGGTGATGGTGATGGTGCTCTTCTACGCTGATAGC Used to amplify Th. maritima ferredoxin gene 
TM0927 to clone into pUNIPROM so it will encode 
a C-terminal 6xHis tag 
POR1for 
 
GCGCTCTAGAAGGAGGAAAAAAAAATGCCCGTTGCGAAGAAATACTTTGAAATACG Used to amplify Th. maritima PFOR operon clone 
into pUNIPROM 
POR1forHis GCGCTCTAGAAGGAGGAAAAAAAAATGCACCATCACCATCACCATCCCGTTGCGAAGAAAT
ACTTTGAAATACG 
Used to amplify Th. maritima PFOR operon to 
clone into pUNIPROM so it will encode an N-
terminal 6xHis tag 
POR1rev GCGCAAGCTTTTATCTAATCGGTTTGTCCTTTGTAACC Used to amplify Th. maritima PFOR operon to 
clone into pUNIPROM 
POR1revHis GCGCAAGCTTTTAATGGTGATGGTGATGGTGTCTAATCGGTTTGTCCTTTGTAACC Used to amplify Th. maritima PFOR operon to 
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clone into pUNIPROM so it will encode a C-
terminal 6xHis tag 
adhEdelcheckfor GGCCACAGACAGGTTGGCTGTAAGG Used to check for successful deletion of adhE 
allele 
adhEdelcheckrev CGATATCAGCCGCTTTGTTGGTGGC Used to check for successful deletion of adhE 
allele 
Table 7.9 of primers used in this study
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 Quikchange™ (site-directed mutagenesis) PCR 7.5.5
Site-directed mutagenesis of pUNI-Tte-Hyd was carried out to change the upstream restriction 
site of the hydA gene on the synthetic Tte hydrogenase operon. This restriction site was 
changed from XhoI to XbaI, in two steps, using the Quikchange® protocol (Agilent) and the 
following primers: SSMAfor and SSMArev; SSMBfor and SSMBrev. 
 Random Mutagenesis through hyper-mutagenic PCR 7.5.6
Hyper-mutagenic PCR was used to construct two libraries of the 1758 bp hydA gene, one with 
an error rate of 2.8 % per clone (low) and the other with an error rate of 4.5 % per clone (high). 
The method used is based on the use of biased dNTPs (Vartanian, et al., 1996b). The primers 
used were rmhydA1 and rmhydA2. The elongation step of each PCR cycle was lengthened to 
10 m and MnCl2 added to the reaction mix, to allow full amplification of mismatch-containing 
PCR fragments (). Each library consisted of plasmid DNA prepared from 1.2 x 106 and 1.5 x 106 
colonies respectively, a 682 and 853 times coverage of the hydA gene. Thus, each base in the 
hydA gene could theoretically be mutated 38 times per mutant library. 
Component Volume 
5 x buffer (GoTaq) 20 µl 
MgCl2 (25 mM) 10 µl 
MnCL2 (5 mM) 10 µl 
Forward primer (10 µM) 1.5 µl 
Reverse primer (10 µM) 1.5 µl 
dTTP (100 mM) 1.0 µl 
dGTP (100 mM) 1.0 µl 
dATP (10 mM) 0.75 µl (low)/0.6 µl (high) 
dCTP (10 mM) 0.75 µl (low)/0.6 µl (high) 
GoTaq polymerase 1.0 µl 
DNA template 1.0 µl 
ddH2O 51.5 µl (low)/ 51.8 µl (high) 
Total 100 µl 
Table 7.10 Random mutagenesis PCR reaction mixtures 
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 Chimeric protein linker-exchange PCR 7.5.7
Amplification of the entire chimeric metalloenzyme-containing plasmid was performed in 
order to change the peptide linkers between HybO and PhsB. The cloning strategy employed is 
detailed in Figure 7.1. This allowed the rapid exchange of a number of different peptide linkers 
of different lengths. Normal PCR cycling conditions and reaction mixtures were used. 
  
Figure 7.1 Fusion protein linker-exchange PCR schematic 
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 Competent cell preparation and transformation of with plasmid DNA 7.5.8
Standard transformations were carried out using chemically-competent cells prepared using 
the TSB method (DMSO) as described (Chung and Miller, 1988). XL10-Gold competent cells 
(Stratagene) were used in the construction of the hydA mutant libraries due to their extremely 
high transformation efficiency, as per manufacturer’s instructions. Electrocompetent cells 
were prepared as described previously (Sambrook, et al., 1989) and used in the screening of 
the hydA mutant libraries. 200 ml of LB media was inoculated 1 in 100 with aerobic RaisynA1 
cultures and grown aerobically with agitation at 37 ˚C to an optical density (OD600) of 0.6 – 0.8. 
Cell cultures were then cooled rapidly at 0 ˚C for 15 min, before pelleting at 3,000 g for 20 min. 
Cell pellets were washed twice in ice-cold MilliQ water before a final wash in 75 ml 10% ice-
cold glycerol. Cell pellets were then resuspended by vortexing in 400 µl 10% ice-cold glycerol. 
Aliquots of 40 µl were used immediately in transformations, to which approximately 200 ng of 
plasmid DNA was added. After 10 – 30 min incubation, the cells were transferred to an ice-cold 
2 mm electroporation cuvette (Molecular BioProducts) and an electrical pulse applied (2.5 kV 
voltage, 25 μF capacitance, 200 Ω resistance, 2 mm cuvette length) using a GenePulser Xcell® 
electroporator (BioRad). 1 ml of LB medium at room temperature was added to the 
electroporation cuvette and the cells mixed by gentle pipetting. Cells were then transferred to 
an Eppendorf tube and incubated at 37 ˚C for 1 h. 100 µl of the cells was spread onto 
appropriate selective media (M9 minimal agar media) supplemented with the required 
antibiotics and grown anaerobically at 37 ˚C. 
 Design of synthetic operon 7.5.9
A BLAST search of the Thermoanaerobacter tengcongensis was performed to obtain the amino 
acid sequences of the gene products encoded by the hydrogenase operons. These sequences 
were reverse-translated using OPTIMIZER, which optimises genes for E. coli codon usage 
(Puigbo, et al., 2007). An optimised RBS and linker sequence was inserted upstream of each 
gene and suitable restriction sites were then inserted before and after every gene. This 
synthetic gene was then synthesised as a service by Biomatik Corporation, Ontario, Canada 
and cloned into suitable vectors. 
 Digestion of DNA by restriction endonucleases for cloning 7.5.10
Digestion of DNA using restriction endonucleases was carried out in the manufacturer supplied 
buffer. Where two enzymes were used, an appropriate buffer was selected to permit efficient 
activity of both enzymes. If this was not possible then two separate digestions were. A typical 
restriction digestion used 1 μl of each enzyme, buffer diluted to 1x concentration, 
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approximately 1 µg DNA, and water up to 40 μl final volume. Digestions were carried out at 37 
˚C for 3 h or overnight for certain PCR products. Digested PCR products for cloning were 
purified by QIAquick® PCR Purification (Qiagen) according to kit instructions to remove 
restriction endonucleases. Digested vectors for cloning were purified using the QIAquick® gel-
extraction kit (Qiagen). In this case, the digestion product was separated agarose gel 
electrophoresis and the cut band of the correct size excised from the gel and purified 
according to kit instructions. Following purification by gel-extraction the cut vector was treated 
with alkaline phosphatase (Roche). This enzyme removes phosphate groups from the 5’ end of 
DNA molecules, preventing re-ligation of the cut vector without the addition of insert. 1 μl of 
alkaline phosphatase was added to the cut vector and incubated at 37 ˚C for 30 min before 
addition of another 1 μl of alkaline phosphatase for a further 30 min. The cut vector was then 
finally purified using PCR clean-up or by heat inactivation at 75 ˚C for 2 min. 
 DNA ligation 7.5.11
Digested DNA fragments were quantified using a Nanodrop® spectrophotometer (Labtech). 
Vector and insert were typically mixed in a 10 ng:30 ng ratio and incubated in 1x ligation buffer 
and 1 unit of T4 DNA ligase (Roche) in a final volume of 10 μl and incubated at 16 ˚C overnight. 
Following ligation, the entire 10 μl ligation mixture was used for transformations of E. coli 
strain DH5α. For troublesome ligations (e.g. random mutant library construction), molar ratios 
of 1:1, 1:3 and 1:5 were used with much higher starting amounts of DNA (e.g. 50 ng of vector). 
 Agarose gel electrophoresis 7.5.12
Agarose gel electrophoresis was used both for diagnostic and to separate DNA fragments for 
cloning. DNA fragments were typically separated 1% (w/v) agarose gels prepared in 1 x TAE 
and containing a 1:10,000 dilution of GelRed® (Biotium). DNA samples were mixed with 10 x 
DNA loading dye before electrophoresis. A DNA standard (1 kb ladder, Roche) was loaded 
adjacent to the DNA samples to allow for estimation of fragment size. Electrophoresis and 
fragment separation was then performed at 100 V for 20-45 min. DNA fragments were 
visualised by exposure to UV light using a Gel Doc XR+ system (BioRad). For use in further 
applications, DNA was extracted from agarose gels using the QIAquick® Gel Extraction Kit 
(Qiagen) as described in Section 7.5.10. 
 Random Mutagenesis using XL1-Red competent cells 7.5.13
XL1-Red mutator cells were transformed with the plasmids to be mutated as per the 
manufacturer’s instructions. The transformation mixture were plated onto LB agar plates 
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containing the appropriate antibiotic and the plates incubated at 37 °C for 24 – 30 h. 1 ml of LB 
medium was added to the plate, swirled for 30 s and then all colonies were scraped off into a 
15 ml Falcon tube. LB medium containing the appropriate antibiotics was added to a final 
volume of 10 ml and this tube was incubated aerobically with shaking overnight at 37 °C. 
Mutated plasmid DNA was isolated using the QIAprep® Spin Miniprep Kit (Qiagen) and eluted 
into 100 ul dH2O to give the mutant library for screening. 
 Chemical mutagenesis using Captan and MMS 7.5.14
5 ml of LB media was inoculated 1 in 1000 with E. coli strains to be mutated and these were 
grown aerobically overnight. These overnight cultures were then used to inoculate 5 ml 
aerobic cultures of LB media, which were grown to OD600 of approximately 0.6 – 0.8. 0.1 ml of 
bacterial culture was added to 10 µl, 50 µl, 75 µl, 100 µl of mutagen (Captan/MMS) and 0.5 ml 
of 100 mM sodium phosphate buffer (pH 7.4) was added. This reaction was allowed to proceed 
at 37 °C for 20 min, 40 min and 1 h with gentle shaking (100 rpm), before the cells were 
pelleted by centrifugation at 13,000 rpm for 2 min, washed twice with buffer and resuspended 
in LB medium, before being plated out onto selective media (M9 minimal agar media) 
supplemented with the required antibiotics and grown anaerobically at 37 ˚C. 
 pMAK705 homologous recombination protocol for chromosomal gene deletions and 7.5.15
insertions 
The pMAK705 allelic exchange protocol was used to generate gene replacements and 
deletions of various E. coli strains as described (Hamilton, et al., 1989). DNA sequence (500 bp 
upstream and downstream) surrounding the chromosomal target to be replaced/deleted was 
amplified and cloned into the suicide vector pMAK705. The resulting plasmid was then 
transformed into the target strain and an overnight culture grown in LB media supplemented 
with chloramphenicol (Cml), at 30 °C. Serial dilutions (10-3, 10-4 and 10-5) were then spread 
onto the LB agar media supplemented with Cml and incubated at 44 °C overnight. As pMAK705 
is temperature sensitive and only replicates at 30 °C, any CmlR colonies must be the result of 
cointegrate formation. A control was also included where cells were diluted at 1 x10-7 and 
incubated at 30 °C. Next, five cultures, each containing five colonies were incubated in the 
relevant antibiotic containing LB medium at 30 °C for 24 h to allow plasmid replication within 
the cell. Two more cycles of this growth was carried out by transferring a loopful of culture 
into fresh antibiotic containing medium. A loopful of each culture was then streaked onto the 
relevant LB media containing Cml and incubated at 30 °C overnight. The final step involved 
curing plasmid from the strain. Twelve cultures containing single colonies were grown in the 
relevant LB media, without any added antibiotic at 44 °C for at least 16 h. A loopful from each 
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culture was then streaked onto the relevant LB agar medium (without antibiotic) and 
incubated at 44 °C overnight. Single colonies were then patched onto LB agar and LB agar 
medium containing Cml and then incubated at 30 °C overnight. CmlS colonies were tested for 
successful integration or deletion by PCR using primers with homology to DNA sequence 
upstream and downstream of the selected region. PCR products were then analysed following 
agarose gel electrophoresis and DNA sequencing. 
 Construction of individual gene knockout strains: P1 transduction 7.5.16
P1 transduction was performed as described previously (Thomason, et al., 2007) using a P1 
lysate prepared from aerobic cultures of various E. coli Keio collection strains (e.g. JW1228 
[ΔadhE]). The remaining KanR cassette was removed using the plasmid pCP-20 and FLP 
recombination as described (Datsenko and Wanner, 2000). Confirmation of deletion was done 
by PCR amplification of the chromosomal region using flanking and internal primers. gDNA 
prepared from wild-type E. coli strains was used as a negative control. 
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 Protein Methods 7.6
 SDS-PAGE 7.6.1
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was employed to separate proteins under 
denaturing conditions according to their molecular weight (Laemmli, 1970) using the Bio-Rad 
Mini-PROTEAN II System.  The resolving gel (12-14% typically) was prepared as indicated in 
Table 7.11 and was poured between two glass plates, leaving enough room for comb insertion.  
Water was then poured on top of the resolving gel, which was left to polymerise.  Following 
polymerisation, the water was removed and the stacking gel added.  This was prepared as 
detailed in Table 7.11.  A comb was immediately inserted into the stacking gel to create sample 
wells. 
Table 7.11 The constituents of the resolving and stacking gels used in SDS-PAGE. 
 
 35S-Met Radiolabelling 7.6.2
E. coli strain K38/pGP1-2 (pGP1-2 is a temperature sensitive plasmid that encodes T7 
polymerase when heat activated) (Tabor and Richardson, 1985) was transformed with 
plasmids containing the gene(s) to be analysed. These plasmids must have a T7 promoter 
upstream of the gene(s) of interest. Successful transformants were used to inoculate aerobic 5 
ml LB media cultures, which were incubated for approximately 16 h, with shaking, at 30 °C. 
These cultures were then subcultured into minimal M9 media containing all amino acids added 
except Met and Cys. This was incubated for one hour at 30 °C and then transcription of T7 RNA 
polymerase was initiated by heatshocking at 42 °C. Rifampicin was then added to the culture 
to inhibit native RNA polymerase transcription and 0.01 μCi of 35S-Met was added to a 1 ml 
aliquot of cells. Following 15 min incubation, the samples were boiled in Laemmli buffer to lyse 
the cells and denature the protein. The protein samples were then separated by SDS-PAGE and 
visualised by autoradiography using an SRX-101A medical film processor (Konica Minolta).  
Resolving Gel constituents Concentration/% Stacking Gel constituents Concentration/% 
Acrylamide/bisacrylamide 
(37:5:1) 
12-14% Acrylamide/bisacrylamide 
(37:5:1) 
6% 
Tris.HCl pH 8.8 0.375 M Tris.HCl pH 6.8 0.125 M 
SDS 0.1% (w/v) SDS 0.1% (w/v) 
APS 0.1% (w/v) APS 0.1% (w/v) 
TEMED 0.1% (v/v) TEMED 0.1% (v/v) 
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 Protein Purification 7.6.3
Aerobic cultures of E. coli strains expressing the His-affinity tagged protein were used to 
inoculate 5 L of LB supplemented with 0.4 % (w/v) glucose, 2 mM cysteine and 2 mM ferric 
ammonium citrate and antibiotics. The cultures were grown anaerobically overnight at 37 °C. 
Cells were harvested by centrifugation at 5009 x g for 20 min in a Beckman J6-MI centrifuge. 
All buffers used throughout purification had been bubbled with N2 for at least 1 h prior to 
resuspension to remove O2 and cell pellets, cell-containing buffers or crude extracts were 
flushed with argon to protect from O2. Cell pellets were resuspended in either 50 ml of B-PER® 
solution (Thermo Scientific) or 50 ml of 50 mM Tris HCl pH7.5, 1 mM DTT, 2 mM flavin 
mononucleotide, 150 mM NaCl and 25 mM imidazole. B-PER lysis was achieved by the addition 
of lysozyme and DNAse I followed by agitation at room temperature for 1 h. Lysis by sonication 
was achieved by the addition of lysozyme and DNAse I, followed by agitation and bubbling 
with N2 at 0 °C for 30 min followed by sonication. The following conditions were used to lyse 
the cells using a 102-C sonication horn (Branson) and Digital 450 Digital Sonifier (Branson): 20% 
amplitude; 5 s pulse on/off; and lysis duration of 20 min (40 min total). Following either 
method of lysis, unbroken cells were pelleted by centrifugation resulting in a crude cell extract. 
Nickel-affinity chromatography was used to isolate His-tagged proteins using an ÄKTA FPLC 
system (Amersham Biosciences). Crude extracts were applied to 5 ml HisTrap HP affinity 
columns (GE Healthcare) at a flow rate of 1 ml min-1, which had been previously equilibrated 
with anaerobic buffer A. Ten column volumes of Ni-purification buffer A were used to wash 
any unbound protein from the column. A linear gradient of 0-100% Ni-purification buffer B was 
then applied to the column to elute bound proteins over a time period of 30 min. Eluted 
protein was collected in 1 ml fraction tubes, flushed with argon and sealed with rubber 
stoppers to prevent O2 damage. Individual peak fractions could then be aliquoted under argon, 
flash frozen in liquid nitrogen and stored under argon at -80 °C in Pyrex® tubes. 
 Size-exclusion chromatography 7.6.4
Size exclusion chromatography was performed using a Superdex 200 10/300 GL gel filtration 
column (GE Healthcare) in order to further purify protein for crystallisation trials. The column 
was first equilibrated with 1.5 column volumes of SEC buffer. A small volume of concentrated 
protein (< 500 μl) was then applied to the column at a flow rate of 0.5 ml min-1 and eluted 
fractions collected in 5 ml fraction collection tubes. Samples were mixed with Laemmli sample 
buffer at a ratio of 2:1 and then analysed following SDS-PAGE. Fractions containing the desired 
protein were concentrated using Vivaspin 20, 50 kDa cut-off spin concentrators (Sartorius 
Stedim). 
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 SEC-MALLS 7.6.5
In collaboration with Colin Hammond of Prof. Tom Owen-Hughes group at the University of 
Dundee, purified hydrogenase was analysed using SEC-MALLS. This couples size-exclusion 
chromatography with multi-angle laser light scattering and refractive index detection. After 
resolution of the purified enzyme using a Dionex Ultimate 3000 HPLC system and a MAbPac 
SEC–1 (Dionex) column, an inline miniDAWN TREOS (Wyatt) multi-angle laser light scattering 
detector, fires a laser continuously at the eluent, which scatters the beam and then the 
detector measures the intensity of the scattered beam at different angles. And a T-rEX 
(Optilab) refractive-index detector determines accurate relative sample concentration. This 
allows information such as molecular mass, polydispersity and the radius of the complex to be 
accurately calculated using ASTRA v6.0.0.108 (Wyatt) software. SEC buffer was used to 
equilibrate and resolve protein complexes. 
 Semi-dry western immunoblotting 7.6.6
Samples for western immunoblotting were first separated by SDS-PAGE. The gel was soaked 
for 15 min in CTB buffer, which was then placed onto a nitrocellulose membrane that had also 
been soaked in CTB buffer, with both then in turn placed between two pieces of 3 MM filter 
paper also soaked in CTB buffer. Protein bands were transferred to the membrane using a 
semi-dry blotting system (BioRad), at 175 mA for 45 min. The membrane was then blocked in 1 
x TBS plus 1% milk powder overnight at 4 °C with shaking. The blocked membrane was then 
washed in ~100 ml 1xTBS-T for 10 min with shaking at room temperature. The membrane was 
incubated with an appropriate dilution of the primary antibody serum in 1x TBS-T for 1 h with 
shaking. Following antibody binding, the membrane was washed three times in ~100 ml 1x 
TBS-T to remove excess antibody. The membrane was then incubated with an appropriate 
dilution of the secondary antibody in 1x TBS-T for 1 h with shaking. The membrane was again 
washed three times in ~100 ml 1x TBS-T to remove excess antibody. Immunoreactive protein 
bands were detected using ECL Western Blotting Detection Reagents (Amersham). Kodak 
BioMax MR scientific imaging film (Sigma) was used to detect reacted bands and was 
developed with an SRX-101A medical film processor (Konica Minolta). 
 Protein concentration determination 7.6.7
Protein concentrations were determined using the DC Protein Assay (BioRad) using the 
manufacturer’s instructions and a microplate reader by recording absorbance at A750. A 
standard curve of bovine serum albumin (BSA) was prepared freshly each time and used as the 
reference protein standard. 
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 Rocket immunoelectrophoresis 7.6.8
Samples of periplasmic, cytoplasmic and membrane fractions were used directly for analysis by 
rocket immunoelectrophoresis. 1% (w/v) agarose gels containing rocket 
immunoelectrophoresis buffer and antisera specific to the protein being investigated were 
assembled on small glass plates and small wells introduced. Plates were then placed in an 
electrophoresis tank containing rocket immunoelectrophoresis buffer and 1-2 μl samples 
added to the wells. Two Whatman™ paper electrode wicks were then placed in the buffer, at 
both the cathode and the anode, ensuring contact with the gels. Samples were 
electrophoresed at 2 mA per plate for 16 h at 4 °C.  As the protein migrates through the gel, 
antibody begins to bind forming a precipitin, which eventually stalls electrophoresis of the 
complex.  Plates were then removed, blotted dry and placed in petri dishes where they were 
immersed in a 50 mM Tris HCl pH 7.5 buffer containing 600 mg benzyl viologen (BV) and 700 
mg tetrazolium red. BV acts as an artificial electron acceptor while tetrazolium red is an 
irreversible redox dye, which can accept electrons from BV and therefore precipitin arcs 
positive for hydrogenase activity can be stained red. Plates were then enclosed within an 
Equitron anaerobic jar and incubated under an H2 for 16 h. H2 oxidation was detected as red 
precipitin arcs. 
 UV-Vis spectroscopy of purified enzyme 7.6.9
Purified enzyme was diluted 1:1 with 100 mM sodium phosphate buffer pH 6.0 and analysed 
over wavelengths from 330 to 710 nm using a Lambda 35 UV/VIS spectrometer (Perkin Elmer). 
Buffer was used as a blank control and subtracted from protein spectra. 
 Oxidoreductase/Hydrogenase Activity Assays 7.7
 Large-scale gas production experiments during fermentations of various E. coli 7.7.1
strains 
10 ml of an aerobic overnight culture of the E. coli strain to be assessed was added to 3.6 l of 
CR-Hyd media pH 6.4 (plus additional nutrients and appropriate antibiotics), in a 5 l Minifors™ 
bioreactor. A weak vacuum was applied to degas the media and remove oxygen from the 
headspace of the fermenter. The culture was incubated at 37 ˚C with gentle stirring (200 rpm). 
The gas output pipe was connected to the gas flow meter and gas produced was measured 
over 16 h. 
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 Small-scale gas production experiments 7.7.2
Test-tubes containing an upturned Durham tube and 20 ml of CR-Hyd media pH 6.4 (with 
additional nutrients and appropriate antibiotics) were inoculated with 50 μl of an aerobic 
overnight culture of the E. coli strain to be assessed. These were sealed and incubated for 3 
days at 37 °C without agitation and then assessed for presence and size of gas bubble 
produced in the upturned Durham tube. 
 Hydrogen-dependent BV reduction assays 7.7.3
The oxidation of electron donors such as H2 or pyruvate can be enzymatically-coupled in vitro 
to the reduction of certain artificial electron acceptors, such as methyl viologen (MV) and 
benzyl viologen (BV). These redox dyes are colourless when oxidised and dark blue/violet 
when reduced. BV was used as electron acceptor for these assays as its standard reduction 
potential (E0’ -348 mV) is above that of the H+/½ H2 redox couple (E0’ -420 mV). For BV 
reduction, one activity unit (U) is defined as 1 µmol BV reduced min-1 mg-1 cells. Hydrogenase 
activity was therefore measured spectroscopically by monitoring the reduction of BV at A578. 
Quartz cuvettes were filled with 1.8 ml of an anaerobic H2-saturated buffer (50 mM Tricine pH 
8.0 or 50 mM Tris HCl pH 8.0) and 14 mM BV, which was titrated to A578 of approximately 0.4 - 
0.6. The reaction was initiated by the addition of whole cells (washed and resuspended in 
anaerobic buffer), crude cell lysates or purified enzyme and the initial velocity of the reaction 
measured using a millimolar extinction coefficient for BV at 578 nm of 8.65 cm-1 mM-1 and the 
following equation: 
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 MV-dependent hydrogen-production assays using Clark-type electrode 7.7.4
H2-production from purified enzyme or crude cell lysate can be artificially driven in vitro by 
using the electron donor methyl viologen (MV; E0’ -443 mV, which is lower than that of the 
H+/½ H2 redox couple (E0’ -420 mV) and a modified Clark-type electrode. The modified Clark-
type electrode consists of an electrode disc with a platinum chloride-plated anode and a silver 
chloride-plated cathode, which are connected via a potassium chloride electrolyte. The 
electrode is separated from the reaction chamber by a P.T.F.E. membrane. Current resulting 
from the oxidation of H2 at the anode surface is recorded and can be easily converted to µmol 
of H2 following calibration with known amounts of H2. For MV-dependent H2 production, one 
unit (U) is defined as 1 µmol H2 evolved min-1 mg-1 cells. 2 ml of anaerobic buffer (100 mM 
sodium phosphate pH 6.0 or 6.8) was added to the reaction chamber and allowed to 
equilibrate. 12.5 mM of MV is then added to the reaction chamber in addition to 650 µM 
sodium dithionite to fully reduce all MV in the chamber and again this is allowed to equilibrate. 
The reaction is initiated by the addition of enzyme or cell lysate and the reaction allowed to 
proceed to completion. 
 Hydrogen production/oxidation assays with Clark-type electrode 7.7.5
H2-production assays with physiological electron donors and acceptors were also performed 
using the Clark-type electrode as described in Section 7.7.4. 2 ml of 100 mM anaerobic buffer 
was added to the reaction chamber and after equilibration, whole cells, cell lysate or purified 
enzyme was added to the reaction chamber and allowed to equilibrate. Finally the reaction 
was initiated by the addition of an excess of substrate (e.g. glycerol, formate, NADH etc.). 
Alternatively, a small volume of H2-saturated buffer could be added to the reaction chamber 
and cells/enzyme added to the reaction chamber followed by the addition of an external 
electron donor such as nitrate, fumarate or NAD+, and the uptake/oxidation of H2 monitored. 
A modified set-up was used in the experiments where a proteorhodopsin was coexpressed in 
order to boost proton motive force (PMF) at the cytoplasmic membrane. The reaction 
chamber was maintained in complete darkness, while buffer and cell equilibration occurred. 
Light from a 100 W halogen bulb  and green light (λ: 550 nm) was used to illuminate the 
reaction chamber for 5/10 min to charge the PMF, before the substrates were added. 
 BV-linked pyruvate: ferredoxin oxidoreductase activity assay 7.7.6
BV was used as the artificial electron acceptor from the oxidation of pyruvate as catalysed by 
pyruvate:ferredoxin oxidoreductase. For BV reduction, one activity unit (U) is defined as 1 
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µmol BV reduced min-1 mg-1 cells. Quartz cuvettes were filled with 1.8 ml of an anaerobic H2-
saturated buffer (50 mM Tricine pH 8.0) and 14 mM BV. 5 mM pyruvate and 100 µM 
coenzymeA (required to accept acetyl group from pyruvate) was added to the cuvette and BV 
was titrated to A578 of approximately 0.4 - 0.6. The reaction was initiated by the addition of 
known amounts of purified enzyme. 
 H2-production assays to investigate a possible bifurcating mechanism 7.7.7
H2-production assays with purified hydrogenase, ferredoxin and pyruvate:ferredoxin 
oxidoreductase were carried out using the Clark-type electrode as described in Section 7.7.5. 5 
mM pyruvate, 100 µM coenzyme A and 20 mM NADH were added to 2 ml of anaerobic 100 
mM sodium phosphate pH 7.0 buffer in the reaction chamber and the reaction initiated by the 
addition of the purified protein. 
 Growth curve analysis 7.8
Test tubes filled with 16 ml L.B. + 0.4% (w/v) glucose or M9 + 0.4% (w/v) glucose were 
inoculated 1:1000 with aerobic cultures of the E. coli strains to be analysed and cultures grown 
anaerobically. The optical density (OD600) of these cultures was recorded at various time points 
over 38 h. It was decided not to convert OD600 to log10 values, to better highlight differences in 
final cell densities. 
 Cell Fractionation 7.9
Subcellular fractionation was performed on E. coli cultures, grown anaerobically 500 ml LB 
media supplemented with 0.5% glycerol and 0.4% fumarate anaerobic at 37 °C.  Cells were 
harvested at 2773 x g, washed in 50 mM Tris HCl pH 7.5 and resuspended in Tris-sucrose buffer 
at 10 ml g-1 wet weight.  EDTA and lysozyme were added to a final concentration of 5 mM and 
0.6 mg/ml respectively and the suspension incubated, without agitation, at 37 °C for 30 min. 
The suspension was centrifuged at 17,387 x g for 12 min in a Beckman Avanti J-26 XP 
centrifuge to pellet sphaeroplasts. The resultant supernatant is the periplasmic fraction. 
Sphaeroplasts were resuspended in 50 mM Tris HCl pH 7.5 at a volume of 10 ml g-1 of original 
wet weight and DNase I added.  Cell suspensions were lysed at 8,000 psi using a French® Press 
cell disruptor (Thermo Scientific) and the sample then centrifuged at 27,000 x g for 20 min to 
remove cell debris.  The supernatant was then centrifuged at 278,000 x g for 30 min in an 
OptimaTM TLX ultracentrifuge (Beckman) to pellet membranes.  The upper 200 μl of the 
supernatant was retained as the cytoplasmic fraction. Membrane pellets were resuspended in 
50 mM Tris HCl pH 7.5 and 250 mM NaCl and suspensions centrifuged again at 278,000 x g for 
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30 min.  For Western immunoblotting, pellets were resuspended in 50 mM Tris HCl pH 7.5 
following removal of the supernatant and then re-centrifuged. For rocket 
immunoelectrophoresis, membranes were solubilised in 50 mM Tris HCl pH 7.6 containing 
0.4% Triton X-100 (v/v), incubated on ice for 20 min and then centrifuged at 278,000 x g for a 
further 30 min. Supernatants containing membranes were added to an equal volume of 
Laemmli sample buffer and flash frozen in liquid nitrogen. 
 High-performance liquid chromatography (HPLC) analysis of organic acids 7.10
16 ml of LB media supplemented with 0.4 % (w/v) glucose was inoculated with various E. coli 
strains to be analysed and grown anaerobically for 72 h. Cells were harvested by centrifugation 
and the culture supernatant was passed through a 0.2 µm filter to remove any remaining cells 
or debris. The spent fermentation broth was analysed with using a Dionex Ultimate 3000 HPLC 
system and an Aminex HPX-87H organic-acid column, which was operated at 0.7 ml min-1 and 
55 °C (to reduce viscosity of complex media and improve resolution). Organic acids were 
detected by UV absorption at 210 nm, except for ethanol and glucose, which were detected 
using an Optilab T-rEX refractive index detector. A standard curve of organic acid standards 
was prepared for each experiment (R2: 99.90%) and used to identify and quantify 
concentrations of pyruvate, succinate, lactate, formate, fumarate, ethanol, glucose and 
acetate. Sample concentrations were normalised by cell pellet wet weight. The concentrations 
of compounds in virgin media (LB + 0.4% (w/v) glucose) were subtracted to reveal changes in 
each metabolite.  
 Metabolomics Sample Preparation 7.11
16 ml of LB media supplemented with 0.4 % (w/v) glucose was inoculated with various E. coli 
strains to be analysed and grown anaerobically for 72 h. Cells were harvested by centrifugation 
and the culture supernatant was passed through a 0.2 µm filter to remove any remaining cells 
or debris. The supernatant was mixed and then 5 μl of supernatant added to 200 ul of 
CHCl3:CH3OH:dH20 (ratio 1:3:1) and mixed vigorously at 4 oC for 1 h. Samples were then 
centrifuged for 3 min at 13,000 rpm at 4 oC and the supernatant flash-frozen in liquid nitrogen 
and stored at -80 oC before sending for LC-MS analysis at the Glasgow Polyomics Wolfson Wohl 
Cancer Research Centre at the University of Glasgow. 
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